<body style="font: 10pt Times New Roman, Times, Serif"> <document>  <type>   10-K   <sequence>    1    <filename>     f10k2020_optimizerx.htm     <description>      ANNUAL REPORT      <text>       <title>       </title>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <!-- Field: Rule-Page -->       <div style="margin-top: 0; margin-bottom: 0; width: 100%">        <div style="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">        </div>       </div>       <!-- Field: /Rule-Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        UNITED STATES       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        SECURITIES AND EXCHANGE COMMISSION       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        WASHINGTON, D.C. 20549       </p>       <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         FORM 10-K        </b>       </p>       <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        ☒ ANNUAL REPORT UNDER SECTION 13 OR15(d) OF THE SECURITIES EXCHANGE ACT OF 1934       </p>       <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        For the fiscal year ended        <b>         December 31,2020        </b>       </p>       <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        ☐ TRANSITION REPORT UNDER SECTION13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934       </p>       <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        For the transition period from _________to ________       </p>       <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        Commission file number:        <b>         001-38543        </b>       </p>       <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">        <tbody>         <tr style="vertical-align: top">          <td style="border-bottom: black 1.5pt solid; text-align: center; font-size: 10pt">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             OptimizeRx Corporation            </b>           </font>          </td>         </tr>         <tr style="vertical-align: top">          <td style="text-align: center; font-size: 10pt">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            (Exact name of registrant as specified in its charter)           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">        <tbody>         <tr style="vertical-align: top">          <td style="width: 49%; border-bottom: black 1.5pt solid; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Nevada            </b>           </font>          </td>          <td style="width: 2%; text-align: center">          </td>          <td style="width: 49%; border-bottom: black 1.5pt solid; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             26-1265381            </b>           </font>          </td>         </tr>         <tr style="vertical-align: top">          <td style="text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            (State or other jurisdiction of            <br/>            incorporation or organization)           </font>          </td>          <td style="text-align: center">          </td>          <td style="text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            (I.R.S. Employer            <br/>            Identification No.)           </font>          </td>         </tr>         <tr style="vertical-align: top">          <td style="text-align: center">          </td>          <td style="text-align: center">          </td>          <td style="text-align: center">          </td>         </tr>         <tr>          <td style="vertical-align: top; border-bottom: black 1.5pt solid">           <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">            <b>             400 Water Street, Ste. 200            </b>           </p>           <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">            <b>             Rochester, MI            </b>           </p>          </td>          <td style="vertical-align: top; text-align: center">          </td>          <td style="vertical-align: bottom; border-bottom: black 1.5pt solid; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             48307            </b>           </font>          </td>         </tr>         <tr style="vertical-align: top">          <td style="text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            (Address of principal executive offices)           </font>          </td>          <td style="text-align: center">          </td>          <td style="text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            (Zip Code)           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        Registrant’s telephone number:        <b>         248-651-6568        </b>       </p>       <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        Securities registered under Section 12(b)of the Exchange Act:       </p>       <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">        <tbody>         <tr style="vertical-align: top">          <td style="width: 49%; border-bottom: black 1.5pt solid; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Title of each class           </font>          </td>          <td style="width: 2%; text-align: center">          </td>          <td style="width: 49%; border-bottom: black 1.5pt solid; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Name of each exchange on which registered           </font>          </td>         </tr>         <tr style="vertical-align: top; background-color: white">          <td style="text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             <u>              Common Stock, par value $0.001             </u>            </b>           </font>          </td>          <td style="text-align: center">          </td>          <td style="text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             <u>              Nasdaq Capital Market             </u>            </b>           </font>          </td>         </tr>         <tr style="vertical-align: top; background-color: white">          <td colspan="3">           <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">           </p>           <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">            Securities registered under Section 12(g)        of the Exchange Act:           </p>           <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">           </p>          </td>         </tr>         <tr style="vertical-align: top; background-color: white">          <td colspan="3" style="text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Title of each class           </font>          </td>         </tr>         <tr style="vertical-align: top; background-color: white">          <td colspan="3" style="text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             <u>              Common Stock, par value of $0.001             </u>            </b>           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Indicate by check mark if the registrantis a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.        <b>         Yes ☒ No ☐        </b>       </p>       <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Indicate by check mark if the registrantis not required to file reports pursuant to Section 13 or Section 15(d) of the Act.        <b>         Yes ☐ No ☒        </b>       </p>       <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Indicate by checkmark whether the registrant(1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to suchfiling requirements for the past 90 days.        <b>         Yes ☒ No ☐        </b>       </p>       <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Indicate by check mark whether the registranthas submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submitsuch files).        <b>         Yes ☒ No ☐        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       </p>       <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        Indicate by check mark whether the registrant is a large acceleratedfiler, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitionsof “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerginggrowth company” in Rule 12b-2 of the Exchange Act.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">        <tbody>         <tr style="vertical-align: top">          <td style="width: 50%; text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             ☐ Large accelerated filer            </b>           </font>          </td>          <td style="width: 50%; text-align: justify">           ☐           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Accelerated filer            </b>           </font>          </td>         </tr>         <tr style="vertical-align: top">          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ☒            <b>             Non-accelerated    filer            </b>           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ☒            <b>             Smaller    reporting company            </b>           </font>          </td>         </tr>         <tr style="vertical-align: top">          <td style="text-align: justify">          </td>          <td style="text-align: justify">           ☐           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Emerging    growth company            </b>           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        If an emerging growth company, indicateby check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financialaccounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐       </p>       <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Indicate by check mark whether the registrantis a shell company (as defined in Rule 12b-2 of the Exchange Act).        <b>         Yes ☐ No ☒        </b>       </p>       <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        State the aggregate market value of thevoting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was lastsold, or the average bid and asked price of such common equity, as of the last business day of the registrant’s most recentlycompleted second fiscal quarter.        <b>         $185,090,055        </b>       </p>       <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Indicate the number of sharesoutstanding of each of the registrant’s classes of common stock, as of the latest practicable date. 16,806,637 commonshares as of March 3, 2021.       </p>       <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       </p>       <!-- Field: Rule-Page -->       <div style="margin-top: 0; margin-bottom: 0; width: 100%">        <div style="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">        </div>       </div>       <!-- Field: /Rule-Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       </p>       <!-- Field: Page; Sequence: 1 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="margin: 0pt">        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         <u>          TABLE OF CONTENTS         </u>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>        </b>       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">        <tbody>         <tr style="background-color: white">          <td style="vertical-align: top; width: 10%; text-align: justify">          </td>          <td style="vertical-align: top; width: 84%; text-align: justify">          </td>          <td style="vertical-align: bottom; width: 6%; border-bottom: black 1.5pt solid; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Page           </font>           <font style="font-size: 10pt">           </font>          </td>         </tr>         <tr style="background-color: white">          <td style="vertical-align: top; text-align: justify">          </td>          <td style="vertical-align: top; text-align: justify">          </td>          <td style="vertical-align: bottom; text-align: center">          </td>         </tr>         <tr style="vertical-align: top; background-color: white">          <td colspan="3" style="text-align: center">           <a href="#a_001">            <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">             PART I            </font>           </a>          </td>         </tr>         <tr style="vertical-align: top; background-color: white">          <td colspan="3" style="text-align: center">          </td>         </tr>         <tr style="background-color: white">          <td style="vertical-align: top; text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Item 1.           </font>          </td>          <td style="vertical-align: top; text-align: justify">           <a href="#a_002">            <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">             Business            </font>           </a>          </td>          <td style="vertical-align: bottom; text-align: center">           1          </td>         </tr>         <tr style="background-color: white">          <td style="vertical-align: top; text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Item 1A.           </font>          </td>          <td style="vertical-align: top; text-align: justify">           <a href="#a_003">            <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">             Risk Factors            </font>           </a>          </td>          <td style="vertical-align: bottom; text-align: center">           6          </td>         </tr>         <tr style="background-color: white">          <td style="vertical-align: top; text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Item 1B.           </font>          </td>          <td style="vertical-align: top; text-align: justify">           <a href="#a_004">            <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">             Unresolved Staff Comments            </font>           </a>          </td>          <td style="vertical-align: bottom; text-align: center">           14          </td>         </tr>         <tr style="background-color: white">          <td style="vertical-align: top; text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Item 2.           </font>          </td>          <td style="vertical-align: top; text-align: justify">           <a href="#a_005">            <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">             Properties            </font>           </a>          </td>          <td style="vertical-align: bottom; text-align: center">           14          </td>         </tr>         <tr style="background-color: white">          <td style="vertical-align: top; text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Item 3.           </font>          </td>          <td style="vertical-align: top; text-align: justify">           <a href="#a_006">            <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">             Legal Proceedings            </font>           </a>          </td>          <td style="vertical-align: bottom; text-align: center">           14          </td>         </tr>         <tr style="background-color: white">          <td style="vertical-align: top; text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Item 4.           </font>          </td>          <td style="vertical-align: top; text-align: justify">           <a href="#a_007">            <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">             Mine Safety Disclosures            </font>           </a>          </td>          <td style="vertical-align: bottom; text-align: center">           14          </td>         </tr>         <tr style="background-color: white">          <td style="vertical-align: top; text-align: justify">          </td>          <td style="vertical-align: top; text-align: justify">          </td>          <td style="vertical-align: bottom; text-align: center">          </td>         </tr>         <tr style="vertical-align: top; background-color: white">          <td colspan="3" style="text-align: center">           <a href="#a_008">            <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">             PART II            </font>           </a>          </td>         </tr>         <tr style="vertical-align: top; background-color: white">          <td colspan="3" style="text-align: center">          </td>         </tr>         <tr style="background-color: white">          <td style="vertical-align: top; text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Item 5.           </font>          </td>          <td style="vertical-align: top; text-align: justify">           <a href="#a_009">            <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">             Market for Registrant’s Common Equity and Related Stockholder Matters and Issuer Purchases of Equity Securities            </font>           </a>          </td>          <td style="vertical-align: bottom; text-align: center">           15          </td>         </tr>         <tr style="background-color: white">          <td style="vertical-align: top; text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Item 6.           </font>          </td>          <td style="vertical-align: top; text-align: justify">           <a href="#a_010">            <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">             Selected Financial Data            </font>           </a>          </td>          <td style="vertical-align: bottom; text-align: center">           17          </td>         </tr>         <tr style="background-color: white">          <td style="vertical-align: top; text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Item 7.           </font>          </td>          <td style="vertical-align: top; text-align: justify">           <a href="#a_011">            <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">             Management’s Discussion and Analysis of Financial Condition and Results of Operations            </font>           </a>          </td>          <td style="vertical-align: bottom; text-align: center">           17          </td>         </tr>         <tr style="background-color: white">          <td style="vertical-align: top; text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Item 8.           </font>          </td>          <td style="vertical-align: top; text-align: justify">           <a href="#a_012">            <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">             Financial Statements and Supplementary Data            </font>           </a>          </td>          <td style="vertical-align: bottom; text-align: center">           26          </td>         </tr>         <tr style="background-color: white">          <td style="vertical-align: top; text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Item 9.           </font>          </td>          <td style="vertical-align: top; text-align: justify">           <a href="#a_013">            <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">             Changes In and Disagreements With Accountants on Accounting and Financial Disclosure            </font>           </a>          </td>          <td style="vertical-align: bottom; text-align: center">           27          </td>         </tr>         <tr style="background-color: white">          <td style="vertical-align: top; text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Item 9A.           </font>          </td>          <td style="vertical-align: top; text-align: justify">           <a href="#a_014">            <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">             Controls and Procedures            </font>           </a>          </td>          <td style="vertical-align: bottom; text-align: center">           27          </td>         </tr>         <tr style="background-color: white">          <td style="vertical-align: top; text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Item 9B.           </font>          </td>          <td style="vertical-align: top; text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Other Information           </font>          </td>          <td style="vertical-align: bottom; text-align: center">          </td>         </tr>         <tr style="background-color: white">          <td style="vertical-align: top; text-align: justify">          </td>          <td style="vertical-align: top; text-align: justify">          </td>          <td style="vertical-align: bottom; text-align: center">          </td>         </tr>         <tr style="vertical-align: top; background-color: white">          <td colspan="3" style="text-align: center">           <a href="#a_015">            <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">             PART III            </font>           </a>          </td>         </tr>         <tr style="vertical-align: top; background-color: white">          <td colspan="3" style="text-align: center">          </td>         </tr>         <tr style="background-color: white">          <td style="vertical-align: top; text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Item 10.           </font>          </td>          <td style="vertical-align: top; text-align: justify">           <a href="#a_016">            <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">             Directors, Executive Officers and Corporate Governance            </font>           </a>          </td>          <td style="vertical-align: bottom; text-align: center">           28          </td>         </tr>         <tr style="background-color: white">          <td style="vertical-align: top; text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Item 11.           </font>          </td>          <td style="vertical-align: top; text-align: justify">           <a href="#a_017">            <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">             Executive Compensation            </font>           </a>          </td>          <td style="vertical-align: bottom; text-align: center">           36          </td>         </tr>         <tr style="background-color: white">          <td style="vertical-align: top; text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Item 12.           </font>          </td>          <td style="vertical-align: top; text-align: justify">           <a href="#a_018">            <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">             Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters            </font>           </a>          </td>          <td style="vertical-align: bottom; text-align: center">           38          </td>         </tr>         <tr style="background-color: white">          <td style="vertical-align: top; text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Item 13.           </font>          </td>          <td style="vertical-align: top; text-align: justify">           <a href="#a_019">            <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">             Certain Relationships and Related Transactions, and Director Independence            </font>           </a>          </td>          <td style="vertical-align: bottom; text-align: center">           39          </td>         </tr>         <tr style="background-color: white">          <td style="vertical-align: top; text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Item 14.           </font>          </td>          <td style="vertical-align: top; text-align: justify">           <a href="#a_020">            <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">             Principal Accountant Fees and Services            </font>           </a>          </td>          <td style="vertical-align: bottom; text-align: center">           40          </td>         </tr>         <tr style="background-color: white">          <td style="vertical-align: top; text-align: justify">          </td>          <td style="vertical-align: top; text-align: justify">          </td>          <td style="vertical-align: bottom; text-align: center">          </td>         </tr>         <tr style="vertical-align: top; background-color: white">          <td colspan="3" style="text-align: center">           <a href="#a_021">            <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">             PART IV            </font>           </a>          </td>         </tr>         <tr style="vertical-align: top; background-color: white">          <td colspan="3" style="text-align: center">          </td>         </tr>         <tr style="background-color: white">          <td style="vertical-align: top; text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Item 15.           </font>          </td>          <td style="vertical-align: top; text-align: justify">           <a href="#a_022">            <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">             Exhibits, Financial Statement Schedules            </font>           </a>          </td>          <td style="text-align: center; vertical-align: bottom">           41          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       </p>       <!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         <!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->         i         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         <u>          <a name="a_001">          </a>          PART I         </u>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         Forward-Looking Statements        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        This Annual Report on Form 10-K containsforward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995. Certain statements, otherthan purely historical information, including estimates, projections, statements relating to our business plans, objectives, andexpected operating results, and the assumptions upon which those statements are based, are “forward-looking statements.”These forward-looking statements generally are identified by the words “believes,” “project,” “expects,”“anticipates,” “estimates,” “intends,” “strategy,” “plan,” “may,”“will,” “would,” “will be,” “will continue,” “will likely result,”and similar expressions. Forward-looking statements are based on current expectations and assumptions that are subject to risksand uncertainties which may cause actual results to differ materially from the forward-looking statements. Our ability to predictresults or the actual effect of future plans or strategies is inherently uncertain. Factors which could have a material adverseeffect on our operations and future prospects on a consolidated basis include but are not limited to: changes in economic conditions,legislative/regulatory changes, availability of capital, interest rates, competition, and generally accepted accounting principles.These risks and uncertainties should also be considered in evaluating forward-looking statements and undue reliance should notbe placed on such statements.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <b>         <a name="a_002">         </a>         Item 1. Business        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         Overview        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        OptimizeRx is a digital health companythat provides communications solutions for life science companies, physicians and patients. Connecting over half of healthcareproviders in the U.S. and millions of patients through a proprietary network, the OptimizeRx digital health platform helps patientsafford and stay on medications. The platform unlocks new patient and physician touchpoints for life science companies along thepatient journey, from point-of-care, to retail pharmacy, through mobile patient engagement.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         2020 Company Highlights        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">        <tbody>         <tr style="vertical-align: top">          <td style="width: 0.25in">          </td>          <td style="width: 0.25in">           1.          </td>          <td style="text-align: justify">           Our net revenue increased to a record $43.3 million in 2020, a 76% increase over 2019          </td>         </tr>        </tbody>       </table>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">        <tbody>         <tr style="vertical-align: top">          <td style="width: 0.25in">          </td>          <td style="width: 0.25in">           2.          </td>          <td style="text-align: justify">           Our net revenue increased to a record $16.4 million in Q4 2020, up 123% over Q4 2019.          </td>         </tr>        </tbody>       </table>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">        <tbody>         <tr style="vertical-align: top">          <td style="width: 0.25in">          </td>          <td style="width: 0.25in">           3.          </td>          <td style="text-align: justify">           We expanded our sales leadership team by a adding a point of care expert and established a strongbase for growth in 2021.          </td>         </tr>        </tbody>       </table>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">        <tbody>         <tr style="vertical-align: top">          <td style="width: 0.25in">          </td>          <td style="width: 0.25in">           4.          </td>          <td style="text-align: justify">           We launched our TelaRep solution in April and in December, it was recognized as one of the mostinnovative products for life sciences in 2020 by PM 360 magazine.          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <b>         Sales and Marketing Update        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Our sales team continues to expand ourbusiness with existing and new clients communicating the increased value of our enterprise platform approach.  We are focusedon increasing the depth and breadth of our business across existing client product portfolios by maximizing the utilization ofour network.  We are expanding our business by providing new solutions and obtaining new clients. Our team is also workingon converting current clients from individual solutions to enterprise platform deals with access to our full set of solutions acrossour network. These enterprise deals enable us to increase our revenue per customer, and give us a more predictable and consistentrevenue stream.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        While our expenditures were down in 2020due to the global pandemic, we have continued to ramp up our marketing efforts by focusing more heavily on strategic content withthought leadership in the media and at events, as well as tailoring our solution marketing with an account-based approach.  Ourefforts are focused on cementing our image as a strategic partner with our buyers, so we have expanded our panel of thought leadershipvoices to include more of our leadership team. They are actively participating as speakers and panelists at industry events, andwe have significantly increased our footprint within earned industry media. Additionally, we hosted a series of webinars featuringindustry leaders in 2020 to foster collaboration, and we introduced the first annual Innovate4Outcomes event, bringing togetherthought leaders from across the healthcare industry to collaborate on solutions to some of the toughest challenges facing lifesciences and providers.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         1         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        We expanded our attendance and participationat investor conferences in 2020, most on a virtual basis. We have built marketing strategy momentum in 2020 with increased industryvisibility that we expect to expand in 2021.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         Operational Update        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        In 2020, we continued to expand our existingnetwork and physician utilization of our partner networks. We continue to work individually with our partners to improve point-of-careworkflow, increase overall revenue derived from each channel and increase coupon utilization by providers who have access. We arealso focused on increasing the number of physicians who have access to our service offerings. In addition to revenue growth providedby new pharma brands and network partners, we believe there is significant revenue growth potential within existing brands by betterutilizing our existing partner networks and expanding our available solutions.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        We also signed agreements with partnersthat give us access to provide messages directly to consumers.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         Technology Update        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        To support our growth and to further improvethe efficiency of our systems, we have moved our core platforms to Amazon Web Services. As a result of our acquisitions in 2018and 2019, we now have tech teams based in both Croatia and Israel, in addition to our core team in the U.S., to help develop furtherapplications throughout the organization.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         Principal Solutions and Applications        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Our principal solutions and applicationscan be summarized as follows:       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">        <tbody>         <tr style="vertical-align: top">          <td style="width: 24px">          </td>          <td style="width: 24px">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Financial Messaging – Our integrated financial messaging platform is a revolutionary virtual “Patient Support Center” that allows doctors and staff to access a universe of sample vouchers, co-pay coupons and other patient support options through their EMR and/or e-Prescribe systems. It allows them to search, print or electronically dispense directly to patients and a national network of pharmacies. Our platform eliminates the need for physicians to manage and store physical drug samples by offering a more convenient and efficient way to allocate, administer and track samples and co-pay savings for their patients. Today, nearly 60% of doctor offices ban or limit drug representatives and the samples they offer. While samples are still valuable, our solution addresses the fact that many healthcare systems and doctors are looking for an easier, more effective way to increase affordable access and adherence to their prescribed branded medications.           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">        <tbody>         <tr style="vertical-align: top">          <td style="width: 24px">          </td>          <td style="width: 24px">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Brand and Therapeutic Support Messaging – Our brand messaging services include a variety of brand awareness and therapeutic support messaging services that can be tailored to meet the needs of a brand. These messages can include brand awareness messages, reminder ads, therapeutic support messages and unbranded messages that can be targeted by specialty, diagnostic code and other criteria. Brand messaging is highly complementary to our core financial messaging solution. Historically, we have sold brand messaging based on specific solutions offered by our Electronic Health Record (“EHR”) partners, but we have developed our own proprietary banner messaging system, rolled this solution out in 2017, and expanded it since then. We also developed our own therapeutic support messaging system and launched it with our first partner in late 2018. We believe brand messaging represents a significant growth opportunity for us.           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">        <tbody>         <tr style="vertical-align: top">          <td style="width: 24px">          </td>          <td style="width: 24px">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Brand Support – Our brand support is focused on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing new eRx media strategies for promoting their solutions. Our services include: 1) Drug File Integration - a service designed to better insure that manufacturers’ drugs are present in every ePrescribing platform available; 2) Sales Force Training – a service to educate the extended field sales force on this new integrated solution and what to look for within their client base to insure maximum exposure of their brands; and 3) Strategy Development – a service that assists pharmaceutical manufacturers in identifying and building a competitive strategy to take advantage of this new digital frontier. Currently, this activity results in less than 10% of our revenue, but represents a significant growth opportunity for us.           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <!-- Field: Page; Sequence: 4; Value: 1 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         2         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">        <tbody>         <tr style="vertical-align: top">          <td style="width: 24px">          </td>          <td style="width: 24px">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Patient Engagement – Our patient engagement activities arose out of our acquisition of CareSpeak Communications in October 2018, followed by our acquisition of RMDY Health in 2019. Our technology solution provides digital messaging services through our cloud based Mobile Health Messenger (“MHM”) Platform. We provide interactive health messaging for improved medication adherence and care coordination. Our HIPAA-compliant, automated, mobile messaging platform allows pharmaceutical manufactures and related entities to directly engage with patients to improve regimen compliance. We also deliver patient programs with treatment and affordability information, lifestyle and condition trackers, Internet device connectivity, forms and surveys, with this all supported by a wide range of communication capabilities delivered via chat, bots, audio and telehealth. We enable this functionality for our customers, with our solutions delivering a variety of intervention mechanisms that help treat chronic conditions, such as diabetes and heart disease.           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         Competition        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Our core platform competes in the highlycompetitive pharmaceutical and life sciences digital marketing industry that is dominated by large well-known companies with establishednames, solid market niches, wide arrays of product offerings and marketing networks. Our messaging offerings compete for pharmaceuticalbudgets with a variety of other forms of advertising and promotion.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        We have a growing list of potential partnerswhom either have content that they want to deliver through our distribution engine and network, or have complementary technologyand want to integrate our solution as a channel partner and thereby increase their reach to clinicians. The primary direct competitorin our space of the market is ConnectiveRx. However, we believe our breadth of brands offered, extensive list of pharmaceuticalclients, and the vast reach of our network give us a substantial advantage and allow us to achieve a dominant position in the marketplace.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         Intellectual Property        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        In 2012, we were awarded a patent for ourinnovative solution (US Patent No. 8,341,015). This award was a result of our extensive research and development efforts. The awardedclaims cover our ability to electronically process, display and distribute eligible prescription savings on the medications andtherapies healthcare providers wish to prescribe for their patients. As part of our acquisition of CareSpeak Communications, wealso acquired (US Patent No. 7,956,727) related to methods and systems for medication management. We also have other patent applicationssubmitted in various stages of review.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        We use a nationally ranked intellectualproperty law firm to further expand and protect our intellectual property. We believe our current and expanding IP will allow usto continue being the leader in this rapidly growing space. We stand ready to prepare additional filings, as necessary, to protectour intellectual property on any forthcoming solutions that will further assist and support physicians, pharmacists and patients.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        OPTIMIZERx, CareSpeak, RMDY Wellness Layers,Diet Watch, and SampleMD are our licensed trademarks.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <!-- Field: Page; Sequence: 5; Value: 1 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         3         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         Government Regulation        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         <i>          Fraud and Abuse Laws         </i>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <i>         Anti-Kickback Statutes        </i>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       </p>       <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        The federal healthcare program Anti-Kickback Statute prohibitspersons from knowingly and willfully soliciting, offering, receiving or providing remuneration, directly or indirectly, in exchangefor or to induce either the referral of an individual for, or the furnishing, arranging for or recommending a good or service forwhich payment may be made in whole or part under a federal healthcare program such as Medicare or Medicaid. The definition of remunerationhas been broadly interpreted to include anything of value, including for example gifts, discounts, the furnishing of supplies orequipment, credit arrangements, payments of cash and waivers of payments. Several courts have interpreted the statute’s intentrequirement to mean that if any one purpose of an arrangement involving remuneration is to induce referrals or otherwise generatebusiness involving goods or services reimbursed in whole or in part under federal healthcare programs, the statute has been violated.The law contains a few statutory exceptions, including payments to bona fide employees, certain discounts and certain paymentsto group purchasing organizations. Violations can result in significant penalties, imprisonment and exclusion from Medicare, Medicaidand other federal healthcare programs. Exclusion of a manufacturer would preclude any federal healthcare program from paying forits products. In addition, kickback arrangements can provide the basis for an action under the Federal False Claims Act, whichis discussed in more detail below. The Anti-Kickback Statute is broad and potentially prohibits many arrangements and practicesthat are lawful in businesses outside of the healthcare industry. Recognizing that the Anti-Kickback Statute is broad and may technicallyprohibit many innocuous or beneficial arrangements, the Office of Inspector General of Health and Human Services, or OIG, issueda series of regulations, known as the safe harbors, beginning in July 1991. These safe harbors set forth provisions that, if allthe applicable requirements are met, will assure healthcare providers and other parties that they will not be prosecuted underthe Anti-Kickback Statute. The failure of a transaction or arrangement to fit precisely within one or more safe harbors does notnecessarily mean that it is illegal or that prosecution will be pursued. However, conduct and business arrangements that do notfully satisfy each applicable safe harbor may result in increased scrutiny by government enforcement authorities such as the OIG.Arrangements that implicate the Anti-Kickback Law, and that do not fall within a safe harbor, are analyzed by the OIG on a case-by-casebasis. Government officials have focused recent enforcement efforts on, among other things, the sales and marketing activitiesof healthcare companies, and recently have brought cases against individuals or entities with personnel who allegedly offered unlawfulinducements to potential or existing customers in an attempt to procure their business. Settlements of these cases by healthcarecompanies have involved significant fines and/or penalties and in some instances criminal pleas. In addition to the Federal Anti-KickbackStatute, many states have their own kickback laws. Often, these laws closely follow the language of the federal law, although theydo not always have the same exceptions or safe harbors. In some states, these anti-kickback laws apply with respect to all payors,including commercial health insurance companies.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <i>         False Claims Laws        </i>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Federal false claims laws prohibit anyperson from knowingly presenting, or causing to be presented, a false claim for payment to the federal government or knowinglymaking, or causing to be made, a false statement to get a false claim paid. Manufacturers can be held liable under false claimslaws, even if they do not submit claims to the government, if they are found to have caused submission of false claims. The FederalCivil False Claims Act also includes whistle blower provisions that allow private citizens to bring suit against an entity or individualon behalf of the United States and to recover a portion of any monetary recovery. Many of the recent highly publicized settlementsin the healthcare industry related to sales and marketing practices have been cases brought under the False Claims Act. The majorityof states also have statutes or regulations similar to the federal false claims laws, which apply to items and services reimbursedunder Medicaid and other state programs, or, in several states, apply regardless of the payor. Sanctions under these federal andstate laws may include civil monetary penalties, exclusion of a manufacturer’s products from reimbursement under governmentprograms, criminal fines and imprisonment.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       </p>       <!-- Field: Page; Sequence: 6; Value: 1 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         4         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <i>         Privacy and Security        </i>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The Health Insurance Portability and AccountabilityAct of 1996, or HIPAA, and the rules promulgated there under require certain entities, referred to as covered entities, to complywith established standards, including standards regarding the privacy and security of protected health information, or PHI. HIPAAfurther requires that covered entities enter into agreements meeting certain regulatory requirements with their business associates,as such term is defined by HIPAA, which, among other things, obligate the business associates to safeguard the covered entity’sPHI against improper use and disclosure. While not directly regulated by HIPAA, our customers or distributors might face significantcontractual liability pursuant to such an agreement if the business associate breaches the agreement or causes the covered entityto fail to comply with HIPAA.  It is possible that HIPPA compliance could become a substantial regulatory burden andexpense to our operations, although we do not believe that this will occur as a general website publisher.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         Employees        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        As of December 31, 2020, we had 57 full-timeemployees in the U.S, as well as 14 full-time international employees. None of our employees are represented by a labor union withrespect to their employment with us. We have not experienced any work stoppages, and we consider our relations with our employeesto be good.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         Subsidiaries        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        We conduct our operations through our wholly-ownedsubsidiaries, OptimizeRx Corporation, a Michigan corporation, CareSpeak Communications, Inc., a New Jersey corporation, CareSpeakCommunications, D.O.O, a controlled foreign corporation incorporated in Croatia, RMDY Health, Inc. a Delaware corporation, andCyberdiet, a controlled foreign corporation incorporated in Israel.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         Recent developments        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">        In March 2021, our Board of Directors amendedthe 2013 Incentive Plan to increase the number of shares authorized under the Plan to 6,000.000 shares.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <!-- Field: Page; Sequence: 7; Value: 1 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         5         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <b>         <a name="a_003">         </a>         Item 1A. Risk Factors        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         Risks Relating to Business and FinancialCondition        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         <i>          Because we have historically experiencedlosses, if we are unable to achieve profitability, our financial condition and company could suffer.         </i>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        While we were profitable for the full yearof 2018 and in the fourth quarter of 2020, since the inception of our business we have historically incurred losses as a resultof investing in growth. We incurred losses in 2019 and 2020 as a result of our increased spending to invest in growth – boththrough additional new hires, as well as through the acquisition of RMDY. While we have increased revenues significantly, we havenot yet consistently achieved profitability due to significant investments in our growth, and non-cash expenses. Our ability toachieve consistent profitability depends on our ability to generate sales through our technology platform and advertising model,while maintaining reasonable expense levels. If we do not achieve sustainable profitability, it may impact our ability to continueour operations.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         <i>          Our business and growth may sufferif we are unable to attract and retain key employees.         </i>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Our success depends on the expertise ofour executive officers and certain other key technical personnel. It may be difficult to find sufficiently qualified individualsto replace management or other key technical personnel in the event of death, disability or resignation, thus frustrating our abilityto implement our business plan, which could negatively affect our operating results.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Furthermore, our ability to expand operationsto accommodate our anticipated growth will also depend on our ability to attract and retain qualified media, management, finance,marketing, sales and technical personnel. However, competition for these types of employees is intense due to the limited numberof qualified professionals. Our ability to meet our business development objectives will depend in part on our ability to recruit,train and retain top quality people with advanced skills who understand our technology and business. If we are unable to engageand retain the necessary personnel, our business may be materially and adversely affected.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         <i>          Our failure to obtain, retain orattract additional customers could prevent us from successfully executing our business plan.         </i>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        We currently work with many leading pharmaceuticalcompanies, medical device manufacturers, medtech, associations, and other companies. Our failure to retain existing customers orexpand with new customers could negatively impact our business.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         <i>          We are dependent on a concentratedgroup of customers.         </i>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Our revenues are concentrated in less than50 customers, primarily large pharmaceutical manufacturers. Loss of one or more of our larger customers could have a negative impacton our operating results. In both 2020 and 2019, we had three customers that each represented slightly over 10% of our revenues;however only one customer represented over 10% of our revenues in both years.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         <i>          We may be unable to support our technologyto further scale our operations successfully.         </i>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Our plan is to grow rapidly through furtherintegration of our technology in electronic platforms. Our growth will place significant demands on our management and technologydevelopment, as well as our financial, administrative and other resources. We cannot guarantee that any of the systems, proceduresand controls we put in place will be adequate to support the commercialization of our operations. Our operating results will dependsubstantially on the ability of our officers and key employees to manage changing business conditions and to implement and improveour financial, administrative and other resources. If we are unable to respond to and manage changing business conditions, or thescale of our solutions, services and operations, then the quality of our services, our ability to retain key personnel and ourbusiness could be harmed.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <!-- Field: Page; Sequence: 8; Value: 1 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         6         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <b>         <i>          If we are unable to maintain our contracts withelectronic prescription platforms, our business will suffer.         </i>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        We are reliant upon our contracts withleading electronic prescribing platforms and electronic health record systems to generate our revenues received from customersSuch arrangements subject us to a number of risks, including the following:       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">        <tbody>         <tr style="vertical-align: top">          <td style="width: 24px">          </td>          <td style="width: 24px">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Our contract partners may experience financial, regulatory or operational difficulties, which may impair their ability to focus on and fulfill their contract obligations to us;           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">        <tbody>         <tr style="vertical-align: top">          <td style="width: 24px">          </td>          <td style="width: 24px">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Legal disputes or disagreements, including the ownership of intellectual property, may occur with one or more of our partners and may lead to lengthy and expensive litigation or arbitration;           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">        <tbody>         <tr style="vertical-align: top">          <td style="width: 24px">          </td>          <td style="width: 24px">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Significant changes in a partner’s business strategy may adversely affect a partner’s willingness or ability to satisfy obligations under any such arrangement; and           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">        <tbody>         <tr style="vertical-align: top">          <td style="width: 24px">          </td>          <td style="width: 24px">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            A partner could terminate the partnership arrangement, which could negatively impact our ability to sell our solutions and achieve revenues.           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        We will need to maintain these relationshipsas well as diversify them. The inability to do so could adversely impact our business. We generated 52.7% and 37.4% of our revenuethrough our largest partner in 2020 and 2019, respectively.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         <i>          Our agreements with electronic prescriptionplatforms and electronic health record systems are subject to audit.         </i>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Our agreements with our partners providefor revenue sharing payments to the platform partners based on the revenue we generate through the platform. These payments aresubject to audit by our partners, at their cost, and if there is a dispute as to the calculation, we may be liable for additionalpayments. If an underpayment is determined to be in excess of a certain amount, for example 10%, some agreements would requireus to pay for the cost of the audit, as well.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         <i>          Developing and implementing new andupdated applications, features and services for our portals may be more difficult than expected, may take longer and cost morethan expected and may not result in sufficient increases in revenue to justify the costs.         </i>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Attracting and retaining users of our portalsrequires us to continue to improve the technology underlying those portals and to continue to develop new and updated applications,features and services for those portals. If we are unable to do so on a timely basis or if we are unable to implement new applications,features and services without disruption to our existing ones, we may lose potential users and clients. The costs of developmentof these enhancements may negatively impact our ability to achieve profitability.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        We rely on a combination of internal development,strategic relationships, licensing and acquisitions to develop our portals and related applications, features and services. Ourdevelopment and/or implementation of new technologies, applications, features and services may cost more than expected, may takelonger than originally expected, may require more testing than originally anticipated and may require the acquisition of additionalpersonnel and other resources. There can be no assurance that the revenue opportunities from any new or updated technologies, applications,features or services will justify the amounts spent.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         <i>          If we are unable to adhere to theregulatory and competitive climate in which we operate, we could be materially and negatively impacted.         </i>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Due to the labyrinth of regulations inhealthcare space, state and federal, as well as political sensitivity of healthcare delivery, our business model could be negativelyimpacted or fail.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       </p>       <!-- Field: Page; Sequence: 9; Value: 1 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         7         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         <i>          The markets in which we operate arecompetitive, continually evolving and, in some cases, subject to rapid change.         </i>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">        <tbody>         <tr style="vertical-align: top">          <td style="width: 24px">          </td>          <td style="width: 24px">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Our portals face competition from numerous other companies, both in attracting users and in generating revenue from advertisers and sponsors. We compete for users with online services and websites that provide savings on medications and healthcare products, including both commercial sites and not-for-profit sites. We compete for advertisers and sponsors with: health-related web sites; general purpose consumer web sites that offer specialized health sub-channels; other high-traffic web sites that include both healthcare-related and non-healthcare-related content and services; search engines that provide specialized health searches; and advertising networks that aggregate traffic from multiple sites.           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">        <tbody>         <tr style="vertical-align: top">          <td style="width: 24px">          </td>          <td style="width: 24px">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Our healthcare provider portals compete with: providers of healthcare decision-support tools and online health management applications; wellness and disease management vendors; and health information services and health management offerings of healthcare benefits companies and their affiliates.           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Many of our competitors have greater financial,technical, product development, marketing and other resources than we do. These organizations may be better known than we are andhave more customers or users than we do. We cannot provide assurance that we will be able to compete successfully against theseorganizations or any alliances they have formed or may form. Since there are no substantial barriers to entry into the marketsin which our public portals participate, we expect that competitors will continue to enter these markets.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         <i>          Developments in the healthcare industrycould adversely affect our business.         </i>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Most of our revenue is derived from thehealthcare industry and could be affected by changes affecting healthcare spending. We are particularly dependent on pharmaceutical,biotechnology and medical device companies for our advertising and sponsorship revenue.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        General reductions in expenditures by healthcareindustry participants could result from, among other things:       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">        <tbody>         <tr style="vertical-align: top">          <td style="width: 24px">          </td>          <td style="width: 24px">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Government regulation or private initiatives that affect the manner in which healthcare providers interact with patients, payers or other healthcare industry participants, including changes in pricing or means of delivery of healthcare products and services;           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">        <tbody>         <tr style="vertical-align: top">          <td style="width: 24px">          </td>          <td style="width: 24px">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Government regulation prohibiting the use of coupons by patients covered by federally funded health insurance programs;           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">        <tbody>         <tr style="vertical-align: top">          <td style="width: 24px">          </td>          <td style="width: 24px">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Consolidation of healthcare industry participants;           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">        <tbody>         <tr style="vertical-align: top">          <td style="width: 24px">          </td>          <td style="width: 24px">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Reductions or changes in governmental funding for healthcare;           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">        <tbody>         <tr style="vertical-align: top">          <td style="width: 24px">          </td>          <td style="width: 24px">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Adverse changes in business or economic conditions affecting healthcare payers or providers, pharmaceutical, biotechnology or medical device companies or other healthcare industry participants; and           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">        <tbody>         <tr style="vertical-align: top">          <td style="width: 24px">          </td>          <td style="width: 24px">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            A move to a single-payer healthcare system in the U.S.           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Even if general expenditures by industryparticipants remain the same or increase, developments in the healthcare industry may result in reduced spending in some or allof the specific market segments that we serve or are planning to serve. For example, use of our solutions and services could beaffected by:       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">        <tbody>         <tr style="vertical-align: top">          <td style="width: 24px">          </td>          <td style="width: 24px">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Changes in the design of health insurance plans;           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <!-- Field: Page; Sequence: 10; Value: 1 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         8         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">        <tbody>         <tr style="vertical-align: top">          <td style="width: 24px">           <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">           </p>           <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">           </p>          </td>          <td style="width: 24px">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            A decrease in the number of new drugs or medical devices coming to market;           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">        <tbody>         <tr style="vertical-align: top">          <td style="width: 24px">          </td>          <td style="width: 24px">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            A decrease in marketing expenditures by pharmaceutical or medical device companies, including as a result of governmental regulation or private initiatives that discourage or prohibit advertising or sponsorship activities by pharmaceutical or medical device companies; and           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">        <tbody>         <tr style="vertical-align: top">          <td style="width: 24px">          </td>          <td style="width: 24px">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Payor pressure to move to generic brands.           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        In addition, our customers’ expectationsregarding pending or potential industry developments may also affect their budgeting processes and spending plans with respectto solutions and services of the types we provide.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The healthcare industry has changed significantlyin recent years and we expect that significant changes will continue to occur. However, the timing and impact of developments inthe healthcare industry are difficult to predict. We cannot assure you that the markets for our solutions and services will continueto exist at current levels or that we will have adequate technical, financial and marketing resources to react to changes in thosemarkets.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">        <b>         <i>          Future acquisitionsmay adversely affect our financial condition.         </i>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        While we currently do not have any immediatearrangements, commitments or understandings regarding any future acquisitions, as part of our strategy for growth, we may continueto explore acquisitions or strategic alliances, which may not be completed or may not be ultimately beneficial to us. Acquisitionsmay pose risks to our operations, including:       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">        <tbody>         <tr style="vertical-align: top">          <td style="width: 0.25in">          </td>          <td style="width: 0.25in; text-align: left">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td>           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            problemsand increased costs in connection with the integration of the personnel, operations, technologies, or products of the acquiredbusinesses;           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">        <tbody>         <tr>          <td style="width: 0.25in">          </td>          <td style="width: 0.25in; text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            unanticipated costs;           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">        <tbody>         <tr>          <td style="width: 0.25in">          </td>          <td style="width: 0.25in; text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            failure to achieve anticipated increases in revenues and profitability;           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">        <tbody>         <tr>          <td style="width: 0.25in">          </td>          <td style="width: 0.25in; text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            diversion of management’s attention from our core business;           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">        <tbody>         <tr>          <td style="width: 0.25in">          </td>          <td style="vertical-align: top; width: 0.25in">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            adverse effects on business relationships with suppliers and customers and those of the acquired company;           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">        <tbody>         <tr>          <td style="width: 0.25in">          </td>          <td style="vertical-align: top; width: 0.25in">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            acquired assets becoming impaired as a result of technical advancements or worse-than-expected performance by the acquired company;           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">        <tbody>         <tr>          <td style="width: 0.25in">          </td>          <td style="width: 0.25in; text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            volatility associated with accounting for earn-outs in a given transaction;           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">        <tbody>         <tr>          <td style="width: 0.25in">          </td>          <td style="width: 0.25in; text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            entering markets in which we have no, or limited, prior experience; and           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">        <tbody>         <tr>          <td style="width: 0.25in">          </td>          <td style="vertical-align: top; width: 0.25in">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            adversely affecting our internal control over financial reporting before the acquiree’s complete integration into our control environment.           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        In addition, in connection with any acquisitionsor investments we could:       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">        <tbody>         <tr>          <td style="width: 0.25in">          </td>          <td style="width: 0.25in; text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            issue stock that would dilute our existing shareholders’ ownership percentages;           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">        <tbody>         <tr>          <td style="width: 0.25in">          </td>          <td style="width: 0.25in; text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            incur debt and assume liabilities;           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">        <tbody>         <tr>          <td style="width: 0.25in">          </td>          <td style="width: 0.25in; text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            obtain financing on unfavorable terms, or not be able to obtain financing on any terms at all;           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">        <tbody>         <tr>          <td style="width: 0.25in">          </td>          <td style="vertical-align: top; width: 0.25in">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            incur amortization expenses related to acquired intangible assets or incur large and immediate write-offs; and           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">        <tbody>         <tr>          <td style="width: 0.25in">          </td>          <td style="width: 0.25in; text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            reduce the cash that would otherwise be available to fund operations or for other purposes.           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <!-- Field: Page; Sequence: 11; Value: 1 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         9         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The failure to successfully integrate anyacquisitions in an efficient or timely manner may negatively impact our financial condition and operating results, or we may notbe able to fully realize anticipated savings. In addition, our competitors could try to emulate our acquisition strategy, leadingto greater competition for scarce acquisition targets and could lead to larger competitors if they succeed in emulating our strategy.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         <i>          The global pandemic may disrupt ourbusiness or the business of our customers.         </i>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        In December 2019, a novel strain of coronavirus, which causes the infectious disease known as COVID-19 was reported. The World Health Organization declared COVID-19 a PublicHealth Emergency and Global Pandemic. COVID-19 has severely impacted economies around the world. We have taken steps to mitigatethe impact on us, but there can be no assurance that such steps will be successful, or that our business operations, or the operationsof our customers will not be materially and adversely affected by the consequences of the pandemic. This could materially impactour results of operations, cash flows, and financial condition.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         <i>          A material weakness in our internalcontrol over financial reporting, if not remediated, could result in material misstatements in our financial statements.         </i>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Management is responsible for establishingand maintaining adequate internal control over financial reporting, as defined in Rule 13a-15(f) under the Securities ExchangeAct of 1934, as amended. A material weakness (as defined in Rule 12b-2) is a deficiency, or combination of deficiencies, in internalcontrol over financial reporting, such that there is a reasonable possibility that a material misstatement of annual or interimfinancial statements will not be prevented or detected on a timely basis. We have had material weaknesses in the past that havebeen remediated as of December 31, 2020. There is no guarantee that material weakness could not arise in the future. If additionalmaterial weaknesses were to be identified, it could result in our consolidated financial statements containing material misstatementsin the future.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         <i>          Our success is dependent in parton obtaining, maintaining and enforcing our proprietary rights and our ability to avoid infringing on the proprietary rights ofothers.         </i>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        We seek patent protection for those inventionsand technologies for which we believe such protection is suitable and is likely to provide a competitive advantage to us. Becausepatent applications in the United States are maintained in secrecy until either the patent application is published, or a patentis issued, we may not be aware of third-party patents, patent applications and other intellectual property relevant to our solutionsthat may block our use of our intellectual property or may be used in third-party products that compete with our solutions andprocesses. In the event a competitor or other party successfully challenges our solutions, processes, patents or licenses or claimsthat we have infringed upon their intellectual property, we could incur substantial litigation costs defending against such claims,be required to pay royalties, license fees or other damages or be barred from using the intellectual property at issue, any ofwhich could have a material adverse effect on our business, operating results and financial condition.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        We also rely substantially on trade secrets,proprietary technology, nondisclosure and other contractual agreements, and technical measures to protect our technology, application,design, and manufacturing know-how, and work actively to foster continuing technological innovation to maintain and protect ourcompetitive position. We cannot assure you that steps taken by us to protect our intellectual property and other contractual agreementsfor our business will be adequate, that our competitors will not independently develop or patent substantially equivalent or superiortechnologies or be able to design around patents that we may receive, or that our intellectual property will not be misappropriated.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         <i>          We could be subject to economic,political, regulatory and other risks arising from our international operations.         </i>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Operating in international markets requiressignificant resources and management attention and will subject us to regulatory, economic and political risks that may be differentfrom and incremental to those in the United States. In addition to the risks that we face in the United States, our internationaloperations, as a result of our acquisitions in 2018 and 2019 wherein we now operate in Israel and Croatia, may involve risks thatcould adversely affect our business, including:       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">        <tbody>         <tr style="vertical-align: top">          <td style="width: 24px">          </td>          <td style="width: 24px">           <font style="font: 10pt Times New Roman, Times, Serif">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font: 10pt Times New Roman, Times, Serif">            the need to adapt our content and user interfaces for specific cultural and language differences;           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">        <tbody>         <tr style="vertical-align: top">          <td style="width: 24px">          </td>          <td style="width: 24px">           <font style="font: 10pt Times New Roman, Times, Serif">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font: 10pt Times New Roman, Times, Serif">            difficulties and costs associated with staffing and managing foreign operations;           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <!-- Field: Page; Sequence: 12; Value: 1 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         10         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">        <tbody>         <tr style="vertical-align: top">          <td style="width: 24px">          </td>          <td style="width: 24px">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            management distraction;           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">        <tbody>         <tr style="vertical-align: top">          <td style="width: 24px">          </td>          <td style="width: 24px">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            natural or man-made disasters, political, social and economic instability, including wars, terrorism and political unrest, outbreak of disease (such as the recent outbreak of the novel coronavirus, or COVID-19), boycotts, curtailment of trade, and other business restrictions;           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">        <tbody>         <tr style="vertical-align: top">          <td style="width: 24px">          </td>          <td style="width: 24px">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            compliance with United States laws, such as the Foreign Corrupt Practices Act, export controls and economic sanctions, and local laws prohibiting corrupt payments to government officials;           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">        <tbody>         <tr style="vertical-align: top">          <td style="width: 24px">          </td>          <td style="width: 24px">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            unexpected changes in regulatory requirements;           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">        <tbody>         <tr style="vertical-align: top">          <td style="width: 24px">          </td>          <td style="width: 24px">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            less favorable foreign intellectual property laws;           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">        <tbody>         <tr style="vertical-align: top">          <td style="width: 24px">          </td>          <td style="width: 24px">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            adverse tax consequences such as those related to repatriation of cash from foreign jurisdictions into the United States, non-income related taxes such as value-added tax or other indirect taxes, changes in tax laws or their interpretations, or the application of judgment in determining our global provision for income taxes and other tax liabilities given inter-company transactions and calculations where the ultimate tax determination is uncertain;           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">        <tbody>         <tr style="vertical-align: top">          <td style="width: 24px">          </td>          <td style="width: 24px">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            fluctuations in currency exchange rates, which could impact revenues and expenses of our international operations and expose us to foreign currency exchange rate risk;           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">        <tbody>         <tr style="vertical-align: top">          <td style="width: 24px">          </td>          <td style="width: 24px">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            profit repatriation and other restrictions on the transfer of funds;           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">        <tbody>         <tr style="vertical-align: top">          <td style="width: 24px">          </td>          <td style="width: 24px">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            differing payment processing systems as well as consumer use and acceptance of electronic payment methods, such as payment cards;           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">        <tbody>         <tr style="vertical-align: top">          <td style="width: 24px">          </td>          <td style="width: 24px">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            new and different sources of competition;           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">        <tbody>         <tr style="vertical-align: top">          <td style="width: 24px">          </td>          <td style="width: 24px">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            different and more stringent user protection, data protection, privacy and other laws; and           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">        <tbody>         <tr style="vertical-align: top">          <td style="width: 24px">          </td>          <td style="width: 24px">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            availability of reliable broadband connectivity and wide area networks in targeted areas for expansion.           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Our failure to manage any of these riskssuccessfully could harm our international operations and our overall business, as well as results of our operations.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         <i>          Our business will suffer if our networksystems fail or become unavailable.         </i>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        A reduction in the performance, reliabilityand availability of our network infrastructure would harm our ability to distribute our solutions to our users, as well as ourreputation and ability to attract and retain customers. Our systems and operations could be damaged or interrupted by fire, flood,power loss, telecommunications failure, Internet breakdown, earthquake and similar events. Our systems could also be subject toviruses, break-ins, sabotage, acts of terrorism, acts of vandalism, hacking, cyber-terrorism and similar misconduct. We might notcarry adequate business interruption insurance to compensate us for losses that may occur from a system outage. Any system erroror failure that causes interruption in availability of our solutions or an increase in response time could result in a loss ofpotential customers, which could have a material adverse effect on our business, financial condition and results of operations.If we suffer sustained or repeated interruptions, then our solutions and services could be less attractive to our users and ourbusiness would be materially harmed.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         <i>          If we are unable to manage growth,our operations could be adversely affected.         </i>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Our progress is expected to require thefull utilization of our management, financial and other resources. Our ability to manage growth effectively will depend on ourability to improve and expand operations, including our financial and management information systems, and to recruit, train andmanage personnel. There can be no absolute assurance that management will be able to manage growth effectively.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        If we do not properly manage the growthof our business, we may experience significant strains on our management and operations and disruptions in our business. Variousrisks arise when companies and industries grow quickly. If our business or industry grows too quickly, our ability to meet customerdemand in a timely and efficient manner could be challenged. We may also experience development delays as we seek to meet increaseddemand for our solutions. Our failure to properly manage the growth that we or our industry might experience could negatively impactour ability to execute on our operating plan and, accordingly, could have an adverse impact on our business, our cash flow andresults of operations, and our reputation with our current or potential customers.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <!-- Field: Page; Sequence: 13; Value: 1 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         11         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         <i>          Our business is subject to changingregulation of corporate governance and public disclosure.         </i>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Because our common stock is publicly traded,we are subject to certain rules and regulations of federal and state entities charged with the protection of investors and theoversight of companies whose securities are publicly traded. These entities have continued to develop additional regulations andrequirements in response to laws enacted by Congress, most notably the Sarbanes-Oxley Act of 2002. Complying with these new regulationshas resulted in, and is likely to continue to result in, increased general and administrative costs and a diversion of managementtime and attention from revenue generating and other business activities to compliance activities.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         Risks Relating to Our Securities        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         <i>          If a market for our common stockis not maintained, shareholders may be unable to sell their shares.         </i>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Our common stock is traded under the symbol“OPRX” on the Nasdaq Capital Market. We do not currently have a consistent active trading market. There can be no assurancethat a consistent active and liquid trading market will develop or, if developed, that it will be sustained.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Historically, our securities have beenthinly traded. Accordingly, it may be difficult to sell shares of our common stock without significantly depressing the value ofthe stock. Unless we are successful in developing continued investor interest in our stock, sales of our stock could continue toresult in major fluctuations in the price of the stock.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         <i>          The market price of our common stockis likely to be highly volatile and could fluctuate widely in price in response to various factors, many of which are beyond ourcontrol.         </i>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Our stock price is subject to a numberof factors, including:       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">        <tbody>         <tr style="vertical-align: top">          <td style="width: 24px">          </td>          <td style="width: 24px">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Technological innovations or new solutions and services by us or our competitors;           </font>          </td>         </tr>         <tr style="vertical-align: top">          <td>          </td>          <td>          </td>          <td style="text-align: justify">          </td>         </tr>         <tr style="vertical-align: top">          <td>          </td>          <td>           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Government regulation of our solutions and services;           </font>          </td>         </tr>         <tr style="vertical-align: top">          <td>          </td>          <td>          </td>          <td style="text-align: justify">          </td>         </tr>         <tr style="vertical-align: top">          <td>          </td>          <td>           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            The establishment of partnerships with other healthcare companies;           </font>          </td>         </tr>         <tr style="vertical-align: top">          <td>          </td>          <td>          </td>          <td style="text-align: justify">          </td>         </tr>         <tr style="vertical-align: top">          <td>          </td>          <td>           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Intellectual property disputes;           </font>          </td>         </tr>         <tr style="vertical-align: top">          <td>          </td>          <td>          </td>          <td style="text-align: justify">          </td>         </tr>         <tr style="vertical-align: top">          <td>          </td>          <td>           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Additions or departures of key personnel;           </font>          </td>         </tr>         <tr style="vertical-align: top">          <td>          </td>          <td>          </td>          <td style="text-align: justify">          </td>         </tr>         <tr style="vertical-align: top">          <td>          </td>          <td>           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Sales of our common stock;           </font>          </td>         </tr>         <tr style="vertical-align: top">          <td>          </td>          <td>          </td>          <td style="text-align: justify">          </td>         </tr>         <tr style="vertical-align: top">          <td>          </td>          <td>           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Our ability to integrate operations, technology, solutions, and services;           </font>          </td>         </tr>         <tr style="vertical-align: top">          <td>          </td>          <td>          </td>          <td style="text-align: justify">          </td>         </tr>         <tr style="vertical-align: top">          <td>          </td>          <td>           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Our ability to execute our business plan;           </font>          </td>         </tr>         <tr style="vertical-align: top">          <td>          </td>          <td>          </td>          <td style="text-align: justify">          </td>         </tr>         <tr style="vertical-align: top">          <td>          </td>          <td>           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Operating results below or exceeding expectations;           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">        <tbody>         <tr style="vertical-align: top">          <td style="width: 24px">          </td>          <td style="width: 24px">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Whether we achieve profits or not;           </font>          </td>         </tr>         <tr style="vertical-align: top">          <td>          </td>          <td>          </td>          <td style="text-align: justify">          </td>         </tr>         <tr style="vertical-align: top">          <td>          </td>          <td>           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Loss or addition of any strategic relationship;           </font>          </td>         </tr>         <tr style="vertical-align: top">          <td>          </td>          <td>          </td>          <td style="text-align: justify">          </td>         </tr>         <tr style="vertical-align: top">          <td>          </td>          <td>           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Industry developments;           </font>          </td>         </tr>         <tr style="vertical-align: top">          <td>          </td>          <td>          </td>          <td style="text-align: justify">          </td>         </tr>         <tr style="vertical-align: top">          <td>          </td>          <td>           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Economic and other external factors; and           </font>          </td>         </tr>         <tr style="vertical-align: top">          <td>          </td>          <td>          </td>          <td style="text-align: justify">          </td>         </tr>         <tr style="vertical-align: top">          <td>          </td>          <td>           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Period-to-period fluctuations in our financial results.           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Our stock price may fluctuate widely asa result of any of the above. In addition, the securities markets have from time to time experienced significant price and volumefluctuations that are unrelated to the operating performance of particular companies. These market fluctuations may also materiallyand adversely affect the market price of our common stock.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <!-- Field: Page; Sequence: 14; Value: 1 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         12         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         <i>          We do not expect to pay dividendsin the foreseeable future and any return on investment may be limited to the value of our common stock.         </i>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        We do not anticipate paying cash dividendson our common stock in the foreseeable future. The payment of dividends on our common stock will depend on earnings, financialcondition and other business and economic factors affecting it at such time as the board of directors may consider relevant. Ifwe do not pay dividends, our common stock may be less valuable because a return on your investment will occur only if our stockprice appreciates.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         <i>          Provisions in the Nevada RevisedStatutes and our Bylaws could make it very difficult for an investor to bring any legal actions against our directors or officersfor violations of their fiduciary duties or could require us to pay any amounts incurred by our directors or officers in any suchactions.         </i>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Members of our board of directors and ourofficers will have no liability for breaches of their fiduciary duty of care as a director or officer, except in limited circumstances,pursuant to provisions in the Nevada Revised Statutes and our Bylaws as authorized by the Nevada Revised Statutes. Specifically,Section 78.138 of the Nevada Revised Statutes provides that a director or officer is not individually liable to the company orits shareholders or creditors for any damages as a result of any act or failure to act in his or her capacity as a director orofficer unless it is proven that (1) the director’s or officer’s act or failure to act constituted a breach of hisor her fiduciary duties as a director or officer and (2) his or her breach of those duties involved intentional misconduct, fraudor a knowing violation of law. This provision is intended to afford directors and officers protection against and to limit theirpotential liability for monetary damages resulting from suits alleging a breach of the duty of care by a director or officer. Accordingly,you may be unable to prevail in a legal action against our directors or officers even if they have breached their fiduciary dutyof care. In addition, our Bylaws allow us to indemnify our directors and officers from and against any and all costs, charges andexpenses resulting from their acting in such capacities with us. This means that if you were able to enforce an action againstour directors or officers, in all likelihood, we would be required to pay any expenses they incurred in defending the lawsuit andany judgment or settlement they otherwise would be required to pay. Accordingly, our indemnification obligations could divert neededfinancial resources and may adversely affect our business, financial condition, results of operations and cash flows, and adverselyaffect prevailing market prices for our common stock.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <!-- Field: Page; Sequence: 15; Value: 1 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         13         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <a name="a_004">        </a>        <b>         Item 1B. Unresolved Staff comments        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        None       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         <i>         </i>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <a name="a_005">        </a>        <b>         Item 2. Properties        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Currently, we do not own any real estate.Our principal executive offices are located at 400 Water Street, Suite 200, Rochester, Michigan 48307.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        We have operating leases with terms greaterthan 12 months for office space in three multitenant facilities. The lease on our headquarters space in Rochester, Michigan expiresNovember 30, 2022, with a three-year renewal option through 2025, with monthly rent payable at rates ranging from $6,384 to $6,688.We have assumed renewal of the lease. We also have a lease on office space in Cranbury, New Jersey, expiring in 2022 with monthlypayments ranging from $3,008 to $3,158, as well as a lease of approximately $1,883 per month in Zagreb, Croatia expiring in 2022.We also lease minor amounts of space in shared space facilities on a month to month basis as necessary.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        We believe that our properties are adequatefor our current needs, but growth potential may require larger facilities due to anticipated addition of personnel. We do not haveany policies regarding investments in real estate, securities or other forms of property.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         <a name="a_006">         </a>         Item 3. Legal Proceedings        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        We have no current legal proceedings.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <a name="a_007">        </a>        <b>         Item 4. Mine Safety Disclosures        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Not applicable.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <!-- Field: Page; Sequence: 16; Value: 1 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         14         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         <u>          <a name="a_008">          </a>          PART II         </u>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         <a name="a_009">         </a>         Item 5. Market for Registrant’sCommon Equity and Related Stockholder Matters and Issuer Purchases of Equity Securities        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         Market Information        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Our common stock is traded under the symbol“OPRX” on the Nasdaq Capital Market.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <b>         Holders of Our Common Stock        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        As of March 3, 2021, we had16,806,637 shares of our common stock issued and outstanding, held by approximately 400 shareholders of record at ourtransfer agent, with approximately 7,000 additional shareholders holding our shares in street name.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         Dividends        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        We currently intend to retain future earningsfor the operation of our business. We have never declared or paid cash dividends on our common stock, and we do not anticipatepaying any cash dividends in the foreseeable future.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        In the event that a dividend is declared,common stockholders on the record date are entitled to share ratably in any dividends that may be declared from time to time onthe common stock by our board of directors from funds legally available.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        There are no restrictions in ourarticles of incorporation or bylaws that restrict us from declaring dividends. The Nevada Revised Statutes, however, do prohibitus from declaring dividends where, after giving effect to the distribution of the dividend:       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">        <tbody>         <tr style="vertical-align: top">          <td style="width: 24px">          </td>          <td style="width: 24px; text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            1.           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            We would not be able to pay our debts as they become due in the usual course of business; or           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">        <tbody>         <tr style="vertical-align: top">          <td style="width: 24px">          </td>          <td style="width: 24px; text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            2.           </font>          </td>          <td style="text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Our total assets would be less than the sum of our total liabilities, plus the amount that would be needed to satisfy the rights of shareholders who have preferential rights superior to those receiving the distribution.           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <b>         Securities Authorized for Issuance under Equity CompensationPlans        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">        On June 13, 2013, our Board of Directors adoptedthe 2013 Equity Incentive Plan (the “Plan”). The purpose of the Plan is to attract and retain the best available personnelfor positions of substantial responsibility with us, to provide additional incentive to employees, directors and consultants, andto promote our success. As of December 31, 2020, under the Plan, as amended, we are currently able to issue up to an aggregatetotal of 3,000,000 incentive or non-qualified options to purchase our common stock, stock awards and other offerings. In March2021, our Board of Directors amended the Plan to increase the number of shares authorized under the plan to 6,000,000 shares.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <b>        </b>       </p>       <!-- Field: Page; Sequence: 17; Value: 1 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         15         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <b>         Equity Compensation Plans as of December 31, 2020        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>        </b>       </p>       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">        <tbody>         <tr style="vertical-align: bottom">          <td style="white-space: nowrap; border-bottom: Black 1.5pt solid">           Equity Compensation Plans Approved by the Shareholders          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>          <td colspan="2" style="white-space: nowrap; text-align: center; border-bottom: Black 1.5pt solid">           Number           <br/>           of Securities to           <br/>           be issued upon           <br/>           exercise           <br/>           of outstanding           <br/>           options or           <br/>           restricted stock           <br/>           awards          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>          <td colspan="2" style="white-space: nowrap; text-align: center; border-bottom: Black 1.5pt solid">           Weighted-           <br/>           average           <br/>           exercise           <br/>           price of           <br/>           outstanding           <br/>           options          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>          <td colspan="2" style="white-space: nowrap; text-align: center; border-bottom: Black 1.5pt solid">           Number of           <br/>           Securities           <br/>           remaining           <br/>           available           <br/>           for future           <br/>           issuance           <br/>           under           <br/>           equity           <br/>           compensation           <br/>           plans          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>         </tr>         <tr style="vertical-align: bottom">          <td>          </td>          <td>          </td>          <td colspan="2" style="text-align: center">          </td>          <td>          </td>          <td>          </td>          <td colspan="2" style="text-align: center">          </td>          <td>          </td>          <td>          </td>          <td colspan="2" style="text-align: center">          </td>          <td>          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="width: 64%; text-align: left">           2013 Equity Compensation Plan - Options          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 9%; text-align: right">           1,545,518          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">           $          </td>          <td style="width: 9%; text-align: right">           7.31          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 9%; text-align: right">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            N/A           </font>          </td>          <td style="width: 1%; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-bottom: 1.5pt">           2013 Equity Compensation Plan – Restricted Stock Awards          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           100,000          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt; text-align: right">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            N/A           </font>          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt; text-align: right">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            N/A           </font>          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="padding-bottom: 4pt">           Total          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           1,645,518          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="padding-bottom: 4pt; text-align: left">           $          </td>          <td style="padding-bottom: 4pt; text-align: right">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            N/A           </font>          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt; text-align: right">           299,461          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <b>         Recent Sales of Unregistered Securities        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The information set forth below relatesto our issuances of securities without registration under the Securities Act of 1933 during the reporting period which were notpreviously included in a Quarterly Report on Form 10-Q or Current Report on Form 8-K.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        In December 2020, we issued 4,010 sharesof restricted common stock to our outside Directors as part of our director compensation package for services rendered in Q4 2020.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        From October through December 2020, weissued 125,918 shares of common stock and received proceeds of $1,156,314 in connection with the exercise of options.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        These securities were issued pursuant toSection 4(2) of the Securities Act and/or Rule 506 promulgated thereunder. The holders represented their intention to acquire thesecurities for investment only and not with a view towards distribution. The investors were given adequate information about usto make an informed investment decision. We did not engage in any general solicitation or advertising. We directed our transferagent to issue the stock certificates with the appropriate restrictive legend affixed to the restricted stock.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <!-- Field: Page; Sequence: 18; Value: 1 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         16         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         <a name="a_010">         </a>         Item 6. Selected Financial Data        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Not required under Regulation S-K for “smallerreporting companies.”       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <a name="a_011">        </a>        <b>         Item 7. Management’s Discussion and Analysis of FinancialCondition and Results of Operations        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <b>         Overview        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <b>        </b>       </p>       <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        We are a pioneering digital health company that provides healthcarecommunications solutions for life science companies to connect and deliver relevant information to healthcare providers and patients.As the largest digital health network of its kind, the OptimizeRx platform bridges the communication gap that exists between keystakeholders in healthcare, including pharmaceutical companies, payers, hospitals, physicians, and patients, providing patientaffordability, access, and adherence directly at the point of care through EHRs and e-prescribing systems.       </p>       <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        Historically, our revenue was generated primarily through thefacilitation of financial messages to health care providers via their EHR and ePrescribe systems using the OptimizeRx proprietarynetwork to solve the ever-increasing communication barriers between pharmaceutical representatives and healthcare providers thathave presented in the rapidly changing healthcare industry. Over time, as the demand for communication of an increasing varietyof different health information between life science companies, providers, and patients continues to rise, our platform has expandedover the years to encompass additional solutions that enable healthcare providers to access information for patients at the pointof care. These solutions include brand messaging, therapeutic support messaging, brand support, and innovative patient engagementservices, all of which now make up a significant portion of our total revenue.       </p>       <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        Our strategic focus remains on growing our existing client baseand generating greater and more consistent revenues in part through our continued shift in our business model toward enterpriselevel engagements with recurring revenue streams, while also broadening our platform with innovative proprietary solutions suchas our TelaRep™ virtual communication solution and our AI-powered real-world evidence solution which uses sophisticated proprietaryalgorithms to derive additional revenue from our existing network. In addition, we have continued to expand our team in preparationfor future growth aspirations, which may be supplemented with future acquisitions and other strategic collaborations and investmentsto further solidify our market dominance in this space.       </p>       <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        Our strategy for driving revenue growth is also expected towork in tandem with our efforts to increase margin and profitability through the use of the aforementioned recurring revenue modelsthat have inherently higher margins.       </p>       <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        Additionally, as the business continues to scale, operatingexpenses are expected to remain relatively consistent given the nature of the Company’s business model, further driving profitability.       </p>       <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        The following discussion includes an analysis and comparisonof the Company’s 2020 and 2019 fiscal year results of operations, liquidity and capital resources, and critical accountingpolicies.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        C        <b>         OVID-19 Business Update        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        During the COVID-19 pandemic, we have remained focused on beinga leading provider of digital health solutions to life science companies and connecting healthcare providers and patients alongthe entire patient journey, while simultaneously expanding our client base, increasing our network of partners, and maintainingthe safety of our employees.       </p>       <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        The COVID-19 pandemic has created unprecedented challenges inthe healthcare industry which has significantly increased the demand for unique solutions ranging from access to accurate and timelyinformation to increasing the accessibility of medications and care management. In March 2020, shortly after the World Health Organization(WHO) declared COVID-19 a global pandemic, we launched a free interactive text message alert program available to the general publicthat delivers current, relevant coronavirus information issued by the Centers for Disease Control and Prevention (CDC) directlyto any SMS-enabled mobile device. In April 2020, we launched our TelaRep communications solution to connect life science companiesand healthcare providers treating patients with specialty drug therapies in an environment facing a critical communication gapwith restricted face-to-face interactions. We also leveraged our digital platform to provide telehealth capabilities for healthcareproviders to adapt to COVID-19 restrictions.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <!-- Field: Page; Sequence: 19; Value: 1 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         17         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        During the beginning of the pandemic and onward, we transitionedour global workforce to working remotely in an effort to maintain the health and safety of our employees. Governments of cities,states, and countries globally have imposed restrictions on travel and business operations, which has curtailed various means ofperforming business and marketing activities such as the attending of health IT conferences. We have been able to continue to achieveour goals by leveraging innovative technology and existing resources while shifting strategies where necessary in areas such assales and marketing. As a result of these practices and initiatives, remote work arrangements and travel restrictions have nothad any adverse effects on our ability to maintain operations or achieve our goals. In addition, we have implemented health andsafety policies in our offices to enable our employees to safely return to traditional working arrangements should it become feasible.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        The COVID-19 pandemic did not have an adverse impact on ourfinancial condition and results of operations in 2020, and we currently do not expect the results of future operations and ournear-and-long-term financial position and growth prospects to be negatively impacted by the pandemic given the nature of the businessand the increased demand for digital health solutions. We reported record year over year and quarterly net revenue results in 2020,and we believe that the markets in which we compete will remain favorable. Additionally, there has been no impact on the accessibilityor terms of acquiring capital; we completed a public offering of common stock in February of 2021.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        Information pertaining to risk factors as it relates to theCOVID-19 pandemic can be found in Item 1A. Risk Factors.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         Results of Operations for the YearsEnded December 31, 2020 and 2019        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         <i>          Net Revenue         </i>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Our net revenue for the year ended December31, 2020 was approximately $43.3 million, an increase of 76% from the year ended December 31, 2019. This increase resulted froma combination of factors, including the shift to enterprise contracts, increased pharmaceutical brands, an increased distributionnetwork, strong growth in our brand messaging solution, and our acquisition of RMDY Health in late 2019. We expect continued strongrevenue growth in 2021 as a result of the foundations laid in 2019 and 2020.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Because the pharmaceutical industry isdominated by large companies with multiple brands, our revenue is concentrated in a relatively small number of companies. We haveapproximately 50 pharmaceutical companies as customers. We have focused our efforts on expanding our customer base and throughour acquisitions, have added medical device manufactures, payers, associations and other entities. In both 2020 and 2019, we hadthree customers that each represented slightly over 10% of our revenues, however only one customer exceeded 10% of revenues inboth years.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         <i>          Cost of Revenues         </i>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Our total cost of revenues, composed primarilyof revenue share expense, increased in the year ended December 31, 2020 compared to the year ended December 31, 2019 due to theincrease in revenues. Our cost of revenues as a percentage of revenue increased from approximately 37% in the year ended December31, 2019 to approximately 44% in the year ended December 31, 2020.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        This increase in our cost of revenues asa percentage of revenue resulted primarily from solution mix, specifically the increase in our core messaging revenues that havehigher revenue share percentages.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <!-- Field: Page; Sequence: 20; Value: 1 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         18         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <b>         <i>         </i>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         <i>          Gross Margin         </i>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Our gross margin, which is simply the differencebetween our revenues and our cost of revenues, discussed above, increased from 2019 to 2020 as a result of the increased revenue.In addition, our gross margin percentage decreased from approximately 63% in 2019 to 56% in 2020 for the reasons discussed abovein the cost of revenues section. We expect our margins to remain in the 56% to 58% range in 2021.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <b>         <i>         </i>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <b>         <i>          Operating Expenses         </i>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Operating expenses increased to approximately$26.2 million for the year ended December 31, 2020, from approximately $19.1 million for the year ended December 31, 2019, an increaseof approximately 37%. The detail by major category is reflected in the table below. Certain 2019 expenses were reclassified inthe table to be comparable to the 2020 presentation.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">        <tbody>         <tr style="vertical-align: bottom">          <td>          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="6" style="white-space: nowrap; text-align: center; border-bottom: Black 1.5pt solid">           Years Ended December 31          </td>          <td style="padding-bottom: 1.5pt">          </td>         </tr>         <tr style="vertical-align: bottom">          <td>          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">           2020          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">           2019          </td>          <td style="padding-bottom: 1.5pt">          </td>         </tr>         <tr style="vertical-align: bottom">          <td>          </td>          <td>          </td>          <td colspan="2">          </td>          <td>          </td>          <td>          </td>          <td colspan="2">          </td>          <td>          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="width: 76%; text-align: left">           Salaries, Wages and Benefits          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">           $          </td>          <td style="width: 9%; text-align: right">           14,538,570          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">           $          </td>          <td style="width: 9%; text-align: right">           8,681,042          </td>          <td style="width: 1%; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left">           Professional Fees          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           1,312,395          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           850,086          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left">           Acquisition Related Costs          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           -          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           799,623          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left">           Board Compensation          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           225,250          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           137,000          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left">           Investor Relations          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           132,652          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           105,639          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td>           Consultants          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           1,053,424          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           425,885          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left">           Advertising and Promotion          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           615,923          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           709,006          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left">           Depreciation and Amortization          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           2,075,888          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           1,282,786          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left">           Research, Development, and Maintenance          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           1,081,137          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           2,282,143          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left">           Integration Incentives          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           811,131          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           208,855          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left">           Office, Facility and Other          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           932,253          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           695,493          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="padding-bottom: 1.5pt">           Travel          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           289,277          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           695,283          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td>          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td>           Subtotal          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           23,067,900          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           16,872,841          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td>          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-bottom: 1.5pt">           Stock-based Compensation          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           3,172,840          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           2,260,298          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td>          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-bottom: 4pt">           Total Operating Expense          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           26,240,740          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           19,133,139          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The main drivers for the overall increasein operating expenses in 2020 was our focus on staffing and scaling our company to foster, and be able to support, acceleratedrevenue growth.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Within the operating expenses, there werea variety of increases, the largest of which was in salaries, wages and benefits, as a result of additional staff added in 2019and 2020, including related benefits. During 2019, we hired a chief commercial officer, a chief technology officer, five new salespeople,a human resources manager, as well as other administrative positions at various times throughout the year. We also added 14 employeesas a result of our RMDY acquisition in October 2019. These 2019 additions were there for the entire year in 2020. During 2020,we added to our staff in several key areas, including a head of product development, additional sales people, and additional ITpeople, among others. We expect our compensation expense to increase in 2021, but at a much lower rate than in 2020.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Professional fees increased primarily becauseof costs associated with our audit, as a result of our change to a larger, national firm, as well as increased legal costs dueto the increased complexity of our contracts. In addition, we incurred costs related to the finalization of our RMDY earnout.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <!-- Field: Page; Sequence: 21; Value: 1 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         19         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Acquisition costs are related to our acquisitionof RMDY Health in 2019. These costs include investment banker fees, legal and accounting due diligence, audit costs associatedwith RMDY, valuation experts for the purchase price allocation, and other miscellaneous costs.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Board compensation increased slightly from2019 to 2020 due to both an increase in the size of our board as well as a revision of the board compensation structure to paya larger portion in cash and a smaller portion in stock. This represents only the cash portion.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The cost of consultants increased from2019 to 2020. The primary reason for the increase was related to consultants used in the IT area, primarily in the patient engagementarea, resulting from a full year of activity from the former RMDY Health business as opposed to a partial year in 2019.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Our advertising and promotion costs decreasedsignificantly from 2019 to 2020 as a result of a reduction in the sponsorship of, and attendance at, conferences as a result ofthe global pandemic.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Expenses related to research, development,management, and maintenance of our technology decreased in 2020 to more normal levels, as 2019 included significant nonrecurringresearch projects.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Integration incentives and exclusivityfees, which are fees paid to accelerate access to new partners and payments for exclusivity, increased in 2020, as we signed morecontracts and contracts with larger payments related to 2020.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Depreciation and amortization increasedsignificantly in 2020 from the 2019 levels. The increased amortization resulting from the acquisition of RMDY Health, and the resultingintangible assets were amortized for a full year in 2020 as opposed to only part of the fourth quarter in 2019. We expect depreciationand amortization expense in 2021 to be similar to 2020 levels.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Office, facility, and other costs increasedfrom 2019 to 2020. The main reason for the change related to a higher level of activity with more employees.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Stock based compensation increased by approximately$900,000 from $2.3 million in 2019 to $3.2 million in 2020 primarily because of more employees and an increase in our stock price.There is a relationship between the price of the stock at the time of the option grant and the value of the option, resulting ina higher cost when the stock price is higher.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         <i>          Net Loss         </i>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        We finished the year ended December 31,2020 with a net loss of approximately $2.2 million, as compared to a net loss of approximately $3.1 million during the year endedDecember 31, 2019. The reasons for specific components are discussed above. Overall, we had an increase in revenue and gross marginpartially offset by increased operating expenses to support future growth. In addition, the income in both periods included significantnoncash items. We had approximately $3.5 million in noncash operating expenses in 2019 and approximately $5.2 million in noncashoperating expenses in 2020.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <!-- Field: Page; Sequence: 22; Value: 1 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         20         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         Quarterly Financial Information        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        Following is a table of our quarterly operating results for2020 for information purposes.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">        <tbody>         <tr style="vertical-align: bottom">          <td style="text-align: center">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">           First           <br/>           Quarter          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">           Second           <br/>           Quarter          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">           Third           <br/>           Quarter          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">           Fourth           <br/>           Quarter          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">           Total Year          </td>          <td style="padding-bottom: 1.5pt">          </td>         </tr>         <tr style="vertical-align: bottom">          <td>          </td>          <td>          </td>          <td colspan="2">          </td>          <td>          </td>          <td>          </td>          <td colspan="2">          </td>          <td>          </td>          <td>          </td>          <td colspan="2">          </td>          <td>          </td>          <td>          </td>          <td colspan="2">          </td>          <td>          </td>          <td>          </td>          <td colspan="2">          </td>          <td>          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="width: 40%">           Revenues          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">           $          </td>          <td style="width: 9%; text-align: right">           7,584,602          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">           $          </td>          <td style="width: 9%; text-align: right">           8,783,230          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">           $          </td>          <td style="width: 9%; text-align: right">           10,519,191          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">           $          </td>          <td style="width: 9%; text-align: right">           16,426,301          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">           $          </td>          <td style="width: 9%; text-align: right">           43,313,324          </td>          <td style="width: 1%; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td>          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="padding-bottom: 1.5pt">           Cost of revenues          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           3,241,763          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           3,639,016          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           4,504,844          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           7,822,280          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           19,207,903          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td>          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left">           Gross Profit          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           4,342,839          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           5,144,214          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           6,014,347          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           8,604,021          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           24,105,421          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td>          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-bottom: 1.5pt">           Operating Expenses          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           6,602,091          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           6,200,027          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           6,191,069          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           7,247,553          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           26,240,740          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td>          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left">           Income (Loss) from Operations          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           (2,259,252          </td>          <td style="text-align: left">           )          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           (1,055,813          </td>          <td style="text-align: left">           )          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           (176,722          </td>          <td style="text-align: left">           )          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           1,356,468          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           (2,135,319          </td>          <td style="text-align: left">           )          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td>          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-bottom: 1.5pt">           Other income (expense)          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           55,321          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           (21,655          </td>          <td style="padding-bottom: 1.5pt; text-align: left">           )          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           (106,172          </td>          <td style="padding-bottom: 1.5pt; text-align: left">           )          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           698          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           (71,808          </td>          <td style="padding-bottom: 1.5pt; text-align: left">           )          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td>          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left">           Income (loss) before Taxes          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           (2,203,931          </td>          <td style="text-align: left">           )          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           (1,077,468          </td>          <td style="text-align: left">           )          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           (282,894          </td>          <td style="text-align: left">           )          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           1,357,166          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           (2,207,127          </td>          <td style="text-align: left">           )          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td>          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-bottom: 1.5pt">           Income tax benefit          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           -          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           -          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           -          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           -          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           -          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td>          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-bottom: 1.5pt">           Net Income (Loss)          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           (2,203,931          </td>          <td style="padding-bottom: 1.5pt; text-align: left">           )          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           (1,077,468          </td>          <td style="padding-bottom: 1.5pt; text-align: left">           )          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           (282,894          </td>          <td style="padding-bottom: 1.5pt; text-align: left">           )          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           1,357,166          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           (2,207,127          </td>          <td style="padding-bottom: 1.5pt; text-align: left">           )          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td>          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td>           Earnings (loss) per share          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="padding-left: 0.125in">           Basic          </td>          <td>          </td>          <td style="text-align: left">           $          </td>          <td style="text-align: right">           (0.15          </td>          <td style="text-align: left">           )          </td>          <td>          </td>          <td style="text-align: left">           $          </td>          <td style="text-align: right">           (0.07          </td>          <td style="text-align: left">           )          </td>          <td>          </td>          <td style="text-align: left">           $          </td>          <td style="text-align: right">           (0.02          </td>          <td style="text-align: left">           )          </td>          <td>          </td>          <td style="text-align: left">           $          </td>          <td style="text-align: right">           0.09          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">           $          </td>          <td style="text-align: right">           (0.15          </td>          <td style="text-align: left">           )          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="padding-bottom: 1.5pt; padding-left: 0.125in">           Diluted          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">           $          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           (0.15          </td>          <td style="padding-bottom: 1.5pt; text-align: left">           )          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">           $          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           (0.07          </td>          <td style="padding-bottom: 1.5pt; text-align: left">           )          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">           $          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           (0.02          </td>          <td style="padding-bottom: 1.5pt; text-align: left">           )          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">           $          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           0.08          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">           $          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           (0.15          </td>          <td style="padding-bottom: 1.5pt; text-align: left">           )          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Sum of four quarterly per share amountsdoes not equal annual total due to rounding and the mechanics of the weighted average shares outstanding calculation.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <!-- Field: Page; Sequence: 23; Value: 1 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         21         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        Following is a table of our quarterly operating results for2019 for information purposes.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">        <tbody>         <tr style="vertical-align: bottom">          <td style="text-align: center">          </td>          <td style="text-align: center; padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">           First           <br/>           Quarter          </td>          <td style="text-align: center; padding-bottom: 1.5pt">          </td>          <td style="text-align: center; padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">           Second           <br/>           Quarter          </td>          <td style="text-align: center; padding-bottom: 1.5pt">          </td>          <td style="text-align: center; padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">           Third           <br/>           Quarter          </td>          <td style="text-align: center; padding-bottom: 1.5pt">          </td>          <td style="text-align: center; padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">           Fourth           <br/>           Quarter          </td>          <td style="text-align: center; padding-bottom: 1.5pt">          </td>          <td style="text-align: center; padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">           Total Year          </td>          <td style="text-align: center; padding-bottom: 1.5pt">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: justify">          </td>          <td>          </td>          <td colspan="2" style="text-align: justify">          </td>          <td>          </td>          <td>          </td>          <td colspan="2" style="text-align: justify">          </td>          <td>          </td>          <td>          </td>          <td colspan="2" style="text-align: justify">          </td>          <td>          </td>          <td>          </td>          <td colspan="2" style="text-align: justify">          </td>          <td>          </td>          <td>          </td>          <td colspan="2" style="text-align: justify">          </td>          <td>          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="width: 40%; text-align: justify">           Revenues          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">           $          </td>          <td style="width: 9%; text-align: right">           5,209,434          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">           $          </td>          <td style="width: 9%; text-align: right">           7,006,291          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">           $          </td>          <td style="width: 9%; text-align: right">           5,002,767          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">           $          </td>          <td style="width: 9%; text-align: right">           7,379,782          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">           $          </td>          <td style="width: 9%; text-align: right">           24,598,274          </td>          <td style="width: 1%; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: justify">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: justify; padding-bottom: 1.5pt">           Cost of revenues          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           1,583,480          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           2,687,143          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           1,981,143          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           2,906,933          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           9,158,699          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: justify">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: justify">           Gross Profit          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           3,625,954          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           4,319,148          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           3,021,624          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           4,472,849          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           15,439,575          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: justify">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: justify; padding-bottom: 1.5pt">           Operating Expenses          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           3,493,789          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           3,839,105          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           5,008,934          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           6,791,311          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           19,133,139          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: justify">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: justify">           Income (Loss) from Operations          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           132,165          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           480,043          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           (1,987,310          </td>          <td style="text-align: left">           )          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           (2,318,462          </td>          <td style="text-align: left">           )          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           (3,693,564          </td>          <td style="text-align: left">           )          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: justify">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: justify; padding-bottom: 1.5pt">           Other income (expense)          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           (125,636          </td>          <td style="padding-bottom: 1.5pt; text-align: left">           )          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           (73,426          </td>          <td style="padding-bottom: 1.5pt; text-align: left">           )          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           416,368          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           (564,278          </td>          <td style="padding-bottom: 1.5pt; text-align: left">           )          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           (346,972          </td>          <td style="padding-bottom: 1.5pt; text-align: left">           )          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: justify">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: justify">           Income (loss) before Taxes          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           6,529          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           406,617          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           (1,570,942          </td>          <td style="text-align: left">           )          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           (2,882,740          </td>          <td style="text-align: left">           )          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           (4,040,536          </td>          <td style="text-align: left">           )          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: justify">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: justify; padding-bottom: 1.5pt">           Income tax benefit          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           -          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           -          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           -          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           897,960          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           897,960          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: justify">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: justify; padding-bottom: 1.5pt">           Net Income (Loss)          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           6,529          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           406,617          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           (1,570,942          </td>          <td style="padding-bottom: 1.5pt; text-align: left">           )          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           (1,984,780          </td>          <td style="padding-bottom: 1.5pt; text-align: left">           )          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           (3,142,576          </td>          <td style="padding-bottom: 1.5pt; text-align: left">           )          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: justify">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: justify">           Earnings (loss) per share          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: justify; padding-left: 9pt">           Basic          </td>          <td>          </td>          <td style="text-align: left">           $          </td>          <td style="text-align: right">           0.00          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">           $          </td>          <td style="text-align: right">           0.03          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">           $          </td>          <td style="text-align: right">           (0.11          </td>          <td style="text-align: left">           )          </td>          <td>          </td>          <td style="text-align: left">           $          </td>          <td style="text-align: right">           (0.14          </td>          <td style="text-align: left">           )          </td>          <td>          </td>          <td style="text-align: left">           $          </td>          <td style="text-align: right">           (0.23          </td>          <td style="text-align: left">           )          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: justify; padding-bottom: 1.5pt; padding-left: 9pt">           Diluted          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">           $          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           0.00          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">           $          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           0.03          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">           $          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           (0.11          </td>          <td style="padding-bottom: 1.5pt; text-align: left">           )          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">           $          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           (0.14          </td>          <td style="padding-bottom: 1.5pt; text-align: left">           )          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">           $          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           (0.23          </td>          <td style="padding-bottom: 1.5pt; text-align: left">           )          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         Liquidity and Capital Resources        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        As of December 31, 2020, we had total currentassets of approximately $32.9 million, compared with current liabilities of approximately $10.0 million, resulting in working capitalof approximately $22.9 million and a current ratio of approximately 3.3 to 1. This compares with the working capital balance ofapproximately $21.0 million and the current ratio of 4.4 to 1 at December 31, 2019. This increase in working capital, as discussedin more detail below, is primarily the result of the earnings before non-cash expenses.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Following is a table with summary datafrom the consolidated statement of cash flows for the years ended December 31, 2020 and 2019, as presented.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">        <tbody>         <tr style="vertical-align: bottom">          <td style="text-align: justify">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">           2020          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">           2019          </td>          <td style="padding-bottom: 1.5pt">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="width: 76%; text-align: justify">           Net cash used in operating activities          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">           $          </td>          <td style="width: 9%; text-align: right">           (6,310,386          </td>          <td style="width: 1%; text-align: left">           )          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">           $          </td>          <td style="width: 9%; text-align: right">           (1,660,796          </td>          <td style="width: 1%; text-align: left">           )          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: justify">           Net cash used in investing activities          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           (124,725          </td>          <td style="text-align: left">           )          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           (10,582,086          </td>          <td style="text-align: left">           )          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: justify; padding-bottom: 1.5pt">           Net cash provided by (used in) financing activities          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           (1,900,793          </td>          <td style="padding-bottom: 1.5pt; text-align: left">           )          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           22,181,528          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: justify">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: justify; padding-bottom: 1.5pt">           Net increase in cash and cash equivalents          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">           $          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           (8,335,904          </td>          <td style="padding-bottom: 1.5pt; text-align: left">           )          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">           $          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           9,938,646          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Our operating activities used approximately$6.3 million in the year ended December 31, 2020, as compared with approximately $1.7 million used in operating activities in theyear ended December 31, 2019. The cash used in both 2019 and 2020 was the result of our net loss and the increased working capitalrequired to support higher revenues, partially offset by our non-cash expenses.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        We used approximately $125,000 in investingactivities in 2020, primarily as the result of purchase of assets. The majority of our approximately $10.6 million in investingin activities in 2019 related to our acquisitions of RMDY Health, Inc., as well as a software purchase.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <!-- Field: Page; Sequence: 24; Value: 1 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         22         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Financing activities provided approximately$22.2 million in the year ended December 31, 2019. The cash provided in 2019 was the result of our underwritten offering in 2019,as well as from the proceeds of option exercises. We used cash of approximately $1.9 million in 2020 as the result of proceedsof option exercises, partially offset by the payment of contingent consideration related to previous acquisitions.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        With our cash on hand, we have sufficientcash to operate our business for more than the next 12 months and we have raised approximately $71 million in February 2021 thatwill enable us to continue to expand our business and accelerate revenue growth. We do not anticipate the need to raise any additionalcash.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         Off Balance Sheet Arrangements        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        As of December 31, 2020, there were nooff-balance sheet arrangements.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         Critical Accounting Policies        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        A “critical accounting policy”is one which is both important to the portrayal of a company’s financial condition and results, and requires management’smost difficult, subjective, or complex judgments, often as a result of the need to make estimates about the effect of matters thatare inherently uncertain.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Our accounting policies are discussed indetail in the footnotes to our financial statements included in this Annual Report on Form 10-K for the year ended December 31,2020; however, we consider our critical accounting policies to be those related to revenue recognition, calculation of revenueshare expense (cost of revenues), stock-based compensation, capitalization and related amortization of intangible assets and impairmentof assets. Following is a summary of those policies.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <u>         Revenue Recognition        </u>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Recognition of revenue requires evidenceof a contract, probable collection of proceeds, and completion of substantially all performance obligations. We use a 5-step modelto recognize revenue. These steps are: identify the contract with a customer, identify the performance obligations in the contract,determine the transaction price, allocate the transaction price to the performance obligations in the contract, and recognize revenuewhen or as the performance obligations are satisfied.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Revenues are primarily generated from contentdelivery activities in which we deliver financial, clinical, or brand messaging through a distribution network of eprescribersand electronic health record technology providers (channel partners), directly to consumers, or from reselling services that complementthe business. This content delivery for a customer is referred to as a program. Unless otherwise specified, revenue is recognizedbased on the selling price to customers.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Our contracts are generally all less thanone year and the primary performance obligation is delivery of messages or other forms of content, but the contract may containadditional services. Additional services may include program design, which is the design of the content delivery program, set up,and reporting. We consider set up and reporting services to be complimentary to the primary performance obligation and recognizedthrough performance of the delivery of content. We consider these design of the programs and related consulting services to beperformance obligations separate from the delivery of messages.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        As the content is distributed through theplatform and network of channel partners (a transaction), these transactions are recorded, and revenue is recognized, over timeas the distributions occur. Revenue for transactions can be realized based on a price per message, a price per redemption, as aflat fee occurring over a period of time, or upon completion of the program, depending on the client contract. We recognize setupfees that are required for integrating client offerings and campaigns into the rule-based content delivery system and network overthe life of the initial program, based either on time, or units delivered, depending upon which is most appropriate in the specificsituation. Should a program be cancelled before completion, the balance of set up revenue is recognized at the time of cancellation,as set up fees are nonrefundable. Additionally, we also recognizes revenue for providing program performance reporting and maintenance,either by our company directly delivering reports or by providing access to its online reporting portal that the client can utilize.This reporting revenue is recognized over time as the messages are delivered. Program design, which is the design of the contentdelivery program, and related consulting services are recognized as services are performed.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <!-- Field: Page; Sequence: 25; Value: 1 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         23         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        We do not disaggregate our revenue as virtuallyall types of revenue are generated through the same core group of customers and generally all involve the delivery of content.Different types of revenue are not impacted by economic factors that affect the nature, amount, timing, or uncertainty of revenuesor cash flows.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        In some instances, we also resell messagingsolutions that are available through channel partners that are complementary to the core business and client base. These partnerspecific solutions are frequently similar to our own solutions and revenue recognition for these programs is the same as describedabove. In instances where we sell solutions on a commission basis, net revenue is recognized based on the commission-based revenuesplit that we receive. There were only minor immaterial programs recorded on a net basis in the years presented. In instances wherewe resell these messaging solutions and have all financial risk and significant operation input and risk, we record the revenuebased on the gross amount sold and the amount paid to the channel partner as a cost of sales.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <u>         Cost of Revenues        </u>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The primary cost of revenue is revenueshare expense. Based on the volume of transactions that are delivered through the channel partner network, we provide a revenueshare to compensate the partner for their promotion of the campaign. Revenue shares are a negotiated percentage of the transactionfees and can also be specific to special considerations and campaigns. In addition, we pay revenue share to ConnectiveRx (formerlyLDM/PDR) as a result of a 2014 legal settlement in an amount equal to the greater of 10% of financial messaging distribution revenuesgenerated through our integrated network, or $0.37 per financial message distributed through our integrated network. The contractualamount due to the channel partners is recorded as an expense at the time the message is distributed.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <u>         Intangible Assets        </u>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Intangible assets are stated at cost. Finite-livedassets are being amortized over their estimated useful lives of 15 to 17 years for patents, 8 to 15 years for customer relationships,2 to 4 years for covenants not to compete, 10 years for technology, and 3 to 4 years for software and websites, all using the straight-linemethod. These assets, as well as our indefinite-lived asset, are evaluated annually in our fiscal fourth quarter for impairment.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <u>         Goodwill        </u>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        We evaluate goodwill for impairment duringour fiscal fourth quarter, or more frequently if an event occurs or circumstances change. We determined there was no impairmentas goodwill had a fair value comfortably in excess of its carrying value.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <u>         Stock-based Compensation        </u>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        We use the fair value method to accountfor stock-based compensation. The fair value of the equity instrument is charged directly to compensation expense and additionalpaid-in capital over the period during which services are rendered. The fair value of each award is estimated on the date of eachgrant. For restricted stock, the fair market value is based on the market value of the stock granted on the date of the grant.For options, it is estimated using the Black-Scholes option pricing model that uses the following assumptions. Estimated volatilitiesare based on the historical volatility of our stock over the same period as the expected term of the options. The expected termof options granted represents the period of time that options granted are expected to be outstanding. We use historical data toestimate option exercise behavior and to determine this term. The risk-free rate used is based on the U.S. Treasury yield curvein effect at the time of the grant using a time period equal to the expected option term. We have never paid dividends and do notexpect to pay any dividends in the future.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The Black-Scholes option valuation modeland other existing models were developed for use in estimating the fair value of traded options that have no vesting restrictionsand are fully transferable. These option valuation models require the input of, and are highly sensitive to, subjective assumptionsincluding the expected stock price volatility. Our stock options have characteristics significantly different from those of tradedoptions, and changes in the subjective input assumptions could materially affect the fair value estimate.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <!-- Field: Page; Sequence: 26; Value: 1 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         24         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         Recently Issued Accounting Pronouncements        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        In June 2016, the Financial AccountingStandards Board (the “FASB”) issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of CreditLosses on Financial Instruments. ASU 2016-13 provides for a new impairment model that requires measurement and recognition of expectedcredit losses for most financial assets and certain other instruments, including but not limited to accounts receivable and availablefor sale debt securities. ASU 2016-13 was effective for us on January 1, 2020. The adoption of this standard did not have a materialeffect on our financial position, results of operations, or cash flows.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        In August 2019, the FASB issued ASU 2018-13,Fair Value Measurement (Topic 820): Disclosure Framework-Changes to the Disclosure Requirements for Fair Value Measurement. ASU2018-13 modifies the disclosure requirements on fair value measurements and became effective for us on January 1, 2020. The adoptionof this standard did not have a material effect on our financial position, results of operations, or cash flows.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        In January 2017, the FASB issued ASU 2017-04,Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. ASU 2017-04 simplifies the subsequentmeasurement of goodwill by eliminating the second step of the goodwill impairment test. The second step measures a goodwill impairmentloss by comparing the implied fair value of a reporting unit’s goodwill with the carrying amount of that goodwill. UnderASU 2017-04, a company will record an impairment charge based on the excess of a reporting unit’s carrying amount over itsfair value. ASU 2017-04 will be applied prospectively and is effective for annual or interim goodwill impairment tests in fiscalyears beginning after December 15, 2019. Early adoption is permitted for interim or annual goodwill impairment tests performedon testing dates after January 1, 2017. The adoption of this standard did not have a material effect on our financial position,results of operations, or cash flows.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <i>         Not Yet Adopted        </i>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        In December 2019, the FASB issued ASU No.2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. ASU 2019-12 is intended to improve consistent applicationand simplify the accounting for income taxes. ASU 2019-12 removes certain exceptions to the general principles in Topic 740 andclarifies and amends existing guidance. ASU 2019-12 is effective for annual and interim reporting periods beginning after December15, 2020, with early adoption permitted. The adoption of this standard is not expected to have a material effect on our financialposition, results of operations, or cash flows.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <!-- Field: Page; Sequence: 27; Value: 1 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         25         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <b>         <a name="a_012">         </a>         Item 8. Financial Statements and Supplementary Data        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Index to Financial Statements Requiredby Article 8 of Regulation S-X:       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">        <tbody>         <tr style="vertical-align: top; background-color: white">          <td colspan="2">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             Audited Financial Statements:            </b>           </font>          </td>         </tr>         <tr style="vertical-align: top; background-color: white">          <td colspan="2">          </td>         </tr>         <tr style="vertical-align: top; background-color: white">          <td style="width: 5%">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            F-1           </font>          </td>          <td style="width: 95%">           <a href="#F_001">            <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">             Reports of Independent Registered Public Accounting Firms;            </font>           </a>          </td>         </tr>         <tr style="vertical-align: top; background-color: white">          <td>           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            F-4           </font>          </td>          <td>           <a href="#F_002">            <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">             Consolidated Balance Sheets as of December 31, 2020 and 2019;            </font>           </a>          </td>         </tr>         <tr style="vertical-align: top; background-color: white">          <td>           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            F-5           </font>          </td>          <td>           <a href="#F_003">            <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">             Consolidated Statements of Operations for the years ended December 31, 2020 and 2019;            </font>           </a>          </td>         </tr>         <tr style="vertical-align: top; background-color: white">          <td>           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            F-6           </font>          </td>          <td>           <a href="#F_004">            <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">             Consolidated Statement of Stockholders’ Equity for the year ended December 31, 2020;            </font>           </a>          </td>         </tr>         <tr style="vertical-align: top; background-color: white">          <td>           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            F-7           </font>          </td>          <td>           <a href="#F_005">            <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">             Consolidated Statement of Stockholders’ Equity for the year ended December 31, 2019;            </font>           </a>          </td>         </tr>         <tr style="vertical-align: top; background-color: white">          <td>           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            F-8           </font>          </td>          <td>           <a href="#F_006">            <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">             Consolidated Statements of Cash Flows for the years ended December 31, 2020 and 2019; and            </font>           </a>          </td>         </tr>         <tr style="vertical-align: top; background-color: white">          <td>           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            F-9           </font>          </td>          <td>           <a href="#F_007">            <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">             Notes to Consolidated Financial Statements            </font>           </a>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <b>        </b>       </p>       <!-- Field: Page; Sequence: 28; Value: 1 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         26         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">        <img alt="" src="image_001.jpg"/>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <font style="background-color: white">         <a name="F_001">         </a>         Reportof Independent Registered Public Accounting Firm        </font>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">        <font style="background-color: white">         To theShareholders and Board of Directors of         <br/>         OptimizeRx Corporation        </font>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <font style="background-color: white">         <b>          Opinionon the Financial Statements         </b>        </font>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <font style="background-color: white">         Wehave audited the accompanying consolidated balance sheet of OptimizeRx Corporation and Subsidiaries (the “Company”)as of December 31, 2020, and the related consolidated statements of operations, stockholders’ equity and cash flows for theyear then ended, and the related notes (collectively referred to as the “consolidated financial statements”). In ouropinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Companyas of December 31, 2020, and the results of its operations and its cash flows for the year then ended, in conformity with accountingprinciples generally accepted in the United States of America.        </font>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <font style="background-color: white">         <b>          Basisfor Opinion         </b>        </font>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <font style="background-color: white">         Theseconsolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express anopinion on the Company’s consolidated financial statements based on our audit. We are a public accounting firm registeredwith the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent withrespect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securitiesand Exchange Commission and the PCAOB.        </font>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <font style="background-color: white">         Weconducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit toobtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether dueto error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financialreporting. As part of our audit, we are required to obtain an understanding of internal control over financial reporting, but notfor the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting.Accordingly, we express no such opinion.        </font>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <font style="background-color: white">         Ouraudit included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whetherdue to error or fraud, and performing procedures that respond to those risks. Such procedures include examining, on a test basis,evidence regarding the amounts and disclosures in the consolidated financial statements. Our audit also included evaluating theaccounting principles used and significant estimates made by management, as well as evaluating the overall presentation of theconsolidated financial statements. We believe that our audit provides a reasonable basis for our opinion.        </font>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <font style="background-color: white">         <b>          CriticalAudit Matter         </b>        </font>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The critical audit matter communicatedbelow is a matter arising from the current period audit of the consolidated financial statements that were communicated or requiredto be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the consolidatedfinancial statements and (2) involved especially challenging, subjective, or complex judgments. The communication of critical auditmatters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicatingthe critical audit matter below, providing separate opinions on the critical audit matter or on the accounts or disclosures towhich they related.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <!-- Field: Page; Sequence: 29; Options: NewSection; Value: 1 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         F-         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         1         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">        <font style="background-color: white">         To theShareholders and Board of Directors of         <br/>         OptimizeRx Corporation        </font>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Page Two       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <font style="background-color: white">         <i>          <u>           CriticalAudit Matter - Revenue Recognition          </u>         </i>        </font>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <i>        </i>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <font style="background-color: white">         Asdisclosed in Note 2 to the consolidated financial statements, the        </font>        Company recognizes revenue upon transfer of control ofpromised products or services to customers in an amount that reflects the consideration the Company expects to receive in exchangefor those products or services.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Significant judgment is excised by theCompany in determining revenue recognition for these customer agreements, and includes the following: (1) determining whether servicesare considered distinct performance obligations that should be accounted for separately versus together (2) the pattern and timingof delivery for each distinct performance obligation, and (3) identification and treatment of contract terms that may impact thetiming and amount of revenue recognized.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <i>        </i>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <font style="background-color: white">         <i>          <u>           Howthe Critical Audit Matter Was Addressed in the Audit          </u>         </i>        </font>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The        <font style="background-color: white">         auditprocedures we performed to address this critical audit matter included the following: (1) obtaining an understanding of thedesign and implementation of controls related to identifying distinct performance obligations, determining the timing ofrevenue recognition and any estimation of variable consideration, (2) selection of a sample of customer agreements andtesting management’s identification and treatment of contract terms, and testing the mathematical accuracy ofmanagement’s calculations of revenue and the associated timing of revenue recognized in the consolidated financialstatements.        </font>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        We have served as the Company’s auditor since 2020.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">        <tbody>         <tr style="vertical-align: top">          <td style="padding-bottom: 1.5pt; width: 40%">          </td>          <td style="padding-bottom: 1.5pt; width: 60%; font-size: 10pt">          </td>         </tr>         <tr style="vertical-align: top">          <td style="border-bottom: Black 1.5pt solid; font-size: 10pt">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            /s/ UHY LLP           </font>          </td>          <td style="padding-bottom: 1.5pt; font-size: 10pt">          </td>         </tr>         <tr style="vertical-align: top">          <td style="padding-right: 4.5pt; padding-left: 4.5pt; font-size: 10pt">          </td>          <td style="font-size: 10pt">          </td>         </tr>         <tr style="vertical-align: top">          <td style="padding-right: 0; padding-left: 0">           <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">            <font style="background-color: white">             Sterling Heights, Michigan            </font>           </p>           <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">            March 8, 2021           </p>          </td>          <td style="font-size: 10pt">          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <!-- Field: Page; Sequence: 30; Value: 1 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         F-         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         2         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         <u>          REPORT OF INDEPENDENT REGISTEREDPUBLIC ACCOUNTING FIRM         </u>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        To the Shareholders and Board of Directorsof       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        OptimizeRx Corporation       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         Opinion on the Financial Statements        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        We have audited the accompanying consolidatedbalance sheet of OptimizeRx Corporation and Subsidiaries (the “Company”) as of December 31, 2019, and the related consolidatedstatements of operations,  stockholders’ equity and cash flows for the year then ended, and the related notes (collectivelyreferred to as the “financial statements”).  In our opinion, the financial statements present fairly, in all materialrespects, the financial position of the Company as of December 31, 2019, and the results of its operations and its cash flows forthe year then ended, in conformity with accounting principles generally accepted in the United States of America.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        We also have audited, in accordance with the standards of thePublic Company Accounting Oversight Board (United States) ("PCAOB"), the Company's internal control over financial reportingas of December 31, 2019, based on the criteria established in Internal Control - Integrated Framework issued by the Committee ofSponsoring Organizations of the Treadway Commission (COSO) in 2013 and our report dated March 26, 2020, expressed an adverse opinionon the effectiveness of the Company’s internal control over financial reporting because of the existence of material weaknesses.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         Adoption of New Accounting Standards        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        As discussed in Note 2 to the financialstatements, the Company changed its method of accounting for leases in 2019 due to the adoption of ASU No. 2016-02, Leases (Topic842), as amended, effective January 1, 2019, using the modified retrospective approach.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         Basis for Opinion        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        These financial statements are the responsibilityof the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audit.We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordancewith the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and thePCAOB.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        We conducted our audit in accordance withthe standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whetherthe financial statements are free of material misstatement, whether due to error or fraud. Our audit included performing proceduresto assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing proceduresthat respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosuresin the consolidated financial statements. Our audit also included evaluating the accounting principles used and significant estimatesmade by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that ouraudit provides a reasonable basis for our opinion.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        /s/ Marcum        <font style="font-variant: small-caps">         llp        </font>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <font style="font-variant: small-caps">        </font>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        Marcum        <font style="font-variant: small-caps">         llp        </font>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <font style="font-variant: small-caps">        </font>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        We served as the Company’s auditor from 2019 to 2020.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        New York, NY       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        March 26, 2020       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <!-- Field: Page; Sequence: 31; Value: 1 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         F-         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         3         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         <a name="F_002">         </a>         OPTIMIZERx CORPORATION        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         Consolidated Balance Sheets        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       </p>       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">        <tbody>         <tr style="vertical-align: bottom">          <td style="white-space: nowrap">          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>          <td colspan="2" style="white-space: nowrap; text-align: center; border-bottom: Black 1.5pt solid">           December 31,           <br/>           2020          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>          <td colspan="2" style="white-space: nowrap; text-align: center; border-bottom: Black 1.5pt solid">           December 31,           <br/>           2019          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="font-weight: bold; text-align: center">           ASSETS          </td>          <td>          </td>          <td colspan="2" style="text-align: right">          </td>          <td>          </td>          <td>          </td>          <td colspan="2" style="text-align: right">          </td>          <td>          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: center">          </td>          <td>          </td>          <td colspan="2" style="text-align: right">          </td>          <td>          </td>          <td>          </td>          <td colspan="2" style="text-align: right">          </td>          <td>          </td>         </tr>         <tr style="vertical-align: bottom">          <td>           Current Assets          </td>          <td>          </td>          <td colspan="2" style="text-align: right">          </td>          <td>          </td>          <td>          </td>          <td colspan="2" style="text-align: right">          </td>          <td>          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="width: 76%; text-align: left; text-indent: -10pt; padding-left: 0.25in">           Cash and cash equivalents          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">           $          </td>          <td style="width: 9%; text-align: right">           10,516,776          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">           $          </td>          <td style="width: 9%; text-align: right">           18,852,680          </td>          <td style="width: 1%; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; text-indent: -10pt; padding-left: 0.25in">           Accounts receivable, net          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           17,885,705          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           7,418,025          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 0.25in">           Prepaid expenses          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           4,456,611          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           871,043          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt">           Total Current Assets          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           32,859,092          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           27,141,748          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt">           Property and equipment, net          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           148,854          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           176,014          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">           Other Assets          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-indent: -10pt; padding-left: 0.25in">           Goodwill          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           14,740,031          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           14,740,031          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; text-indent: -10pt; padding-left: 0.25in">           Technology assets, net          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           5,251,822          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           6,238,453          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; text-indent: -10pt; padding-left: 0.25in">           Patent rights, net          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           2,349,570          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           2,550,587          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; text-indent: -10pt; padding-left: 0.25in">           Right of use assets, net          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           445,974          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           559,863          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; text-indent: -10pt; padding-left: 0.25in">           Other intangible assets, net          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           4,519,552          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           5,151,102          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 0.25in">           Security deposits and other assets          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           12,859          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           80,727          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt">           Total Other Assets          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           27,319,808          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           29,320,763          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-bottom: 4pt; text-indent: -10pt; padding-left: 10pt">           TOTAL ASSETS          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           60,327,754          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           56,638,525          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-indent: -10pt; padding-left: 10pt">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="font-weight: bold; text-align: center; padding-left: 10pt">           LIABILITIES AND STOCKHOLDERS’ EQUITY          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: center; padding-left: 10pt">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">           Current Liabilities          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; text-indent: -10pt; padding-left: 0.25in">           Accounts payable – trade          </td>          <td>          </td>          <td style="text-align: left">           $          </td>          <td style="text-align: right">           618,250          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">           $          </td>          <td style="text-align: right">           492,995          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; text-indent: -10pt; padding-left: 0.25in">           Accrued expenses          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           2,420,361          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           1,800,635          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-indent: -10pt; padding-left: 0.25in">           Revenue share payable          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           4,969,868          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           1,618,438          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; text-indent: -10pt; padding-left: 0.25in">           Current portion of lease liabilities          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           123,220          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           115,431          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; text-indent: -10pt; padding-left: 0.25in">           Contingent purchase price payable          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           1,610,813          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           1,500,000          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 0.25in">           Deferred revenue          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           285,795          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           580,014          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 0.25in">           Total Current Liabilities          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           10,028,307          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           6,107,513          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">           Non-current Liabilities          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">           Lease liabilities, net of current portion          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           325,533          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           448,753          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 0.25in">           Contingent purchase price payable, net of current portion          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           -          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           5,220,000          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt">           Total Non-Current Liabilities          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           325,533          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           5,668,753          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt">           Total Liabilities          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           10,353,840          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           11,776,266          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt">           Commitments and contingencies (See Note 15)          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           -          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           -          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">           Stockholders’ Equity          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; text-indent: -10pt; padding-left: 0.25in">           Preferred stock, $0.001 par value, 10,000,000 shares authorized, none issued and outstanding at December 31, 2020 and 2019,          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           -          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           -          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; text-indent: -10pt; padding-left: 0.25in">           Common stock, $0.001 par value, 166,666,667 shares authorized, 15,223,340 and 14,609,579 shares issued and outstanding at December 31, 2020 and 2019, respectively          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           15,223          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           14,601          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; text-indent: -10pt; padding-left: 0.25in">           Additional paid-in-capital          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           85,590,428          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           78,272,268          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 0.25in">           Accumulated deficit          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           (35,631,737          </td>          <td style="padding-bottom: 1.5pt; text-align: left">           )          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           (33,424,610          </td>          <td style="padding-bottom: 1.5pt; text-align: left">           )          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt">           Total Stockholders’ Equity          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           49,973,914          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           44,862,259          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-bottom: 4pt; text-indent: -10pt; padding-left: 10pt">           TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           60,327,754          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           56,638,525          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        The accompanying notes are an integral partof these financial statements.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       </p>       <!-- Field: Page; Sequence: 32; Value: 1 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         F-         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         4         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         <a name="F_003">         </a>         OPTIMIZERx CORPORATION        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         Consolidated Statements of Operations        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       </p>       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">        <tbody>         <tr style="vertical-align: bottom">          <td style="white-space: nowrap">          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>          <td colspan="2" style="white-space: nowrap; text-align: center; border-bottom: Black 1.5pt solid">           For the           <br/>           year ended           <br/>           December 31,           <br/>           2020          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>          <td colspan="2" style="white-space: nowrap; text-align: center; border-bottom: Black 1.5pt solid">           For the           <br/>           year ended           <br/>           December 31,           <br/>           2019          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>         </tr>         <tr style="vertical-align: bottom">          <td>          </td>          <td>          </td>          <td colspan="2" style="text-align: right">          </td>          <td>          </td>          <td>          </td>          <td colspan="2" style="text-align: right">          </td>          <td>          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="width: 76%">           Revenue          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">           $          </td>          <td style="width: 9%; text-align: right">           43,313,323          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">           $          </td>          <td style="width: 9%; text-align: right">           24,598,274          </td>          <td style="width: 1%; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="padding-bottom: 1.5pt">           Cost of revenues          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           19,207,902          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           9,158,699          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-bottom: 1.5pt">           Gross margin          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           24,105,421          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           15,439,575          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td>          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-left: 9pt">           Operating expenses          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-left: 0.25in">           Stock-based compensation          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           3,172,840          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           2,260,298          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-left: 0.25in">           Depreciation and amortization          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           2,075,888          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           1,282,787          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in">           Other general and administrative expenses          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           20,992,012          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           15,590,054          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-bottom: 1.5pt">           Total operating expenses          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           26,240,740          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           19,133,139          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-bottom: 1.5pt">           Loss from operations          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           (2,135,319          </td>          <td style="padding-bottom: 1.5pt; text-align: left">           )          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           (3,693,564          </td>          <td style="padding-bottom: 1.5pt; text-align: left">           )          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left">           Other income (expense)          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="padding-left: 0.25in; text-align: left">           Interest income          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           68,582          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           288,028          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="padding-left: 0.25in; text-align: left; padding-bottom: 1.5pt">           Change in fair value of contingent consideration          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           (140,390          </td>          <td style="padding-bottom: 1.5pt; text-align: left">           )          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           (635,000          </td>          <td style="padding-bottom: 1.5pt; text-align: left">           )          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-bottom: 1.5pt">           Total other expense          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           (71,808          </td>          <td style="padding-bottom: 1.5pt; text-align: left">           )          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           (346,972          </td>          <td style="padding-bottom: 1.5pt; text-align: left">           )          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left">           Loss before provision for income taxes          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           (2,207,127          </td>          <td style="text-align: left">           )          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           (4,040,536          </td>          <td style="text-align: left">           )          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-bottom: 1.5pt">           Income tax benefit          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           -          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           897,960          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-bottom: 4pt">           Net  loss          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           (2,207,127          </td>          <td style="padding-bottom: 4pt; text-align: left">           )          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           (3,142,576          </td>          <td style="padding-bottom: 4pt; text-align: left">           )          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="padding-bottom: 4pt">           Weighted average number of shares outstanding – basic          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           14,827,923          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           13,387,863          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="padding-bottom: 4pt">           Weighted average number of shares outstanding – diluted          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           14,827,923          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           13,387,863          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td>           Loss per share – basic          </td>          <td>          </td>          <td style="text-align: left">           $          </td>          <td style="text-align: right">           (0.15          </td>          <td style="text-align: left">           )          </td>          <td>          </td>          <td style="text-align: left">           $          </td>          <td style="text-align: right">           (0.23          </td>          <td style="text-align: left">           )          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="padding-bottom: 4pt">           Loss per share – diluted          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           (0.15          </td>          <td style="padding-bottom: 4pt; text-align: left">           )          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           (0.23          </td>          <td style="padding-bottom: 4pt; text-align: left">           )          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        The accompanying notes are an integral partof these financial statements.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <!-- Field: Page; Sequence: 33; Value: 1 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         F-         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         5         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         <a name="F_004">         </a>         OPTIMIZERx CORPORATION        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         Consolidated Statement of Stockholders’Equity for the Year        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         Ended December 31, 2020        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>        </b>       </p>       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">        <tbody>         <tr style="vertical-align: bottom">          <td style="text-align: center">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">           Common           <br/>           Stock           <br/>           Shares          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">           Common           <br/>           Stock           <br/>           Amount          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">           Additional           <br/>           Paid-in           <br/>           Capital          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">           Accumulated           <br/>           Deficit          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">           Total           <br/>           Stockholders’           <br/>           Equity          </td>          <td style="padding-bottom: 1.5pt">          </td>         </tr>         <tr style="vertical-align: bottom">          <td>          </td>          <td>          </td>          <td colspan="2" style="text-align: right">          </td>          <td>          </td>          <td>          </td>          <td colspan="2" style="text-align: right">          </td>          <td>          </td>          <td>          </td>          <td colspan="2" style="text-align: right">          </td>          <td>          </td>          <td>          </td>          <td colspan="2" style="text-align: right">          </td>          <td>          </td>          <td>          </td>          <td colspan="2" style="text-align: right">          </td>          <td>          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="width: 40%; text-indent: -10pt; padding-left: 10pt">           Balance, January 1, 2020          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 9%; text-align: right">           14,600,579          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">           $          </td>          <td style="width: 9%; text-align: right">           14,601          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">           $          </td>          <td style="width: 9%; text-align: right">           78,272,268          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">           $          </td>          <td style="width: 9%; text-align: right">           (33,424,610          </td>          <td style="width: 1%; text-align: left">           )          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">           $          </td>          <td style="width: 9%; text-align: right">           44,862,259          </td>          <td style="width: 1%; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">           Stock-based compensation expense          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-indent: -10pt; padding-left: 0.25in">           Options          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           1,884,202          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           1,884,202          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; text-indent: -10pt; padding-left: 0.25in">           Restricted Stock          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           84,746          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           84          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           838,430          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           838,514          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">           Issuance of common stock:          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; text-indent: -10pt; padding-left: 0.25in">           For board compensation          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           28,809          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           29          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           450,095          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           450,124          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; text-indent: -10pt; padding-left: 0.25in">           For stock options exercised          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           414,705          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           415          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           2,487,979          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           2,488,394          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; text-indent: -10pt; padding-left: 0.25in">           For contingent purchase price and escrow hold back          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           94,501          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           94          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           1,657,454          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           1,657,548          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt">           Net loss for the year          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           (2,207,127          </td>          <td style="padding-bottom: 1.5pt; text-align: left">           )          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           (2,207,127          </td>          <td style="padding-bottom: 1.5pt; text-align: left">           )          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="padding-bottom: 4pt; text-indent: -10pt; padding-left: 10pt">           Balance, December 31, 2020          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           15,223,340          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           15,223          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           85,590,428          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           (35,631,737          </td>          <td style="padding-bottom: 4pt; text-align: left">           )          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           49,973,914          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        The accompanying notes are an integral partof these financial statements.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       </p>       <!-- Field: Page; Sequence: 34; Value: 1 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         F-         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         6         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <a name="F_005">        </a>        <b>         OPTIMIZERx CORPORATION        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         Consolidated Statement of Stockholders’Equity for the Year        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         Ended December 31, 2019        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">        <tbody>         <tr style="vertical-align: bottom">          <td style="text-align: center">          </td>          <td>          </td>          <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Common            <br/>            Stock            <br/>            Shares           </font>          </td>          <td>          </td>          <td>          </td>          <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Common            <br/>            Stock            <br/>            Amount           </font>          </td>          <td>          </td>          <td>          </td>          <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Additional            <br/>            Paid-in            <br/>            Capital           </font>          </td>          <td>          </td>          <td>          </td>          <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Accumulated            <br/>            Deficit           </font>          </td>          <td>          </td>          <td>          </td>          <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Total            <br/>            Stockholders’            <br/>            Equity           </font>          </td>          <td>          </td>         </tr>         <tr style="vertical-align: bottom">          <td>          </td>          <td>          </td>          <td colspan="2" style="text-align: right">          </td>          <td>          </td>          <td>          </td>          <td colspan="2" style="text-align: right">          </td>          <td>          </td>          <td>          </td>          <td colspan="2" style="text-align: right">          </td>          <td>          </td>          <td>          </td>          <td colspan="2" style="text-align: right">          </td>          <td>          </td>          <td>          </td>          <td colspan="2" style="text-align: right">          </td>          <td>          </td>         </tr>         <tr style="vertical-align: bottom; background-color: white">          <td style="width: 40%; padding-left: 10pt; text-indent: -10pt">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Balance, January 1, 2019           </font>          </td>          <td style="width: 1%">          </td>          <td style="width: 1%">          </td>          <td style="width: 9%; text-align: right">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            12,038,618,           </font>          </td>          <td style="width: 1%">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            $           </font>          </td>          <td style="width: 9%; text-align: right">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            12,039           </font>          </td>          <td style="width: 1%">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            $           </font>          </td>          <td style="width: 9%; text-align: right">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            48,725,211           </font>          </td>          <td style="width: 1%">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            $           </font>          </td>          <td style="width: 9%; text-align: right">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            (30,278,805           </font>          </td>          <td style="width: 1%">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            )           </font>          </td>          <td style="width: 1%">          </td>          <td style="width: 1%">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            $           </font>          </td>          <td style="width: 9%; text-align: right">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            18,458,445           </font>          </td>          <td style="width: 1%">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: white">          <td style="padding-left: 10pt; text-indent: -10pt">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Cumulative effect of change in accounting principle related to lease accounting           </font>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            (3,229           </font>          </td>          <td>           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            )           </font>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            (3,229           </font>          </td>          <td>           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            )           </font>          </td>         </tr>         <tr style="vertical-align: bottom; background-color: white">          <td style="padding-left: 10pt; text-indent: -10pt">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Shares issued in 2019 for restricted stock awards granted and expensed in 2018           </font>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            130,001           </font>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            130           </font>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            (130           </font>          </td>          <td>           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            )           </font>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            -           </font>          </td>          <td>          </td>         </tr>         <tr style="vertical-align: bottom; background-color: white">          <td style="padding-left: 10pt; text-indent: -10pt">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Stock-based compensation expense           </font>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">          </td>          <td>          </td>         </tr>         <tr style="vertical-align: bottom; background-color: white">          <td style="padding-left: 20pt; text-indent: -10pt">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Options           </font>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            1,687,745           </font>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            1,687,745           </font>          </td>          <td>          </td>         </tr>         <tr style="vertical-align: bottom; background-color: white">          <td style="padding-left: 20pt; text-indent: -10pt">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Restricted Stock           </font>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            125,160           </font>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            125,160           </font>          </td>          <td>          </td>         </tr>         <tr style="vertical-align: bottom; background-color: white">          <td style="padding-left: 10pt; text-indent: -10pt">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Issuance of common stock:           </font>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">          </td>          <td>          </td>         </tr>         <tr style="vertical-align: bottom; background-color: white">          <td style="padding-left: 0.25in; text-indent: -10pt">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            For board compensation           </font>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            33,344           </font>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            33           </font>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            447,360           </font>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            447,393           </font>          </td>          <td>          </td>         </tr>         <tr style="vertical-align: bottom; background-color: white">          <td style="padding-left: 0.25in; text-indent: -10pt">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            For cash           </font>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            1,769,275           </font>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            1,769           </font>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            21,302,057           </font>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            21,303,826           </font>          </td>          <td>          </td>         </tr>         <tr style="vertical-align: bottom; background-color: white">          <td style="padding-left: 0.25in; text-indent: -10pt">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            For stock options exercised           </font>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            246,448           </font>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            247           </font>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            877,455           </font>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            877,702           </font>          </td>          <td>          </td>         </tr>         <tr style="vertical-align: bottom; background-color: white">          <td style="padding-left: 10pt; text-indent: -10pt">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Shares issued for acquisition           </font>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            382,893           </font>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            383           </font>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            5,107,410           </font>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            5,107,793           </font>          </td>          <td>          </td>         </tr>         <tr style="vertical-align: bottom; background-color: white">          <td style="padding-left: 10pt; text-indent: -10pt">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Net loss for the year           </font>          </td>          <td>          </td>          <td style="border-bottom: black 1.5pt solid">          </td>          <td style="border-bottom: black 1.5pt solid; text-align: right">          </td>          <td>          </td>          <td>          </td>          <td style="border-bottom: black 1.5pt solid">          </td>          <td style="border-bottom: black 1.5pt solid; text-align: right">          </td>          <td>          </td>          <td>          </td>          <td style="border-bottom: black 1.5pt solid">          </td>          <td style="border-bottom: black 1.5pt solid; text-align: right">          </td>          <td>          </td>          <td>          </td>          <td style="border-bottom: black 1.5pt solid">          </td>          <td style="border-bottom: black 1.5pt solid; text-align: right">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            (3,142,576           </font>          </td>          <td>           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            )           </font>          </td>          <td>          </td>          <td style="border-bottom: black 1.5pt solid">          </td>          <td style="border-bottom: black 1.5pt solid; text-align: right">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            (3,142,576           </font>          </td>          <td>           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            )           </font>          </td>         </tr>         <tr style="vertical-align: bottom; background-color: white">          <td style="padding-left: 10pt; text-indent: -10pt">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Balance, December 31, 2019           </font>          </td>          <td>          </td>          <td style="border-bottom: black 4.5pt double">          </td>          <td style="border-bottom: black 4.5pt double; text-align: right">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            14,600,579           </font>          </td>          <td>          </td>          <td>          </td>          <td style="border-bottom: black 4.5pt double">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            $           </font>          </td>          <td style="border-bottom: black 4.5pt double; text-align: right">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            14,601           </font>          </td>          <td>          </td>          <td>          </td>          <td style="border-bottom: black 4.5pt double">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            $           </font>          </td>          <td style="border-bottom: black 4.5pt double; text-align: right">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            78,272,268           </font>          </td>          <td>          </td>          <td>          </td>          <td style="border-bottom: black 4.5pt double">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            $           </font>          </td>          <td style="border-bottom: black 4.5pt double; text-align: right">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            (33,424,610           </font>          </td>          <td>           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            )           </font>          </td>          <td>          </td>          <td style="border-bottom: black 4.5pt double">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            $           </font>          </td>          <td style="border-bottom: black 4.5pt double; text-align: right">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            44,862,259           </font>          </td>          <td>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        The accompanying notes are an integralpart of these financial statements.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <!-- Field: Page; Sequence: 35; Value: 1 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         F-         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         7         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         <a name="F_006">         </a>         OPTIMIZERx CORPORATION        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         Consolidated Statements of Cash Flows        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>        </b>       </p>       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">        <tbody>         <tr style="vertical-align: bottom">          <td style="white-space: nowrap">          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>          <td colspan="2" style="white-space: nowrap; text-align: center; border-bottom: Black 1.5pt solid">           For the           <br/>           year ended           <br/>           December 31,           <br/>           2020          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>          <td colspan="2" style="white-space: nowrap; text-align: center; border-bottom: Black 1.5pt solid">           For the           <br/>           year ended           <br/>           December 31,           <br/>           2019          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="font-weight: bold">           CASH FLOWS FROM OPERATING ACTIVITIES:          </td>          <td>          </td>          <td colspan="2" style="text-align: right">          </td>          <td>          </td>          <td>          </td>          <td colspan="2" style="text-align: right">          </td>          <td>          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="width: 76%; text-align: left; padding-left: 9pt">           Net loss          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">           $          </td>          <td style="width: 9%; text-align: right">           (2,207,127          </td>          <td style="width: 1%; text-align: left">           )          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">           $          </td>          <td style="width: 9%; text-align: right">           (3,142,576          </td>          <td style="width: 1%; text-align: left">           )          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left">           Adjustments to reconcile net loss to net cash used in operating activities:          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-left: 9pt">           Depreciation and amortization          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           1,971,083          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           1,175,131          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-left: 9pt">           Noncash lease expense          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           104,805          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           107,656          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-left: 9pt">           Increase in bad debt reserve          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           200,000          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           80,000          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-left: 9pt">           Stock-based compensation          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           3,172,840          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           2,260,298          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-left: 9pt">           Income tax benefit          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           -          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           (897,960          </td>          <td style="text-align: left">           )          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-left: 9pt">           Change in fair value of contingent consideration          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           140,390          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           635,000          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left">           Changes in:          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-left: 9pt">           Accounts receivable          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           (10,667,680          </td>          <td style="text-align: left">           )          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           (628,830          </td>          <td style="text-align: left">           )          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-left: 9pt">           Prepaid expenses and other assets          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           (3,517,700          </td>          <td style="text-align: left">           )          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           (343,838          </td>          <td style="text-align: left">           )          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-left: 9pt">           Accounts payable          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           125,255          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           (46,249          </td>          <td style="text-align: left">           )          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="padding-left: 9pt">           Revenue share payable          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           3,351,430          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           (290,178          </td>          <td style="text-align: left">           )          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-left: 9pt">           Accrued expenses and other          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           1,416,884          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           (432,075          </td>          <td style="text-align: left">           )          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-left: 9pt">           Change in operating lease liabilities          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           (106,347          </td>          <td style="text-align: left">           )          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           (106,564          </td>          <td style="text-align: left">           )          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt">           Deferred revenue          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           (294,219          </td>          <td style="padding-bottom: 1.5pt; text-align: left">           )          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           (30,611          </td>          <td style="padding-bottom: 1.5pt; text-align: left">           )          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">           NET CASH USED IN OPERATING ACTIVITIES          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           (6,310,386          </td>          <td style="padding-bottom: 1.5pt; text-align: left">           )          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           (1,660,796          </td>          <td style="padding-bottom: 1.5pt; text-align: left">           )          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="font-weight: bold; text-align: left">           CASH FLOWS FROM INVESTING ACTIVITIES:          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-left: 9pt">           Purchases of property and equipment          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           (68,041          </td>          <td style="text-align: left">           )          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           (87,717          </td>          <td style="text-align: left">           )          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-left: 9pt">           Acquisition of intangible assets, including intellectual property rights          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           (11,932          </td>          <td style="text-align: left">           )          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           (1,500,000          </td>          <td style="text-align: left">           )          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-left: 9pt">           Capitalized software development costs          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           (44,752          </td>          <td style="text-align: left">           )          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           -          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt">           Cash paid in acquisition, net of cash acquired          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           -          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           (8,994,369          </td>          <td style="padding-bottom: 1.5pt; text-align: left">           )          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">           NET CASH USED IN INVESTING ACTIVITIES          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           (124,725          </td>          <td style="padding-bottom: 1.5pt; text-align: left">           )          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           (10,582,086          </td>          <td style="padding-bottom: 1.5pt; text-align: left">           )          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="font-weight: bold; text-align: left">           CASH FLOWS FROM FINANCING ACTIVITIES:          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-left: 9pt">           Proceeds from issuance of common stock, net of offering costs          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           -          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           21,303,826          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-left: 9pt">           Proceeds from exercise of stock options          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           2,488,394          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           877,702          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt">           Payment of contingent consideration          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           (4,389,187          </td>          <td style="padding-bottom: 1.5pt; text-align: left">           )          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           -          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">           NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           (1,900,793          </td>          <td style="padding-bottom: 1.5pt; text-align: left">           )          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           22,181,528          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="font-weight: bold; text-align: left">           NET INCREASE (DECREASE IN) CASH AND CASH EQUIVALENTS          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           (8,335,904          </td>          <td style="text-align: left">           )          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           9,938,646          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">           CASH AND CASH EQUIVALENTS – BEGINNING OF PERIOD          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           18,852,680          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           8,914,034          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">           CASH AND CASH EQUIVALENTS – END OF PERIOD          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           10,516,776          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           18,852,680          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="font-weight: bold; text-align: left">           SUPPLEMENTAL CASH FLOW INFORMATION:          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-bottom: 4pt; padding-left: 9pt">           Cash paid for interest          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           -          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           -          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-bottom: 4pt; padding-left: 9pt">           Cash paid for income taxes          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           -          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           -          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="font-weight: bold; text-align: left">           NON-CASH INVESTING AND FINANCING ACTIVITIES:          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-bottom: 4pt; padding-left: 9pt">           Lease liabilities arising from right of use assets          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           -          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           207,559          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-bottom: 4pt; padding-left: 9pt">           Acquisition liabilities paid in stock          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           1,657,548          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           -          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-bottom: 4pt; padding-left: 9pt">           Shares issued in connection with acquisitions          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           -          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           5,107,793          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-bottom: 4pt; padding-left: 9pt">           Non-cash effect of cumulative adjustments to accumulated deficit          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           -          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           3,229          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        The accompanying notes are an integral partof these financial statements.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       </p>       <!-- Field: Page; Sequence: 36; Value: 1 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         F-         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         8         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         <a name="F_007">         </a>         OPTIMIZERx CORPORATION        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         DECEMBER 31, 2020        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        NOTE 1 – ORGANIZATION AND NATUREOF BUSINESS       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        OptimizeRx is a digital health companythat provides communications solutions for life science companies, physicians and patients. Connecting over half of healthcareproviders in the U.S. and millions of patients through a proprietary network, the OptimizeRx digital health platform helps patientsafford and stay on medications. The platform unlocks new patient and physician touchpoints for life science companies along thepatient journey, from point-of-care, to retail pharmacy, through mobile patient engagement.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <u>         Basis of Presentation        </u>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The financial statements of the Companyhave been prepared in accordance with generally accepted accounting principles in the United States of America and are presentedin US dollars.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <u>         Use of Estimates        </u>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The preparation of financial statementsin conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect thereported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expensesduring the reporting period. Estimates and assumptions have been made in determining the carrying value of assets, depreciableand amortizable lives of tangible and intangible assets, the carrying value of liabilities, the valuation allowance for the deferredtax asset, the timing of revenue recognition and related revenue share expenses, and inputs used in the calculation of stock basedcompensation. Actual results could differ from these estimates.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <u>         Principles of Consolidation        </u>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The financial statements reflect the consolidatedresults of OptimizeRx Corporation, a Nevada corporation, and its wholly owned subsidiaries: OptimizeRx Corporation, a Michigancorporation, RMDY Health, Inc., a Delaware corporation, CareSpeak Communications, Inc., a New Jersey corporation, Cyberdiet, acontrolled foreign corporation incorporated in Israel, and CareSpeak Communications D.O.O., a Controlled Foreign Corporation incorporatedin Croatia. Together, these companies are referred to as “OptimizeRx” and “the Company.” All material intercompanytransactions have been eliminated.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <u>         Reclassifications        </u>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Certain items in the previous year financialstatements have been reclassified to match the current year presentation.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <u>         Cash and Cash Equivalents        </u>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        For purposes of the accompanying financialstatements, the Company considers all highly liquid instruments, consisting of money market accounts, with an initial maturityof three months or less to be cash equivalents.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <u>         Fair Value of Financial Instruments        </u>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Fair value is defined as the price thatwould be received upon sale of an asset or paid upon transfer of a liability in an orderly transaction between market participantsat the measurement date and in the principal or most advantageous market for that asset or liability. The fair value should becalculated based on assumptions that market participants would use in pricing the asset or liability, not on assumptions specificto the entity. In addition, the fair value of liabilities should include consideration of non-performance risk including our owncredit risk.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <b>        </b>       </p>       <!-- Field: Page; Sequence: 37; Value: 1 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         F-         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         9         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">        <b>         OPTIMIZERx CORPORATION        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">        <b>         NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         DECEMBER 31, 2020        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        In addition to defining fair value, thedisclosure requirements around fair value establish a fair value hierarchy for valuation inputs, which is expanded. The hierarchyprioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in themarket. Each fair value measurement is reported in one of the three levels, which is determined by the lowest level input thatis significant to the fair value measurement in its entirety. These levels are:       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Level 1 – Inputs are based upon unadjustedquoted prices for identical instruments traded in active markets.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Level 2 – Inputs are based upon significantobservable inputs other than quoted prices included in Level 1, such as quoted prices for identical or similar instruments in marketsthat are not active, and model-based valuation techniques for which all significant assumptions are observable in the market orcan be corroborated by observable market data for substantially the full term of the assets or liabilities.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Level 3 – Inputs are generally unobservableand typically reflect management’s estimates of assumptions that market participants would use in pricing the asset or liability.The fair values are therefore determined using model-based techniques that include option pricing models, discounted cash flowmodels, and similar techniques. The Company’s stock options and warrants are valued using level 3 inputs.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The following tables present the fair valuesand carrying values of the Company’s financial assets and liabilities measured on a recurring basis as of December 31, 2020and 2019 and the valuation techniques used by the Company to determine those fair values.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">        <tbody>         <tr style="vertical-align: bottom">          <td>          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="18" style="border-bottom: Black 1.5pt solid; text-align: center">           2020          </td>          <td style="padding-bottom: 1.5pt">          </td>         </tr>         <tr style="vertical-align: bottom">          <td>          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">           Level 1          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">           Level 2          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">           Level 3          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">           Fair Value          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">           Carrying           <br/>           Value          </td>          <td style="padding-bottom: 1.5pt">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: center">          </td>          <td>          </td>          <td colspan="2" style="text-align: right">          </td>          <td>          </td>          <td>          </td>          <td colspan="2" style="text-align: right">          </td>          <td>          </td>          <td>          </td>          <td colspan="2" style="text-align: right">          </td>          <td>          </td>          <td>          </td>          <td colspan="2" style="text-align: right">          </td>          <td>          </td>          <td>          </td>          <td colspan="2" style="text-align: right">          </td>          <td>          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="width: 40%">           Liabilities          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 9%; text-align: right">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 9%; text-align: right">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 9%; text-align: right">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 9%; text-align: right">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 9%; text-align: right">          </td>          <td style="width: 1%; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: left; padding-bottom: 4pt">           Contingent Purchase Price Payable (1)          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           -          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           -          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           1,610,813          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           1,610,813          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           1,610,813          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">        <tbody>         <tr style="vertical-align: bottom">          <td>          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="18" style="border-bottom: Black 1.5pt solid; text-align: center">           2019          </td>          <td style="padding-bottom: 1.5pt">          </td>         </tr>         <tr style="vertical-align: bottom">          <td>          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">           Level 1          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">           Level 2          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">           Level 3          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">           Fair Value          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">           Carrying           <br/>           Value          </td>          <td style="padding-bottom: 1.5pt">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: center">          </td>          <td>          </td>          <td colspan="2" style="text-align: right">          </td>          <td>          </td>          <td>          </td>          <td colspan="2" style="text-align: right">          </td>          <td>          </td>          <td>          </td>          <td colspan="2" style="text-align: right">          </td>          <td>          </td>          <td>          </td>          <td colspan="2" style="text-align: right">          </td>          <td>          </td>          <td>          </td>          <td colspan="2" style="text-align: right">          </td>          <td>          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="width: 40%">           Liabilities          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 9%; text-align: right">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 9%; text-align: right">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 9%; text-align: right">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 9%; text-align: right">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 9%; text-align: right">          </td>          <td style="width: 1%; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: left; padding-bottom: 4pt">           Contingent Purchase Price Payable (1)          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           -          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           -          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           6,720,000          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           6,720,000          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           6,720,000          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">        <tbody>         <tr style="vertical-align: top">          <td style="width: 0px">          </td>          <td style="width: 24px; font-size: 10pt">           <font style="font-size: 10pt">            (1)           </font>          </td>          <td style="font-size: 10pt; text-align: justify">           <font style="font-size: 10pt">            The contingent consideration is based off achieving certain revenue milestones in each of the next two years. The Geometric-Brownian motion analysis was used to generate spot prices for use in an option pricing model. For 2019, the hypothetical spot prices were simulated using a Monte Carlo simulation utilizing 2020 and 2021 projected revenue as a base and revenue volatility of 40%. The risk-free rate of return and terms utilized were 1.4 % and 1-2 years, respectively, and expected volatility was 40%. For 2020, the final payout has been determined and is payable in 2021.           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <!-- Field: Page; Sequence: 38; Value: 1 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         F-         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         10         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">        <b>         OPTIMIZERx CORPORATION        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         DECEMBER 31, 2020        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The following table provides a summaryof changes in fair value of the Company’s Level 3 financial instruments for the years ended December 31, 2020 and 2019.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">        <tbody>         <tr style="vertical-align: bottom">          <td>          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">           Amount          </td>          <td style="padding-bottom: 1.5pt">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="width: 88%">           Balance December 31, 2018          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">           $          </td>          <td style="width: 9%; text-align: right">           2,365,000          </td>          <td style="width: 1%; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: left">           Contingent consideration liability recorded as the result of the RMDY Health, Inc. acquisition (see note 3)          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           3,720,000          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: left; padding-bottom: 1.5pt">           Increase in the value of the CareSpeak Communication consideration          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           635,000          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td>           Balance December 31, 2019          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           6,720,000          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: left">           Increase in fair value of the RMDY Health, Inc. contingent consideration          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           140,390          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: left">           Payment of CareSpeak Communication contingent consideration          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           (1,389,187          </td>          <td style="text-align: left">           )          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: left; padding-bottom: 1.5pt">           Payment of RMDY Health, Inc. contingent consideration          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           (3,860,390          </td>          <td style="padding-bottom: 1.5pt; text-align: left">           )          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="padding-bottom: 4pt">           Balance December 31, 2020          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           1,610,813          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <u>         Accounts Receivable and Allowance forDoubtful Accounts        </u>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Accounts receivable are reported at realizablevalue, net of allowances for doubtful accounts, which is estimated and recorded in the period the related revenue is recorded.The Company has a standardized approach to estimate and review the collectability of its receivables based on a number of factors,including the period they have been outstanding. Historical collection and payer reimbursement experience is an integral part ofthe estimation process related to allowances for doubtful accounts. In addition, the Company regularly assesses the state of itsbilling operations in order to identify issues, which may impact the collectability of these receivables or reserve estimates.Because the Company’s customers are primarily large well-capitalized companies, historically there has been very little baddebt expense. Bad debt expense was $200,000 for the year ended December 31, 2020 and $80,000 for the year ended December 31,2019. The allowance for doubtful accounts was $158,163 and $80,000 as of December 31, 2020 and 2019, respectively. From timeto time, we may record revenue based on our revenue recognition policies described below in advance of being able to invoice thecustomer. These amounts are included in accounts receivable and are immaterial, representing substantially less than 1% of theaccounts receivable balance at December 31, 2020.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <u>         Property and Equipment        </u>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Property and equipment are stated at costand are being depreciated over their estimated useful lives of three to five years for office equipment and three years for computerequipment using the straight-line method of depreciation for book purposes. Maintenance and repair charges are expensed as incurred.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <u>         Intangible Assets        </u>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Intangible assets are stated at cost. Finite-livedassets are being amortized over their estimated useful lives of fifteen to seventeen years for patents, eight years for customerrelationships, fifteen years for tradenames, four years for covenants not to compete, and three to four years for software andwebsites, all using the straight-line method. These assets are evaluated when there is a triggering event. There was no impairmentof our intangible assets in either year presented.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <u>         Goodwill        </u>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        We evaluate goodwill for impairment duringour fiscal fourth quarter, or more frequently if an event occurs or circumstances change. Our analysis determined that there wasno impairment of our goodwill.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <!-- Field: Page; Sequence: 39; Value: 1 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         F-         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         11         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         OPTIMIZERx CORPORATION        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         DECEMBER 31, 2020        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <u>         Revenue Recognition        </u>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Recognition of revenue requires evidenceof a contract, probable collection of proceeds, and completion of substantially all performance obligations. We use a 5-step modelto recognize revenue. These steps are: identify the contract with a customer, identify the performance obligations in the contract,determine the transaction price, allocate the transaction price to the performance obligations in the contract, and recognize revenuewhen or as the performance obligations are satisfied.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Revenues are primarily generated from contentdelivery activities in which the Company delivers financial, clinical, or brand messaging through a distribution network of eprescribersand electronic health record technology providers (channel partners), directly to consumers, or from reselling services that complementthe business. This content delivery for a customer is referred to as a program. Unless otherwise specified, revenue is recognizedbased on the selling price to customers.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The Company’s contracts are generallyall less than one year and the primary performance obligation is delivery of messages, or content, but the contract may containadditional services. Additional services may include program design, which is the design of the content delivery program, set up,and reporting. We consider set up and reporting services to be complimentary to the primary performance obligation and recognizedthrough performance of the delivery of content. We consider program design and related consulting services to be performance obligationsseparate from the delivery of messages.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        As the content is distributed through theplatform and network of channel partners (a transaction), these transactions are recorded, and revenue is recognized, over timeas the distributions occur. Revenue for transactions can be realized based on a price per message, a price per redemption, as aflat fee occurring over a period of time, or upon completion of the program, depending on the client contract. The Company recognizessetup fees that are required for integrating client offerings and campaigns into the rule-based content delivery system and networkover the life of the initial program, based either on time, or units delivered, depending upon which is most appropriate in thespecific situation. Should a program be cancelled before completion, the balance of set up revenue is recognized at the time ofcancellation, as set up fees are nonrefundable. Additionally, the Company also recognizes revenue for providing program performancereporting and maintenance, either by the Company directly delivering reports or by providing access to its online reporting portalthat the client can utilize. This reporting revenue is recognized over time as the messages are delivered. Program design, whichis the design of the content delivery program, and related consulting services are recognized as services are performed.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The Company does not disaggregate its revenueas virtually all types of revenue are generated through the same core group of customers and generally all involve the deliveryof content. Different types of revenue are not impacted by economic factors that affect the nature, amount, timing, or uncertaintyof revenues or cash flows.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        In some instances, the Company also resellsmessaging solutions that are available through channel partners that are complementary to the core business and client base. Thesepartner specific solutions are frequently similar to our own solutions and revenue recognition for these programs is the same asdescribed above. In instances where the Company sells solutions on a commission basis, net revenue is recognized based on the commission-basedrevenue split that the Company receives. There were only minor immaterial programs recorded on a net basis in the years presented.In instances where the Company resells these messaging solutions and has all financial risk and significant operation input andrisk, the Company records the revenue based on the gross amount sold and the amount paid to the channel partner as a cost of sales.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <!-- Field: Page; Sequence: 40; Value: 1 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         F-         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         12         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         OPTIMIZERx CORPORATION        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         DECEMBER 31, 2020        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <u>         Cost of Revenues        </u>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The primary cost of revenue is revenueshare expense. Based on the volume of transactions that are delivered through the channel partner network, the Company providesa revenue share to compensate the partner, or others, for their promotion of the campaign. Revenue shares are a negotiated percentageof the transaction fees and can also be specific to special considerations and campaigns.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <u>         Income Taxes        </u>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Income taxes are computed using the assetand liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based onthe differences between the financial reporting and tax basis of assets and liabilities and are measured using the currently enactedtax rates and laws. A valuation allowance is provided for the amount of deferred tax assets that, based on available evidence,are not expected to be realized.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <font style="background-color: white">         TheCompany recognizes the tax benefit from uncertain tax positions if it is more likely than not that the tax positions will be sustainedon examination by the tax authorities, based on the technical merits of the position. The tax benefit is measured based on thelargest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. It is the Company’s policyto include interest and penalties related to tax positions as a component of income tax expense.        </font>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <u>         Concentration of Credit Risks        </u>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The Company maintains its cash and cash equivalents in bankdeposit accounts, which, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts;however, amounts in excess of the federally insured limit may be at risk if the bank experiences financial difficulties. As ofDecember 31, 2020, and 2019 the Company had $9,936,806 and $18,047,903, respectively, in cash balances in excess of federally insuredlimits, primarily at Bank of America/Merrill Lynch.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <u>         Research and Development        </u>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The Company expenses research and developmentexpenses as incurred. Research and development expense was $0 and $1,604,195 in 2020 and 2019, respectively.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <u>         Stock-based Compensation        </u>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The Company uses the fair value methodto account for stock-based compensation. The fair value of the equity instrument is charged directly to compensation expense andadditional paid-in capital over the period during which services are rendered. The fair value of each award is estimated on thedate of each grant. For restricted stock, the fair market value is based on the market value of the stock granted on the date ofthe grant. For options, it is estimated using the Black-Scholes option pricing model that uses the assumptions noted in the followingtable. Estimated volatilities are based on the historical volatility of the Company’s stock over the same period as the expectedterm of the options. The expected term of options granted represents the period of time that options granted are expected to beoutstanding. The Company uses historical data to estimate option exercise behavior, forfeitures, and to determine this term. Historicallyforfeitures have been negligible and immaterial, so the impact of forfeitures are recorded at the time of forfeiture. The risk-freerate used is based on the U.S. Treasury yield curve in effect at the time of the grant using a time period equal to the expectedoption term. The Company has never paid dividends and does not expect to pay any dividends in the future.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <!-- Field: Page; Sequence: 41; Value: 1 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         F-         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         13         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         OPTIMIZERx CORPORATION        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         DECEMBER 31, 2020        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">        <tbody>         <tr style="vertical-align: bottom">          <td>          </td>          <td>          </td>          <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">           <font style="font: 10pt Times New Roman, Times, Serif">            2020           </font>          </td>          <td>          </td>          <td>          </td>          <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">           <font style="font: 10pt Times New Roman, Times, Serif">            2019           </font>          </td>          <td>          </td>         </tr>         <tr style="vertical-align: bottom">          <td>          </td>          <td>          </td>          <td colspan="2" style="text-align: center">          </td>          <td>          </td>          <td>          </td>          <td colspan="2" style="text-align: center">          </td>          <td>          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="width: 68%">           <font style="font: 10pt Times New Roman, Times, Serif">            Expected dividend yield           </font>          </td>          <td style="width: 1%">          </td>          <td style="width: 1%">          </td>          <td style="width: 12%; text-align: right">           <font style="font: 10pt Times New Roman, Times, Serif">            0           </font>          </td>          <td style="width: 2%">           <font style="font: 10pt Times New Roman, Times, Serif">            %           </font>          </td>          <td style="width: 1%">          </td>          <td style="width: 1%">          </td>          <td style="width: 12%; text-align: right">           <font style="font: 10pt Times New Roman, Times, Serif">            0           </font>          </td>          <td style="width: 2%">           <font style="font: 10pt Times New Roman, Times, Serif">            %           </font>          </td>         </tr>         <tr style="vertical-align: bottom; background-color: white">          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            Risk free interest rate           </font>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">           <font style="font: 10pt Times New Roman, Times, Serif">            0.16% - 1.63           </font>          </td>          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            %           </font>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">           <font style="font: 10pt Times New Roman, Times, Serif">            1.51% - 2.37           </font>          </td>          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            %           </font>          </td>         </tr>         <tr style="vertical-align: bottom">          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            Expected option term           </font>          </td>          <td>          </td>          <td>          </td>          <td style="white-space: nowrap; text-align: right">           <font style="font: 10pt Times New Roman, Times, Serif">            3.5 years           </font>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td style="white-space: nowrap; text-align: right">           <font style="font: 10pt Times New Roman, Times, Serif">            3.5 years           </font>          </td>          <td>          </td>         </tr>         <tr style="vertical-align: bottom; background-color: white">          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            Turnover/forfeiture rate           </font>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">           <font style="font: 10pt Times New Roman, Times, Serif">            0           </font>          </td>          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            %           </font>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">           <font style="font: 10pt Times New Roman, Times, Serif">            0           </font>          </td>          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            %           </font>          </td>         </tr>         <tr style="vertical-align: bottom">          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            Expected volatility           </font>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">           <font style="font: 10pt Times New Roman, Times, Serif">            65 % - 71           </font>          </td>          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            %           </font>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">           <font style="font: 10pt Times New Roman, Times, Serif">            64% - 67           </font>          </td>          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            %           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The Black-Scholes option valuation modeland other existing models were developed for use in estimating the fair value of traded options that have no vesting restrictionsand are fully transferable. These option valuation models require the input of, and are highly sensitive to, subjective assumptionsincluding the expected stock price volatility. The Company’s stock options have characteristics significantly different fromthose of traded options, and changes in the subjective input assumptions could materially affect the fair value estimate.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <u>         Loss Per Common and Common Equivalent Share        </u>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The computation of basic (loss) earningsper common share is computed using the weighted average number of common shares outstanding during the year. The computation ofdiluted (loss) earnings per common share is based on the basic weighted average number of shares outstanding during the year pluscommon stock equivalents, which would arise from the exercise of options and warrants outstanding using the treasury stock methodand the average market price per share during the year. The number of common shares potentially issuable upon the exercise of certainoptions that were excluded from the diluted loss per common share calculation in 2019 was 891,224 related to options, and 59,918related to restricted stock, for a total of 951,142 because they are anti-dilutive, as a result of a net loss for the year endedDecember 31, 2019. The number of common shares potentially issuable upon the exercise of certain options that were excluded fromthe diluted loss per common share calculation in 2020 was 820,059 related to options, and 91,667 related to restricted stock, fora total of 911,726 because they are anti-dilutive, as a result of a net loss for the year ended December 31, 2020.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The computation of weighted average sharesoutstanding and the basic and diluted earnings per common share for the years ended December 31, 2020 and 2019 consisted of thefollowing:       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">        <tbody>         <tr style="vertical-align: bottom">          <td>          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">           Net Loss          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">           Shares          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">           Per Share           <br/>           Amount          </td>          <td style="padding-bottom: 1.5pt">          </td>         </tr>         <tr style="vertical-align: bottom">          <td>           Year ended December 31, 2020          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="padding-left: 0.125in; width: 64%; text-align: left; padding-bottom: 4pt">           Basic EPS          </td>          <td style="width: 1%; padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; width: 9%; text-align: right">           (2,207,127          </td>          <td style="width: 1%; padding-bottom: 4pt; text-align: left">           )          </td>          <td style="width: 1%; padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">          </td>          <td style="border-bottom: Black 4pt double; width: 9%; text-align: right">           14,827,923          </td>          <td style="width: 1%; padding-bottom: 4pt; text-align: left">          </td>          <td style="width: 1%; padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; width: 9%; text-align: right">           (0.15          </td>          <td style="width: 1%; padding-bottom: 4pt; text-align: left">           )          </td>         </tr>         <tr style="vertical-align: bottom">          <td>          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="padding-left: 0.125in; text-align: left; padding-bottom: 4pt">           Diluted EPS          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           (2,207,127          </td>          <td style="padding-bottom: 4pt; text-align: left">           )          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           14,827,923          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           (0.15          </td>          <td style="padding-bottom: 4pt; text-align: left">           )          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">        <tbody>         <tr style="vertical-align: bottom">          <td>          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">           Net Loss          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">           Shares          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">           Per Share           <br/>           Amount          </td>          <td style="padding-bottom: 1.5pt">          </td>         </tr>         <tr style="vertical-align: bottom">          <td>           Year ended December 31, 2019          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="padding-left: 0.125in; width: 64%; text-align: left; padding-bottom: 4pt">           Basic EPS          </td>          <td style="width: 1%; padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; width: 9%; text-align: right">           (3,142,576          </td>          <td style="width: 1%; padding-bottom: 4pt; text-align: left">           )          </td>          <td style="width: 1%; padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">          </td>          <td style="border-bottom: Black 4pt double; width: 9%; text-align: right">           13,387,863          </td>          <td style="width: 1%; padding-bottom: 4pt; text-align: left">          </td>          <td style="width: 1%; padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; width: 9%; text-align: right">           (0.23          </td>          <td style="width: 1%; padding-bottom: 4pt; text-align: left">           )          </td>         </tr>         <tr style="vertical-align: bottom">          <td>          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="padding-left: 0.125in; text-align: left; padding-bottom: 4pt">           Diluted EPS          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           (3,142,576          </td>          <td style="padding-bottom: 4pt; text-align: left">           )          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           13,387,863          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           (0.23          </td>          <td style="padding-bottom: 4pt; text-align: left">           )          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <!-- Field: Page; Sequence: 42; Value: 1 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         F-         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         14         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         OPTIMIZERx CORPORATION        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         DECEMBER 31, 2020        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <u>         Impairment of Long-Lived Assets        </u>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The Company continually monitors eventsand changes in circumstances that could indicate carrying amounts of long-lived assets may not be recoverable. When such eventsor changes in circumstances are present, the Company assesses the recoverability of long-lived assets by determining whether thecarrying value of such assets will be recovered through undiscounted expected future cash flows. If the total of the future cashflows is less than the carrying amount of those assets, the Company recognizes an impairment loss based on the excess of the carryingamount over the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or the fairvalue less costs to sell.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <u>         Segment reporting        </u>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        We operate in one reportable segment. Overall,our business involves connecting life science companies to patients and providers. We have a common customer base for all of oursolution, which are primarily all communications with healthcare providers or patients on behalf of life science customers. Ourcustomers are geographically located in the U.S although we have two technology centers located internationally. We do not prepareseparate internal income statements by solution as our focus is on selling enterprise arrangements covering multiple solutionsthat span the entire patient journey with a specific brand.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <u>         Recently Issued Accounting Guidance        </u>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        In June 2016, the Financial AccountingStandards Board (the “FASB”) issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of CreditLosses on Financial Instruments. ASU 2016-13 provides for a new impairment model that requires measurement and recognition of expectedcredit losses for most financial assets and certain other instruments, including but not limited to accounts receivable and availablefor sale debt securities. ASU 2016-13 was effective for the Company on January 1, 2020. The adoption of this standard did not havea material effect on our financial position, results of operations, or cash flows.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        In August 2019, the FASB issued ASU 2018-13,Fair Value Measurement (Topic 820): Disclosure Framework-Changes to the Disclosure Requirements for Fair Value Measurement. ASU2018-13 modifies the disclosure requirements on fair value measurements and became effective for the Company on January 1, 2020.The adoption of this standard did not have a material effect on our financial position, results of operations, or cash flows.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        In January 2017, the FASB issued ASU 2017-04,Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. ASU 2017-04 simplifies the subsequentmeasurement of goodwill by eliminating the second step of the goodwill impairment test. The second step measures a goodwill impairmentloss by comparing the implied fair value of a reporting unit’s goodwill with the carrying amount of that goodwill. UnderASU 2017-04, a company will record an impairment charge based on the excess of a reporting unit’s carrying amount over itsfair value. ASU 2017-04 will be applied prospectively and is effective for annual or interim goodwill impairment tests in fiscalyears beginning after December 15, 2019. Early adoption is permitted for interim or annual goodwill impairment tests performedon testing dates after January 1, 2017. The adoption of this standard did not have a material effect on our financial position,results of operations, or cash flows.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <!-- Field: Page; Sequence: 43; Value: 1 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         F-         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         15         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         OPTIMIZERx CORPORATION        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         DECEMBER 31, 2020        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTINGPOLICIES (CONTINUED)       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <i>        </i>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <i>         Not Yet Adopted        </i>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        In December 2019, the FASB issued ASU No.2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. ASU 2019-12 is intended to improve consistent applicationand simplify the accounting for income taxes. ASU 2019-12 removes certain exceptions to the general principles in Topic 740 andclarifies and amends existing guidance. ASU 2019-12 is effective for annual and interim reporting periods beginning after December15, 2020, with early adoption permitted. The adoption of this standard is not expected to have a material effect on our financialposition, results of operations, or cash flows.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        NOTE 3 – ACQUISITIONS       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        On October 4, 2019, we acquired RMDY Health,Inc. (“RMDY”), a Delaware corporation and technology solutions company engaged in developing and marketing digitalhealth SAAS solutions across a range of healthcare and life science initiatives, used by pharmaceutical companies, payers, medtech companies, and medical associations nationwide to improve medication adherence and care coordination. The total purchase pricewas $17,822,162. Acquisition costs of approximately $799,623 were expensed as incurred.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The purchase price contains a contingentelement that will be paid only if the Company achieves certain revenues related to the legacy RMDY business in 2020 and 2021. Thetotal contingent payment may be up to $30.0 million, with a minimum payment of $1.0 million each year. The contingent payment waspaid in 2020. No remaining liability exists at December 31, 2020.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The purchase price of the RMDY acquisitionwas allocated as follows:       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">        <tbody>         <tr style="vertical-align: bottom">          <td style="font-weight: bold">           Purchase Price          </td>          <td>          </td>          <td colspan="2" style="text-align: right">          </td>          <td>          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="padding-left: 0.125in; width: 88%; text-align: left">           Cash paid          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">           $          </td>          <td style="width: 9%; text-align: right">           8,994,369          </td>          <td style="width: 1%; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="padding-left: 0.125in; text-align: left">           Common stock issued          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           5,107,793          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">           Contingent payment          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           3,720,000          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="padding-left: 0.25in; padding-bottom: 4pt">           Total          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           17,822,162          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td>          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td>           Allocation          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="padding-left: 0.125in; text-align: left">           Current assets          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="padding-left: 0.25in; text-align: left">           Accounts receivable          </td>          <td>          </td>          <td style="text-align: left">           $          </td>          <td style="text-align: right">           411,354          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="padding-left: 0.25in; text-align: left">           Prepaid Expense          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           12,139          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="padding-left: 0.125in; text-align: left">           Property and equipment          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           19,173          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="padding-left: 0.125in">           Intangibles          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="padding-left: 0.25in; text-align: left">           Goodwill, including assembled workforce in place          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           11,061,518          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="padding-left: 0.25in; text-align: left">           Web technology          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           5,125,000          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="padding-left: 0.25in">           Tradename          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           2,604,000          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="padding-left: 0.25in; text-align: left">           Non-compete agreements          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           116,000          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="padding-left: 0.25in; text-align: left">           Customer relationships          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           431,000          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="padding-left: 0.125in; text-align: left">           Current liabilities assumed          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="padding-left: 0.25in; text-align: left">           Accounts payable          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           (128,234          </td>          <td style="text-align: left">           )          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="padding-left: 0.25in; text-align: left">           Accrued expenses          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           (931,828          </td>          <td style="text-align: left">           )          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">           Deferred tax liability          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           (897,960          </td>          <td style="padding-bottom: 1.5pt; text-align: left">           )          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="padding-left: 0.375in; padding-bottom: 4pt">           Total          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           17,822,162          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       </p>       <!-- Field: Page; Sequence: 44; Value: 1 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         F-         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         16         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         OPTIMIZERx CORPORATION        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         DECEMBER 31, 2020        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        NOTE 3 – ACQUISITIONS        <font style="text-transform: uppercase">         (continued)        </font>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        As described in greater detail in Note6, the amortizable intangible assets acquired have estimated useful lives ranging from 2 to 15 years. We determined the estimatedfair value of the identifiable intangible assets acquired primarily by using the income approach.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        As of December 31, 2019, $800,000 was includedin accrued expenses as part of an indemnification provision against potential future claims. This balance was paid via the issuanceof common stock during the year ended December 31, 2020.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        We began consolidating the results of RMDYoperations and cashflows after October 3, 2019, the date of that acquisition. The unaudited Pro forma results of operations asthe acquisition had occurred January 1, 2019 are presented in the following table:       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">        <tbody>         <tr style="vertical-align: bottom">          <td style="text-align: justify">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">           2019          </td>          <td style="padding-bottom: 1.5pt">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="white-space: nowrap; text-align: justify">          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center">           As Reported          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center">           Pro Forma          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="width: 76%; text-align: justify">           Revenues          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">           $          </td>          <td style="width: 9%; text-align: right">           24,598,278          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">           $          </td>          <td style="width: 9%; text-align: right">           26,118,278          </td>          <td style="width: 1%; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: justify">           Net Loss          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           (3,142,576          </td>          <td style="text-align: left">           )          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           (3,869,577          </td>          <td style="text-align: left">           )          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: justify">           Loss per common share:          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="padding-left: 0.125in; text-align: justify; padding-bottom: 4pt">           Basic          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           (0.23          </td>          <td style="padding-bottom: 4pt; text-align: left">           )          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           (0.29          </td>          <td style="padding-bottom: 4pt; text-align: left">           )          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="padding-left: 0.125in; text-align: justify; padding-bottom: 4pt">           Diluted          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           (0.23          </td>          <td style="padding-bottom: 4pt; text-align: left">           )          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           (0.29          </td>          <td style="padding-bottom: 4pt; text-align: left">           )          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        NOTE 4 – PREPAID EXPENSES       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Prepaid expenses consisted of the followingas of December 31, 2020 and 2019:       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">        <tbody>         <tr style="vertical-align: bottom">          <td>          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">           2020          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">           2019          </td>          <td style="padding-bottom: 1.5pt">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="width: 76%">           Insurance          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">           $          </td>          <td style="width: 9%; text-align: right">           77,887          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">           $          </td>          <td style="width: 9%; text-align: right">           69,250          </td>          <td style="width: 1%; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: left">           Prepaid revenue share  and exclusivity payments          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           3,750,000          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           201,114          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: left">           EHR access fees          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           317,726          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           313,121          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="padding-bottom: 1.5pt">           Other          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           310,998          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           287,558          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: left; padding-bottom: 4pt">           Total prepaid expenses          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           4,456,611          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           871,043          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <!-- Field: Page; Sequence: 45; Value: 1 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         F-         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         17         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         OPTIMIZERx CORPORATION        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         DECEMBER 31, 2020        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        NOTE 5 – PROPERTY AND EQUIPMENT       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The Company owned equipment recorded atcost, which consisted of the following as of December 31, 2020 and 2019:       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">        <tbody>         <tr style="vertical-align: bottom">          <td>          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">           2020          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">           2019          </td>          <td style="padding-bottom: 1.5pt">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="width: 76%; text-align: left">           Computer equipment          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">           $          </td>          <td style="width: 9%; text-align: right">           169,247          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">           $          </td>          <td style="width: 9%; text-align: right">           137,763          </td>          <td style="width: 1%; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: left; padding-bottom: 1.5pt">           Furniture and fixtures          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           198,665          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           187,167          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td>          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           367,912          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           324,930          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: left; padding-bottom: 1.5pt">           Less accumulated depreciation          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           219,058          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           148,916          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="padding-left: 0.125in; text-align: left; padding-bottom: 4pt">           Property and equipment, net          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           148,854          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           176,014          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Depreciation expense was $95,202 and $80,206for the years ended December 31, 2020 and 2019, respectively.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        NOTE 6 – INTANBIGLE ASSETS       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         Goodwill        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The goodwill is related to the acquisitionof RMDY Health, Inc. in 2019 and CareSpeak Communications in 2018 and is primarily related to expected improvements and technologyperformance and functionality, sales growth from future solutions and service offerings and new customers, together with certainintangible assets that do not qualify for separate recognition, such as the assembled workforce in place. Goodwill is generallynot amortizable for tax purposes and is not amortizable for financial statement purposes.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         Intangible Assets        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Intangible assets included on the consolidatedbalance sheet consist of the following:       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">        <tbody>         <tr style="vertical-align: bottom">          <td style="text-align: justify">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center">           December 31, 2020          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="text-align: center">          </td>          <td style="padding-bottom: 1.5pt">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: center">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">           Gross           <br/>           Carrying           <br/>           Amount          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">           Accumulated           <br/>           Amortization          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">           Net          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">           Weighted           <br/>           Average Life           <br/>           Remaining          </td>          <td style="padding-bottom: 1.5pt">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="width: 52%; text-align: justify; padding-bottom: 4pt">           Patent rights          </td>          <td style="width: 1%; padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; width: 9%; text-align: right">           3,341,388          </td>          <td style="width: 1%; padding-bottom: 4pt; text-align: left">          </td>          <td style="width: 1%; padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; width: 9%; text-align: right">           991,818          </td>          <td style="width: 1%; padding-bottom: 4pt; text-align: left">          </td>          <td style="width: 1%; padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">          </td>          <td style="border-bottom: Black 4pt double; width: 9%; text-align: right">           2,349,570          </td>          <td style="width: 1%; padding-bottom: 4pt; text-align: left">          </td>          <td style="width: 1%; padding-bottom: 4pt">          </td>          <td style="width: 1%; padding-bottom: 4pt; text-align: left">          </td>          <td style="width: 9%; padding-bottom: 4pt; text-align: center">           11.5          </td>          <td style="width: 1%; padding-bottom: 4pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: justify; padding-bottom: 4pt">           Technology Assets          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           8,184,765          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           2,932,943          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           5,251,822          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt; text-align: center">           7.7          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: left">           Other intangible assets          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: center">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="padding-left: 0.125in; text-align: justify">           Tradename          </td>          <td>          </td>          <td style="text-align: left">           $          </td>          <td style="text-align: right">           3,586,000          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">           $          </td>          <td style="text-align: right">           298,833          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           3,287,167          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: center">           13.7          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="padding-left: 0.125in; text-align: left">           Non-compete agreements          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           1,093,000          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           611,885          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           481,115          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: center">           1.6          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="padding-left: 0.125in; text-align: justify; padding-bottom: 1.5pt">           Customer relationships          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           923,000          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           171,730          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           751,270          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt; text-align: center">           9.8          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: justify; padding-bottom: 4pt">           Total other          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           5,602,000          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           1,082,448          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           4,519,552          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt; text-align: center">          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: justify; padding-bottom: 4pt">           Total Intangibles          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           17,128,153          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           5,007,209          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           12,120,944          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt; text-align: center">          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <!-- Field: Page; Sequence: 46; Value: 1 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         F-         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         18         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         OPTIMIZERx CORPORATION        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         DECEMBER 31, 2020        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        NOTE 6 – INTANBIGLE ASSETS (CONTINUED)       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">        <tbody>         <tr style="vertical-align: bottom">          <td style="text-align: justify">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center">           December 31, 2019          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="text-align: center">          </td>          <td style="padding-bottom: 1.5pt">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: center">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">           Gross           <br/>           Carrying           <br/>           Amount          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">           Accumulated           <br/>           Amortization          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">           Net          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">           Weighted           <br/>           Average Life           <br/>           Remaining          </td>          <td style="padding-bottom: 1.5pt">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="width: 52%; text-align: justify; padding-bottom: 4pt">           Patent rights          </td>          <td style="width: 1%; padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; width: 9%; text-align: right">           3,329,457          </td>          <td style="width: 1%; padding-bottom: 4pt; text-align: left">          </td>          <td style="width: 1%; padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; width: 9%; text-align: right">           778,870          </td>          <td style="width: 1%; padding-bottom: 4pt; text-align: left">          </td>          <td style="width: 1%; padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; width: 9%; text-align: right">           2,550,587          </td>          <td style="width: 1%; padding-bottom: 4pt; text-align: left">          </td>          <td style="width: 1%; padding-bottom: 4pt">          </td>          <td style="width: 1%; padding-bottom: 4pt; text-align: left">          </td>          <td style="width: 9%; padding-bottom: 4pt; text-align: center">           11.7          </td>          <td style="width: 1%; padding-bottom: 4pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: justify; padding-bottom: 4pt">           Technology assets          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           8,140,013          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           1,901,560          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           6,238,453          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt; text-align: center">           8.0          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: left">           Other intangible assets          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: center">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="padding-left: 0.125in; text-align: justify">           Tradename          </td>          <td>          </td>          <td style="text-align: left">           $          </td>          <td style="text-align: right">           3,586,000          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">           $          </td>          <td style="text-align: right">           59,767          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">           $          </td>          <td style="text-align: right">           3,526,233          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: center">           14.5          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="padding-left: 0.125in; text-align: left">           Non-compete agreements          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           1,093,000          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           309,635          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           783,365          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: center">           2.7          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="padding-left: 0.125in; text-align: justify; padding-bottom: 1.5pt">           Customer relationships          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           923,000          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           81,496          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           841,504          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt; text-align: center">           10.5          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: justify; padding-bottom: 4pt">           Total other          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           5,602,000          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           450,898          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           5,151,102          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt; text-align: center">          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: justify; padding-bottom: 4pt">           Total Intangibles          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           17,071,470          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           3,131,328          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           13,940,142          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt; text-align: center">          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Intangibles are being amortized on a straight-linebasis over the following estimated useful lives.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">        <tbody>         <tr style="vertical-align: bottom; background-color: white">          <td style="width: 50%">           <font style="font: 10pt Times New Roman, Times, Serif">            Patents           </font>          </td>          <td style="width: 1%">          </td>          <td style="width: 1%">          </td>          <td style="width: 47%; text-align: right">           <font style="font: 10pt Times New Roman, Times, Serif">            15 – 17 years           </font>          </td>          <td style="width: 1%">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: white">          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            Tradenames           </font>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">           <font style="font: 10pt Times New Roman, Times, Serif">            15 years           </font>          </td>          <td>          </td>         </tr>         <tr style="vertical-align: bottom; background-color: white">          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            Non-compete agreements           </font>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">           <font style="font: 10pt Times New Roman, Times, Serif">            2 – 4 years           </font>          </td>          <td>          </td>         </tr>         <tr style="vertical-align: bottom; background-color: white">          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            Customer relationships           </font>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">           <font style="font: 10pt Times New Roman, Times, Serif">            8 – 15 years           </font>          </td>          <td>          </td>         </tr>         <tr style="vertical-align: bottom; background-color: white">          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            Technology assets           </font>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">           <font style="font: 10pt Times New Roman, Times, Serif">            3 – 10 years           </font>          </td>          <td>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The Company recorded amortization expenseof $1,875,882 and $1,094,924 in the years ended December 31, 2020 and 2019, respectively. Expected future amortization expensesof the intangibles assets as of December 31, 2020 is as follows:       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">        <tbody>         <tr style="vertical-align: bottom">          <td style="text-align: justify">           Year ended December 31,          </td>          <td>          </td>          <td colspan="2" style="text-align: justify">          </td>          <td>          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="padding-left: 0.125in; width: 88%; text-align: justify">           2021          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">           $          </td>          <td style="width: 9%; text-align: right">           1,859,840          </td>          <td style="width: 1%; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="padding-left: 0.125in; text-align: justify">           2022          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           1,459,427          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="padding-left: 0.125in; text-align: justify">           2023          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           1,057,728          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="padding-left: 0.125in; text-align: justify">           2024          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           1,057,728          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="padding-left: 0.125in; text-align: justify">           2025          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           1,057,728          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="padding-left: 0.125in; text-align: justify; padding-bottom: 1.5pt">           Thereafter          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           5,628,494          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="padding-left: 0.25in; text-align: justify; padding-bottom: 4pt">           Total          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           12,120,945          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        In addition to the technology assets acquiredin connection with the RMDY acquisition, the Company also acquired software with a cost of $1.5 million in 2019.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <!-- Field: Page; Sequence: 47; Value: 1 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         F-         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         19         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         OPTIMIZERx CORPORATION        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         DECEMBER 31, 2020        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        NOTE 7 – DEFERRED REVENUE       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The Company has several signed contractswith customers for the distribution of financial messaging, or other services, which include payment in advance. The payments arenot recorded as revenue until the revenue is earned under its revenue recognition policy discussed in Note 2. Deferred revenuewas $285,795 and $580,014 as of December 31, 2020 and 2019, respectively. These contracts are all short term in nature andall revenue is expected to be recognized within 12 months, or less. Following is a summary of activity in the deferred revenueaccount for the year ended December 31, 2020.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">        <tbody>         <tr style="vertical-align: bottom">          <td style="width: 88%; text-align: justify">           Balance January 1, 2020          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">           $          </td>          <td style="width: 9%; text-align: right">           580,014          </td>          <td style="width: 1%; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: justify">           Revenue recognized          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           (16,260,166          </td>          <td style="text-align: left">           )          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: justify; padding-bottom: 1.5pt">           Amount collected          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           15,680,152          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: justify; padding-bottom: 4pt">           Balance December 31, 2020          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           285,795          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        NOTE 8 – RELATED PARTY TRANSACTIONS       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        During the year ended December 31,2010, the Company acquired the technical contributions and assignment of all exclusive rights to and for a key patent in processat the time from a former CEO in exchange for a total payment in shares of common stock and options valued at $930,000 at the timeof the acquisition, and recorded the patent at that cost. That patent remains in Patents on the consolidated balance sheet as ofDecember 31, 2020.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        NOTE 9 – CONTINGENT PURCHASE PRICE       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Our purchase of CareSpeak Communicationscontained a contingent element that would be paid only if the Company achieved certain patient engagement revenues in 2019 and2020. The total contingent payment could have been up to $3.0 million. The target patient engagement revenues were achieved inboth 2019 and in 2020. The calculated fair value of the contingent payment was $3,000,000 at December 31, 2019 and $1,610,813 atDecember 31, 2020.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Our purchase of RMDY Health, Inc. also contained a contingentelement that would be paid only if the Company achieves certain revenues in 2020 and 2021 related to the RMDY business. The totalcontingent payment may be up to $30.0 million. The minimum payment was $1.0 million in each of the two years. The calculated fairvalue of the contingent payment was $3,720,000 at December 31, 2019. We determined the fair value of the Contingent Purchase PricePayable at December 31, 2019 using a Geometric-Brownian motion analysis of the expected revenue and resulting earnout payment usinginputs that include the spot price, a risk free rate of return of 1.4%, a term of 1-2 years, and volatility of 40%. During 2020,we reached agreement with the former shareholders of RMDY to fix the liability at $3.75 million, payable in a combination of cashand stock. Because of the change in the share price between the date of agreement and the date of payment, the amount recordedfor the stock amount varied from the agreed amount. The liability was paid $3.0 million in cash and the remainder in the commonstock.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The total fair value of contingent purchaseprice payable at December 31, 2020 is as follows.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">        <tbody>         <tr style="vertical-align: bottom">          <td style="text-align: justify">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">           Current          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">           Long-Term          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">           Total          </td>          <td style="padding-bottom: 1.5pt">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="width: 64%; text-align: justify">           CareSpeak Communications, Inc.          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">           $          </td>          <td style="width: 9%; text-align: right">           1,610,813          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 9%; text-align: right">           -          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">           $          </td>          <td style="width: 9%; text-align: right">           1,610,813          </td>          <td style="width: 1%; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: justify; padding-bottom: 1.5pt">           RMDY Health          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           -          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           -          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           -          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: justify; padding-bottom: 4pt">           Total          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           1,610,813          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           -          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           1,610,813          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <!-- Field: Page; Sequence: 48; Value: 1 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         F-         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         20         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         OPTIMIZERx CORPORATION        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         DECEMBER 31, 2020        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        NOTE 10 – STOCKHOLDERS’ EQUITY       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         <u>          Preferred Stock         </u>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The Company has 10,000,000 shares of preferredstock, $.001 par value per share, authorized as of December 31, 2020. No shares were issued or outstanding in either 2019 or 2020.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         <u>          Common Stock         </u>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The Company had 166,666,667 shares of commonstock, $.001 par value per share, authorized as of December 31, 2020. There were 15,223,340 and 14,600,579 shares of common stockissued and outstanding at December 31, 2020 and 2019, respectively.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        During 2019, in an underwritten publicoffering, we issued 1,769,275 shares of our common stock for gross proceeds of $23,000,575. In connection with this transaction,we incurred equity issuance costs of $1,696,749 related to payments to the underwriter, advisors and legal fees associated withthe transaction, resulting in net proceeds to the Company of $21,303,826.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The Company has a Director Compensationplan covering its independent non-employee Directors. A total of 28,809 and 33,344 shares were granted and issued in the yearsended December 31, 2020 and 2019, respectively, in connection with this compensation plan. These shares were valued at $450,124and $447,393, respectively.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        We issued 414,705 shares of common stockand received proceeds of $2,488,394 in 2020 in connection with the exercise of options. We also issued 246,448 shares of commonstock and received proceeds of $877,702 in 2019 in connection with the exercise of options.        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        During 2019, we issued 382,893 shares ofcommon stock, valued at $5,107,793, to the former shareholders of RMDY Health, Inc. in connection with the acquisition of RMDYin 2019. We also issued 94,501 shares of common stock in 2020, valued at $1,657,548 to the former shareholders of RMDY Health,Inc. in connection with the escrow holdback from the initial transaction and finalization of the earnout amount due.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        We adopted the new lease accounting standardASC 842 as of January 1, 2019, which resulted in a charge of $3,229 to Retained Earnings on that date.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <!-- Field: Page; Sequence: 49; Value: 1 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         F-         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         21         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         OPTIMIZERx CORPORATION        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         DECEMBER 31, 2020        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        NOTE 11 – STOCK COMPENSATION       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <font style="font-size: 8pt">        </font>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The Company sponsors a stock-based incentivecompensation plan known as the 2013 Equity Compensation Plan (the “Plan”), which was established by the Board of Directorsof the Company in June 2013. The Plan was amended several times since then to eventually increase the authorized shares to 3,000,000as of December 31, 2020. The amended plan has been approved by shareholders. A total of 1,545,518 shares of common stock underlyingoptions and 100,000 shares of common stock underlying restricted stock awards were outstanding at December 31, 2020. The Companyhad 299,461 remaining shares available to grant under the Plan at December 31, 2020.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <font style="font-size: 8pt">        </font>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The Plan allows the Company to grant incentivestock options, non-qualified stock options, stock appreciation rights, or restricted stock. The incentive stock options are exercisablefor up to ten years, at an option price per share not less than the fair market value on the date the option is granted. The incentivestock options are limited to persons who are regular full-time employees of the Company at the date of the grant of the option.Non-qualified options may be granted to any person, including, but not limited to, employees, independent agents, consultants andattorneys, who the Company’s Board or Compensation Committee believes have contributed, or will contribute, to the successof the Company. Non-qualified options may be issued at option prices of less than fair market value on the date of grant and maybe exercisable for up to ten years from date of grant. The option vesting schedule for options granted is determined by the CompensationCommittee of the Board of Directors at the time of the grant. The Plan provides for accelerated vesting of unvested options ifthere is a change in control, as defined in the Plan.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <font style="font-size: 8pt">        </font>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The compensation cost that has been chargedagainst income related to options for the years ended December 31, 2020 and 2019, was $1,884,202 and $1,687,745, respectively.No income tax benefit was recognized in the income statement and no compensation was capitalized in any of the years presented.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <font style="font-size: 8pt">        </font>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The Company had the following option activityduring the year ended December 31, 2020:       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <font style="font-size: 8pt">        </font>       </p>       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">        <tbody>         <tr style="vertical-align: bottom">          <td>          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">           Number of           <br/>           Options          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">           Weighted           <br/>           average           <br/>           exercise           <br/>           price          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">           Weighted           <br/>           average           <br/>           remaining           <br/>           contractual           <br/>           life (years)          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">           Aggregate           <br/>           intrinsic           <br/>           value $          </td>          <td style="padding-bottom: 1.5pt">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="width: 52%">           Outstanding, January 1, 2019          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 9%; text-align: right">           1,554,700          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">           $          </td>          <td style="width: 9%; text-align: right">           4.63          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 9%; text-align: right">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 9%; text-align: right">          </td>          <td style="width: 1%; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td>           Granted          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           410,134          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">           $          </td>          <td style="text-align: right">           12.28          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td>           Exercised          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           (251,063          </td>          <td style="text-align: left">           )          </td>          <td>          </td>          <td style="text-align: left">           $          </td>          <td style="text-align: right">           3.73          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-bottom: 1.5pt">           Expired or forfeited          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           (89,550          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">           $          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           12.55          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt; text-align: right">          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt; text-align: right">          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td>           Outstanding at December 31, 2019          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           1,624,221          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">           $          </td>          <td style="text-align: right">           6.27          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           2.6          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">           $          </td>          <td style="text-align: right">           7,925,643          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td>           Granted          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           467,549          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">           $          </td>          <td style="text-align: right">           11.39          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td>           Exercised          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           (420,586          </td>          <td style="text-align: left">           )          </td>          <td>          </td>          <td style="text-align: left">           $          </td>          <td style="text-align: right">           6.45          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: left; padding-bottom: 1.5pt">           Expired or forfeited          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           (125,666          </td>          <td style="padding-bottom: 1.5pt; text-align: left">           )          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">           $          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           13.09          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt; text-align: right">          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt; text-align: right">          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="padding-bottom: 1.5pt">           Outstanding, December 31, 2020          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           1,545,518          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">           $          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           7.31          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           2.3          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">           $          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           36,862,947          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="padding-bottom: 4pt">           Exercisable, December 31, 2020          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           1,214,512          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           4.64          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           1.5          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           30,666,752          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <font style="font-size: 8pt">        </font>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        The exercise price of outstanding options ranges from$2.46 per share to $28.48 per share.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <font style="font-size: 8pt">        </font>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">        A summary of the status of the Company’s nonvested optionsas of December 31, 2020, and changes during the year ended December 31, 2020, is presented below.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <font style="font-size: 8pt">        </font>       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">        <tbody>         <tr style="vertical-align: bottom">          <td style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: left">           Nonvested Options          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center">           Options          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center">           Weighted-Average           <br/>           Exercise Price          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="width: 76%">           Nonvested at January 1, 2020          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 9%; text-align: right">           480,584          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">           $          </td>          <td style="width: 9%; text-align: right">           10.72          </td>          <td style="width: 1%; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td>           Granted          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           467,549          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           11.39          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td>           Vested          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           (531,461          </td>          <td style="text-align: left">           )          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           9.95          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="padding-bottom: 1.5pt">           Forfeited          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           (85,666          </td>          <td style="padding-bottom: 1.5pt; text-align: left">           )          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           12.48          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="padding-bottom: 4pt">           Nonvested at December 31, 2020          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           331,006          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           12.44          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <font style="font-size: 8pt">        </font>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        There is $1,787,888 of expense remainingto be recognized over a period of approximately 2.5 years related to options outstanding at December 31, 2020.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <font style="font-size: 8pt">        </font>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The Company granted restricted stock awardsof 94,746 and 90,000 shares in 2020 and 2019, respectively, and valued at $850,985 and $938,700, respectively. These awards vestover a period of 1 to 5 years. The Company recognized expense of $838,514 and $125,160 in 2020 and 2019, respectively related tothis award. A total of $826,010 remains to be recognized at December 31, 2020 over a period of 3.2 years.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <font style="font-size: 8pt">        </font>       </p>       <table cellpadding="0" cellspacing="0" style="background-color: White; border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">        <tbody>         <tr style="vertical-align: bottom">          <td style="border-bottom: Black 1.5pt solid">           Restricted Stock Awards          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">           Shares          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">           Weighted-Average           <br/>           Grant Date Fair Value          </td>          <td style="padding-bottom: 1.5pt">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="width: 70%">           Outstanding at January 1, 2020          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 12%; text-align: right">           90,000          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">           $          </td>          <td style="width: 12%; text-align: right">           10.43          </td>          <td style="width: 1%; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td>           Granted          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           94,746          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           8.98          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: left; padding-bottom: 1.5pt">           Vested and issued          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           (84,746          </td>          <td style="padding-bottom: 1.5pt; text-align: left">           )          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           7.54          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="padding-bottom: 4pt">           Outstanding at December 31, 2020          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           100,000          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           11.51          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>         </tr>        </tbody>       </table>       <!-- Field: Page; Sequence: 50; Value: 1 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         F-         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         22         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         OPTIMIZERx CORPORATION        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         DECEMBER 31, 2020        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        NOTE 12 – LEASES       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        In February 2016, the Financial AccountingStandards Board (“FASB”) issued new accounting guidance on leases. The accounting standard, effective January 1, 2019,requires virtually all leases to be recognized on the balance sheet. Effective January 1, 2019, we adopted the standard using themodified retrospective method, under which we elected the package of practical expedients and transition provisions allowing usto bring our existing operating leases onto the consolidated balance sheet without adjusting comparative periods, but recognizinga cumulative-effect adjustment to the opening balance of accumulated deficit on January 1, 2019. Under the guidance, we have alsoelected not to separate lease and non-lease components in recognition of the lease-related assets and liabilities, as well as therelated lease expense.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        We have operating leases with terms greaterthan 12 months for office space in three multitenant facilities, which are recorded as assets and liabilities. The lease on ourheadquarters space in Rochester, Michigan expires November 30, 2022, with a three-year renewal option through 2025, with monthlyrent payable at rates ranging from $6,384 to $6,688. We have assumed renewal of the lease. We also have a lease on office spacein Cranbury, New Jersey, expiring in 2022 with monthly payments ranging from $3,008 to $3,158, as well as a lease of approximately$1,883 per month in Zagreb, Croatia expiring in 2022.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Lease-related assets, or right-of-use assets,are recognized at the lease commencement date at amounts equal to the respective lease liabilities, adjusted for prepaid leasepayments, initial direct costs, and lease incentives received. Lease-related liabilities are recognized at the present value ofthe remaining contractual fixed lease payments, discounted using our incremental borrowing rate. Operating lease expense is recognizedon a straight-line basis over the lease term, while variable lease payments are expensed as incurred.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Upon adoption of the standard on January1, 2019, we recorded approximately $462,000 of right of use assets and $465,000 of lease-related liabilities, with the differencerecorded in accumulated deficit as the cumulative effect of change in accounting principle at that date.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        For the year ended December 31, 2020, theCompany’s lease cost consisted of the following components, each of which is included in operating expenses within the Company’sconsolidated statements of operations:       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 11pt">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">        <tbody>         <tr style="vertical-align: bottom">          <td>          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">           Year Ended           <br/>           December 31,           <br/>           2020          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">           Year Ended           <br/>           December 31,           <br/>           2019          </td>          <td style="padding-bottom: 1.5pt">          </td>         </tr>         <tr style="vertical-align: bottom">          <td>          </td>          <td>          </td>          <td colspan="2">          </td>          <td>          </td>          <td>          </td>          <td colspan="2">          </td>          <td>          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="width: 76%; text-align: left">           Operating lease cost          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">           $          </td>          <td style="width: 9%; text-align: right">           119,954          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">           $          </td>          <td style="width: 9%; text-align: right">           132,020          </td>          <td style="width: 1%; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: left; padding-bottom: 1.5pt">           Short-term lease cost (1)          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           130,216          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           84,935          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: left; padding-bottom: 4pt">           Total lease cost          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           250,170          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           216,955          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        (1) Short-term lease cost includes anylease with a term of less than 12 months.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <!-- Field: Page; Sequence: 51; Value: 1 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         F-         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         23         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         OPTIMIZERx CORPORATION        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         DECEMBER 31, 2020        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        NOTE 12 – LEASES (CONTINUED)       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The table below presents the future minimumlease payments to be made under operating leases as of December 31, 2020:       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">        <tbody>         <tr style="vertical-align: bottom">          <td style="text-align: left">           For the year ending December 31,          </td>          <td>          </td>          <td colspan="2">          </td>          <td>          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="width: 88%; text-align: left">           2021          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">           $          </td>          <td style="width: 9%; text-align: right">           140,367          </td>          <td style="width: 1%; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: left">           2022          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           102,367          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: left">           2023          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           99,209          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: left">           2024          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           80,375          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: left">           2025          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           70,224          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: left">           Total          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           492,452          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: left; padding-bottom: 1.5pt">           Less: present value discount          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           43,789          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: left; padding-bottom: 4pt">           Total lease liabilities          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           448,753          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The weighted average remaining lease termfor operating leases is 4.3 years and the weighted average discount rate used in calculating the operating lease asset and liabilityis 4.5%. Cash paid for amounts included in the measurement of lease liabilities was $115,431. For the year ended December 31, 2020,payments on lease obligations were $138,019 and amortization on the right of use assets was $104,805. For the year ended December31, 2019, payments on lease obligations were $132,867 and amortization on the right of use assets was $107,656.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        NOTE 13 – MAJOR CUSTOMERS AND VENDORS       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The Company had the following customersthat accounted for 10% or greater of revenue in either 2020 or 2019. No other customers accounted for more than 10% of revenuein either year presented.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">        <tbody>         <tr style="vertical-align: bottom">          <td>          </td>          <td>          </td>          <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">           <font style="font: 10pt Times New Roman, Times, Serif">            2020           </font>          </td>          <td>          </td>          <td>          </td>          <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">           <font style="font: 10pt Times New Roman, Times, Serif">            2019           </font>          </td>          <td>          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: justify">          </td>          <td>          </td>          <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">           <font style="font: 10pt Times New Roman, Times, Serif">            $           </font>          </td>          <td>          </td>          <td>          </td>          <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">           <font style="font: 10pt Times New Roman, Times, Serif">            %           </font>          </td>          <td>          </td>          <td>          </td>          <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">           <font style="font: 10pt Times New Roman, Times, Serif">            $           </font>          </td>          <td>          </td>          <td>          </td>          <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">           <font style="font: 10pt Times New Roman, Times, Serif">            %           </font>          </td>          <td>          </td>         </tr>         <tr style="vertical-align: bottom; background-color: white">          <td style="width: 52%; text-align: justify">           <font style="font: 10pt Times New Roman, Times, Serif">            Customer A           </font>          </td>          <td style="width: 1%">          </td>          <td style="width: 1%">          </td>          <td style="width: 9%; text-align: right">           <font style="font: 10pt Times New Roman, Times, Serif">            5,469,126           </font>          </td>          <td style="width: 1%">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%">          </td>          <td style="width: 9%; text-align: right">           <font style="font: 10pt Times New Roman, Times, Serif">            12.6           </font>          </td>          <td style="width: 1%">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%">          </td>          <td style="width: 9%; text-align: right">           <font style="font: 10pt Times New Roman, Times, Serif">            1,349,214           </font>          </td>          <td style="width: 1%">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%">          </td>          <td style="width: 9%; text-align: right">           5.5          </td>          <td style="width: 1%">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: white">          <td style="text-align: justify">           <font style="font: 10pt Times New Roman, Times, Serif">            Customer B           </font>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">           <font style="font: 10pt Times New Roman, Times, Serif">            5,037,888           </font>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">           <font style="font: 10pt Times New Roman, Times, Serif">            11.6           </font>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">           <font style="font: 10pt Times New Roman, Times, Serif">            1,032,377           </font>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">           4.2          </td>          <td>          </td>         </tr>         <tr style="vertical-align: bottom; background-color: white">          <td style="text-align: justify">           <font style="font: 10pt Times New Roman, Times, Serif">            Customer C           </font>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">           <font style="font: 10pt Times New Roman, Times, Serif">            4,824,454           </font>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">           <font style="font: 10pt Times New Roman, Times, Serif">            11.1           </font>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">           <font style="font: 10pt Times New Roman, Times, Serif">            3,883,589           </font>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">           15.8          </td>          <td>          </td>         </tr>         <tr style="vertical-align: bottom; background-color: white">          <td style="text-align: justify">           <font style="font: 10pt Times New Roman, Times, Serif">            Customer D           </font>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">           <font style="font: 10pt Times New Roman, Times, Serif">            3,551,241           </font>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">           <font style="font: 10pt Times New Roman, Times, Serif">            8.2           </font>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">           <font style="font: 10pt Times New Roman, Times, Serif">            2,533,766           </font>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">           10.3          </td>          <td>          </td>         </tr>         <tr style="vertical-align: bottom; background-color: white">          <td style="text-align: justify">           <font style="font: 10pt Times New Roman, Times, Serif">            Customer E           </font>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">           <font style="font: 10pt Times New Roman, Times, Serif">            1,113,599           </font>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">           <font style="font: 10pt Times New Roman, Times, Serif">            2.6           </font>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">           <font style="font: 10pt Times New Roman, Times, Serif">            2,801,748           </font>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">           11.4          </td>          <td>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <!-- Field: Page; Sequence: 52; Value: 1 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         F-         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         24         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         OPTIMIZERx CORPORATION        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         DECEMBER 31, 2020        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        NOTE 13 – MAJOR CUSTOMERS AND VENDORS (CONTINUED)       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Our accounts receivable includes 4 entities,included agencies that represent multiple customers that individually make up more than 10% of our accounts receivable at December31, 2020 in the percentages of 19.7%, 16.2%, 15.8% and 14.4%.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The Company generates its revenues throughits EHR and ePrescribe partners. It had two key partners and/or vendors through which 10% or greater of its revenue was generatedin either 2020 or 2019 as set forth below. The amounts in the table below reflect the amount of revenue generated through thosepartners.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">        <tbody>         <tr style="vertical-align: bottom">          <td>          </td>          <td>          </td>          <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">           <font style="font: 10pt Times New Roman, Times, Serif">            2020           </font>          </td>          <td>          </td>          <td>          </td>          <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">           <font style="font: 10pt Times New Roman, Times, Serif">            2019           </font>          </td>          <td>          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: justify">          </td>          <td>          </td>          <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">           <font style="font: 10pt Times New Roman, Times, Serif">            $           </font>          </td>          <td>          </td>          <td>          </td>          <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">           <font style="font: 10pt Times New Roman, Times, Serif">            %           </font>          </td>          <td>          </td>          <td>          </td>          <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">           <font style="font: 10pt Times New Roman, Times, Serif">            $           </font>          </td>          <td>          </td>          <td>          </td>          <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">           <font style="font: 10pt Times New Roman, Times, Serif">            %           </font>          </td>          <td>          </td>         </tr>         <tr style="vertical-align: bottom; background-color: white">          <td style="text-align: justify; width: 52%">           <font style="font: 10pt Times New Roman, Times, Serif">            Partner A           </font>          </td>          <td style="width: 1%">          </td>          <td style="width: 1%">          </td>          <td style="text-align: right; width: 9%">           <font style="font: 10pt Times New Roman, Times, Serif">            22,813,574           </font>          </td>          <td style="width: 1%">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%">          </td>          <td style="text-align: right; width: 9%">           <font style="font: 10pt Times New Roman, Times, Serif">            52.7           </font>          </td>          <td style="width: 1%">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%">          </td>          <td style="text-align: right; width: 9%">           <font style="font: 10pt Times New Roman, Times, Serif">            9,210,347           </font>          </td>          <td style="width: 1%">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%">          </td>          <td style="text-align: right; width: 9%">           <font style="font: 10pt Times New Roman, Times, Serif">            37.4           </font>          </td>          <td style="width: 1%">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: white">          <td style="text-align: justify">           <font style="font: 10pt Times New Roman, Times, Serif">            Partner B           </font>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">           <font style="font: 10pt Times New Roman, Times, Serif">            7,092,477           </font>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">           <font style="font: 10pt Times New Roman, Times, Serif">            16.4           </font>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">           <font style="font: 10pt Times New Roman, Times, Serif">            4,051,217           </font>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td style="text-align: right">           <font style="font: 10pt Times New Roman, Times, Serif">            16.5           </font>          </td>          <td>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        NOTE 14 – INCOME TAXES       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        As of December 31, 2020, the Company hadnet operating loss carry-forwards for federal income tax purposes of approximately $19.3 million, consisting of pre-2018 lossesin the amount of approximately $13.3 million that expire from 2020 through 2037, and post-2017 losses in the amount of approximately$6 million that never expire. These net operating losses are available to offset future taxable income. The Company was formedin 2006 as a limited liability company and changed to a corporation in 2007. Activity prior to incorporation is not reflected inthe Company’s corporate tax returns. In the future, the cumulative net operating loss carry-forward for income tax purposesmay differ from the cumulative financial statement loss due to timing differences between book and tax reporting.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The provision for Federal income tax consistsof the following for the years ended December 31, 2020 and 2019:       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">        <tbody>         <tr style="font-style: normal; vertical-align: bottom; font-weight: normal">          <td style="font-style: normal; font-weight: normal">          </td>          <td style="font-style: normal; font-weight: normal; padding-bottom: 1.5pt">          </td>          <td colspan="2" style="font-style: normal; border-bottom: Black 1.5pt solid; font-weight: normal; text-align: center">           2020          </td>          <td style="font-style: normal; padding-bottom: 1.5pt; font-weight: normal">          </td>          <td style="font-style: normal; font-weight: normal; padding-bottom: 1.5pt">          </td>          <td colspan="2" style="font-style: normal; border-bottom: Black 1.5pt solid; font-weight: normal; text-align: center">           2019          </td>          <td style="font-style: normal; padding-bottom: 1.5pt; font-weight: normal">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: justify">           Federal income tax benefit (expense) attributable to:          </td>          <td>          </td>          <td colspan="2" style="text-align: right">          </td>          <td>          </td>          <td>          </td>          <td colspan="2" style="text-align: right">          </td>          <td>          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="width: 76%; text-align: justify">           Current operations          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">           $          </td>          <td style="width: 9%; text-align: right">           463,000          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">           $          </td>          <td style="width: 9%; text-align: right">           848,000          </td>          <td style="width: 1%; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: justify">           Acquisition costs          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           -          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           (143,000          </td>          <td style="text-align: left">           )          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: justify">           Change in fair value of contingent consideration          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           (29,000          </td>          <td style="text-align: left">           )          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           (133,000          </td>          <td style="text-align: left">           )          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: justify">           Other permanent items          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           200,000          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           29,000          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: justify">           Deferred adjustment          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           (913,000          </td>          <td style="text-align: left">           )          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           (913,000          </td>          <td style="text-align: left">           )          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: justify">           Other adjustments          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           104,000          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           -          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: justify">           NOLs expiring          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           (209,000          </td>          <td style="text-align: left">           )          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           -          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: justify; padding-bottom: 1.5pt">           Valuation allowance          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           (529,000          </td>          <td style="padding-bottom: 1.5pt; text-align: left">           )          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           1,209,960          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: justify; padding-bottom: 4pt">           Net provision for federal income tax          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           -          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           897,960          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">        <tbody>         <tr style="font-style: normal; vertical-align: bottom; font-weight: normal">          <td style="font-style: normal; font-weight: normal">          </td>          <td style="font-style: normal; font-weight: normal; padding-bottom: 1.5pt">          </td>          <td colspan="2" style="font-style: normal; border-bottom: Black 1.5pt solid; font-weight: normal; text-align: center">           2020          </td>          <td style="font-style: normal; padding-bottom: 1.5pt; font-weight: normal">          </td>          <td style="font-style: normal; font-weight: normal; padding-bottom: 1.5pt">          </td>          <td colspan="2" style="font-style: normal; border-bottom: Black 1.5pt solid; font-weight: normal; text-align: center">           2019          </td>          <td style="font-style: normal; padding-bottom: 1.5pt; font-weight: normal">          </td>         </tr>         <tr style="vertical-align: bottom">          <td>          </td>          <td>          </td>          <td colspan="2">          </td>          <td>          </td>          <td>          </td>          <td colspan="2">          </td>          <td>          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: justify">           Current tax benefit (expense) - Federal          </td>          <td>          </td>          <td style="text-align: left">           $          </td>          <td style="text-align: right">           -          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">           $          </td>          <td style="text-align: right">           -          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: justify">           Deferred tax benefit (expense) - Federal          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           -          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           -          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="width: 76%; text-align: justify; padding-bottom: 1.5pt">           Adjustment of valuation allowance from business combination          </td>          <td style="width: 1%; padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">           -          </td>          <td style="width: 1%; padding-bottom: 1.5pt; text-align: left">          </td>          <td style="width: 1%; padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">           897,960          </td>          <td style="width: 1%; padding-bottom: 1.5pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: justify; padding-bottom: 4pt">           Total tax benefit (expense) on income          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           -          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           897,960          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <!-- Field: Page; Sequence: 53; Value: 1 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         F-         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         25         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         OPTIMIZERx CORPORATION        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         DECEMBER 31, 2020        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        NOTE 14 – INCOME TAXES (CONTINUED)       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The cumulative tax effect of significantitems comprising our net deferred tax amount at the expected rate of 21% is as follows as of December 31, 2020 and 2019:       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">        <tbody>         <tr style="font-style: normal; vertical-align: bottom; font-weight: normal">          <td style="font-style: normal; font-weight: normal">          </td>          <td style="font-style: normal; font-weight: normal; padding-bottom: 1.5pt">          </td>          <td colspan="2" style="font-style: normal; border-bottom: Black 1.5pt solid; font-weight: normal; text-align: center">           2020          </td>          <td style="font-style: normal; padding-bottom: 1.5pt; font-weight: normal">          </td>          <td style="font-style: normal; font-weight: normal; padding-bottom: 1.5pt">          </td>          <td colspan="2" style="font-style: normal; border-bottom: Black 1.5pt solid; font-weight: normal; text-align: center">           2019          </td>          <td style="font-style: normal; padding-bottom: 1.5pt; font-weight: normal">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: justify">           Deferred tax asset attributable to:          </td>          <td>          </td>          <td colspan="2">          </td>          <td>          </td>          <td>          </td>          <td colspan="2">          </td>          <td>          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="width: 76%; text-align: justify">           Net operating loss carryover          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">           $          </td>          <td style="width: 9%; text-align: right">           4,057,000          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">           $          </td>          <td style="width: 9%; text-align: right">           3,839,000          </td>          <td style="width: 1%; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: justify">           Stock compensation          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           353,000          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           320,000          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: justify">           Operating lease liability          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           94,000          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           -          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: justify; padding-bottom: 1.5pt">           Other          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           44,000          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           36,000          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: justify; padding-bottom: 4pt">           Deferred tax asset          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           4,548,000          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           4,195,000          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td>          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: justify">           Deferred tax liabilities attributable to:          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: justify">           Fixed assets          </td>          <td>          </td>          <td style="text-align: left">           $          </td>          <td style="text-align: right">           -          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">           $          </td>          <td style="text-align: right">           (13,000          </td>          <td style="text-align: left">           )          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: justify">           Intangibles          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           (2,181,000          </td>          <td style="text-align: left">           )          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           (2,438,000          </td>          <td style="text-align: left">           )          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: justify">           Operating lease right of use assets          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           (94,000          </td>          <td style="text-align: left">           )          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           -          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="width: 76%; text-align: justify; padding-bottom: 1.5pt">           Other          </td>          <td style="width: 1%; padding-bottom: 1.5pt">          </td>          <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">           (16,000          </td>          <td style="width: 1%; padding-bottom: 1.5pt; text-align: left">           )          </td>          <td style="width: 1%; padding-bottom: 1.5pt">          </td>          <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">           (16,000          </td>          <td style="width: 1%; padding-bottom: 1.5pt; text-align: left">           )          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: justify; padding-bottom: 4pt">           Deferred tax liability          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           (2,291,000          </td>          <td style="padding-bottom: 4pt; text-align: left">           )          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           (2,467,000          </td>          <td style="padding-bottom: 4pt; text-align: left">           )          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: justify; padding-bottom: 4pt">           Valuation allowance          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           2,257,000          </td>          <td style="padding-bottom: 4pt; text-align: left">           )          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           (1,728,000          </td>          <td style="padding-bottom: 4pt; text-align: left">           )          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td>          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom; background-color: White">          <td style="text-align: justify; padding-bottom: 4pt">           Net deferred tax asset          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           -          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>          <td style="padding-bottom: 4pt">          </td>          <td style="border-bottom: Black 4pt double; text-align: left">           $          </td>          <td style="border-bottom: Black 4pt double; text-align: right">           -          </td>          <td style="padding-bottom: 4pt; text-align: left">          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The ultimate realization of deferred taxassets is dependent upon the Company’s ability to generate sufficient taxable income during the periods in which the netoperating losses expire and the temporary differences become deductible. The Company has determined that there is significant uncertaintythat the results of future operations and the reversals of existing taxable temporary differences will generate sufficient taxableincome to realize the deferred tax assets; therefore, a valuation allowance has been recorded. In making this determination, theCompany considered historical levels of income, projections for future periods, and the significant amount of tax deductions tobe generated from the future exercise of stock options.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The tax years 2017 to 2020 remain openfor potential audit by the Internal Revenue Service. There are no uncertain tax positions as of December 31, 2019 or December 31,2020, and none are expected in the next 12 months. The Company’s foreign subsidiaries are cost centers that are primarilyreimbursed for expenses, as a result they generate an immaterial amount of income or loss. Pretax book income (loss) is all fromdomestic operations. Up to four years of returns remain open for potential audit in foreign jurisdictions, however any audits forperiods prior to ownership by the Company are the responsibility of the previous owners.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Under certain circumstances issuance ofcommon shares can result in an ownership change under Internal Revenue Code Section 382, which limits the Company’s abilityto utilize carry-forwards from prior to the ownership change. Any such ownership change resulting from stock issuances and redemptionscould limit the Company’s ability to utilize any net operating loss carry-forwards or credits generated before this changein ownership. These limitations can limit both the timing of usage of these laws, as well as the loss of the ability to use thesenet operating losses. It is likely that fundraising activities have resulted in such an ownership change.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <!-- Field: Page; Sequence: 54; Value: 1 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         F-         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         26         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         OPTIMIZERx CORPORATION        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         DECEMBER 31, 2020        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        NOTE 15 – COMMITMENTS AND CONTINGENT LIABILITIES       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <u>         Legal        </u>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The Company is not involved in any legalproceedings.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <u>         Revenue-share contracts        </u>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The Company has contacts with variouselectronic health records systems and ePrescribe platforms, whereby we agree to share a portion of the revenue we generatefor eCoupons distributed through their networks. These contracts grant audit rights related to the payments to our partners,and, in some cases would require us to pay for the audit if the audit determined there was an underpayment and theunderpayment meets certain thresholds, such as 10%. From time to time the Company enters into arrangements with a partner toacquire minimum amounts of messaging capabilities. As of December 31, 2020, the Company had commitments for future minimumpayments of $7.5 million that will be reflected in cost of revenues during the years from 2021 through 2022. Minimum paymentsare due in 2021 and 2022, in the amounts of $6.25 million and $1.5 million, respectively.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        NOTE 16 – RETIREMENT PLAN       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The Company sponsors a defined contribution401(k) profit sharing plan which was adopted in December 2015, effective in January 2016. Under the terms of the plan, the Companymatches 100% of the first 3% of payroll contributed by the employee and 50% of the next 2% of payroll contributed by the employeeto a maximum of 4% of an employee’s payroll. There was expense of $373,027 and $126,557 recorded in 2020 and 2019, respectively,for company contributions to the plan.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        NOTE 17 – SUBSEQUENT EVENTS       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        During February 2021, in an underwrittenpublic offering, we issued 1,523,750 shares of our common stock for gross proceeds of $75,425,625. In connection with this transaction,we incurred equity issuance costs of $4,744,652 related to payments to the underwriter, advisors, legal fees, and other costs associatedwith the transaction, resulting in net proceeds to the Company of approximately $70,680,973.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">        In 2021, the Company issued 59,547 shares andreceived proceeds of $495,288 in connection with the exercise of options. In March 2021, the Company’s Board of Directorsamended the 2013 Equity Compensation Plan to increase the number of shares authorized under the plan to 6.0 million shares.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <!-- Field: Page; Sequence: 55; Value: 1 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         F-         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         27         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <b>         <a name="a_013">         </a>         Item 9. Changes In and Disagreements with Accountants onAccounting and Financial Disclosure        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">        On June 22, 2020, the Company engaged UHY LLP as the Company’sindependent registered public accounting firm and dismissed Marcum LLP as the Company’s independent registered public accountingfirm. There were no disagreements or reportable events required to be disclosed under Item 304(b) of Regulation S-K.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <a name="a_014">        </a>        <b>         Item 9A. Controls and Procedures        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         Evaluation of Disclosure Controls andProcedures        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Our disclosure controls and procedures(as defined in Rules 13a-15I or 15d-15I under the Securities Exchange Act of 1934, as amended) are designed to ensure that informationrequired to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reportedwithin the time periods specified in the rules and forms of the Securities and Exchange Commission and to ensure that informationrequired to be disclosed is accumulated and communicated to management, including our principal executive and financial officers,to allow timely decisions regarding disclosure. Based on an evaluation under the supervision and with the participation ofthe Company’s management, the Company’s principal executive officer and principal financial officer have concludedthat the Company’s disclosure controls and procedures as defined in Rules 13a-15I and 15d-15I under the Exchange Act wereeffective as of December 31, 2020.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         Management’s Report on InternalControl over Financial Reporting        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The Company’s management is responsiblefor establishing and maintaining adequate internal control over financial reporting (as defined in Rule 13a-15(f) under the ExchangeAct). Our internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financialreporting and the preparation of financial statements for external purposes in accordance with U.S. GAAP and includes those policiesand procedures that: (1) pertain to the maintenance of records that in reasonable detail accurately and fairly reflect our transactionsand the dispositions of our assets; (2) provide reasonable assurance that our transactions are recorded as necessary to permitpreparation of financial statements in accordance with generally accepted accounting principles and that our receipts and expendituresare being made only in accordance with appropriate authorizations; and (3) provide reasonable assurance regarding prevention ortimely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on our financialstatements.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Because of its inherent limitations, internalcontrol over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness for futureperiods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliancewith the policies or procedures may deteriorate.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Management conducted an assessment of theeffectiveness of the Company’s internal control over financial reporting based on the criteria set forth in Internal Control– Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework). Amaterial weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that thereis a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented ordetected on a timely basis.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Based on this assessment as of December 31, 2020, managementconcluded that there were no material weaknesses. As part of the assessment at December 31, 2019, management identified the followingmaterial weaknesses which caused management to conclude that our disclosure controls and procedures were not effective at thatdate: (i) inadequate information technology general controls (ITGCs) in the areas of user access security, change management, IToperations and third-party management over its key financial information technology (IT) systems; and (ii) inadequate controlsto ensure that data received from third parties is complete and accurate. Those weaknesses have been remediated as of December31, 2020.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The material weaknesses in 2019 did notresult in any identified misstatements to the financial statements, and there were no changes to previously released financialresults.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        This annual report does not include anattestation report of the Company’s independent registered public accounting firm regarding internal controls over financialreporting as of December 31, 2020 because we became a smaller reporting company under Section 404 of the Sarbanes-Oxley Act of2002 pursuant to the provisions of Section 989G(a) set forth in the Dodd-Frank Wall Street Reform and Consumer Protection Act enactedinto federal law in July 2010.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         Changes in Internal Control Over FinancialReporting        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        During 2020, the Company improved itsinformation technology general controls and the documentation of those controls to address the material weaknesses identifiedin 2019. It also implemented new controls to ensure that the data received from third parties is complete and accurate. Otherthan the changes to internal controls described above, there has been no material changes in our internal control over financialreporting during the most recently completed fiscal quarter that has materially affected, or is reasonably likely to materiallyaffect, our internal control over financial reporting.       </p>       <!-- Field: Page; Sequence: 56; Options: NewSection; Value: 27 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         27         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         <u>          <a name="a_015">          </a>          PART III         </u>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         <a name="a_016">         </a>         Item 10. Directors, Executive Officersand Corporate Governance        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The following information sets forth thenames, ages, and positions of our current directors and executive officers.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">        <tbody>         <tr style="vertical-align: top">          <td style="border-bottom: black 1.5pt solid; width: 35%; text-align: left">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Name           </font>          </td>          <td style="width: 1%; text-align: center">          </td>          <td style="border-bottom: black 1.5pt solid; width: 7%; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Age           </font>          </td>          <td style="width: 1%; text-align: center">          </td>          <td style="border-bottom: black 1.5pt solid; width: 56%; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Positions    and Offices Held           </font>          </td>         </tr>         <tr style="vertical-align: top">          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            William J. Febbo           </font>          </td>          <td style="text-align: center">          </td>          <td style="text-align: center">           <font style="font: 10pt Times New Roman, Times, Serif">            52           </font>          </td>          <td>          </td>          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            Chief Executive Officer and Director           </font>          </td>         </tr>         <tr style="vertical-align: top">          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            Stephen L. Silvestro           </font>          </td>          <td style="text-align: center">          </td>          <td style="text-align: center">           <font style="font: 10pt Times New Roman, Times, Serif">            43           </font>          </td>          <td>          </td>          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            Chief Commercial Officer           </font>          </td>         </tr>         <tr style="vertical-align: top">          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            Miriam J. Paramore           </font>          </td>          <td style="text-align: center">          </td>          <td style="text-align: center">           <font style="font: 10pt Times New Roman, Times, Serif">            57           </font>          </td>          <td>          </td>          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            President and Chief Strategy Officer           </font>          </td>         </tr>         <tr style="vertical-align: top">          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            Marion Odence-Ford           </font>          </td>          <td style="text-align: center">          </td>          <td style="text-align: center">           <font style="font: 10pt Times New Roman, Times, Serif">            56           </font>          </td>          <td>          </td>          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            General Counsel and Chief Compliance Officer           </font>          </td>         </tr>         <tr style="vertical-align: top">          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            Douglas P. Baker           </font>          </td>          <td style="text-align: center">          </td>          <td style="text-align: center">           <font style="font: 10pt Times New Roman, Times, Serif">            64           </font>          </td>          <td>          </td>          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            Chief Financial Officer           </font>          </td>         </tr>         <tr style="vertical-align: top">          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            Gus D. Halas           </font>          </td>          <td style="text-align: center">          </td>          <td style="text-align: center">           <font style="font: 10pt Times New Roman, Times, Serif">            70           </font>          </td>          <td>          </td>          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            Chairperson and Director           </font>          </td>         </tr>         <tr style="vertical-align: top">          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            Patrick Spangler           </font>          </td>          <td style="text-align: center">          </td>          <td style="text-align: center">           <font style="font: 10pt Times New Roman, Times, Serif">            65           </font>          </td>          <td>          </td>          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            Director           </font>          </td>         </tr>         <tr style="vertical-align: top">          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            Lynn Vos           </font>          </td>          <td style="text-align: center">          </td>          <td style="text-align: center">           <font style="font: 10pt Times New Roman, Times, Serif">            65           </font>          </td>          <td>          </td>          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            Director           </font>          </td>         </tr>         <tr style="vertical-align: top">          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            James Lang           </font>          </td>          <td style="text-align: center">          </td>          <td style="text-align: center">           <font style="font: 10pt Times New Roman, Times, Serif">            56           </font>          </td>          <td>          </td>          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            Director           </font>          </td>         </tr>         <tr style="vertical-align: top">          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            Greg Wasson           </font>          </td>          <td style="text-align: center">          </td>          <td style="text-align: center">          </td>          <td>          </td>          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            Director           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Set forth below is a brief descriptionof the background and business experience of each of our current executive officers and directors.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         William J. Febbo        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Mr. Febbo joined our company as Chief ExecutiveOfficer and Director on February 22, 2016. Mr. Febbo brings more than 20 years of experience in building and managing health servicesand financial businesses. From 2007 to 2015, he worked with Merriman Holdings, Inc., an investment banking firm. There he servedas Chief Operating Officer and assisted with capital raises in the tech, biotech, cleantech, consumer and resources industries.Prior to Merriman, Mr. Febbo was CEO and co-founder of MedPanel, a provider of market intelligence and communications for the pharmaceutical,biomedical, and medical device industries, which was eventually acquired by MCF Corporation.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Mr. Febbo holds a Bachelor of Arts in InternationalStudies from Dickinson College, in Pennsylvania. Febbo serves on the board of The United Nations of Greater Boston, a non-profitfocused on building global citizens within inner-city schools in Massachusetts, is faculty on the MIT linq program and currentlyserves as a board member of Modular Medical (MODD).       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Aside from that provided above, Mr. Febbodoes not hold and has not held over the past five years any other directorships in any company with a class of securities registeredpursuant to Section 12 of the Exchange Act or subject to the requirements of Section 15(d) of the Exchange Act or any company registeredas an investment company under the Investment Company Act of 1940.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Mr. Febbo is qualified to serve on ourBoard of Directors because of his wealth of experience in building and managing health services and financial businesses.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         Stephen L. Silvestro        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Mr. Silvestro joined the company as ChiefCommercial Officer on April 29, 2019. Mr. Silvestro was with CCH® Tagetik as its Vice President and General Manager from January2018 until he joined us. From April 2017 to January 2018, Mr. Silvestro was with Prognos as its Chief Commercial Officer and, beforethat, from September 2007 to April 2017, he was with Decision Resources Group in various capacitates with him last serving as ExecutiveVice President, Head of Global Sales.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <!-- Field: Page; Sequence: 57; Value: 27 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         28         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Aside from that provided above, Mr. Silvestrodoes not hold and has not held over the past five years any other directorships in any company with a class of securities registeredpursuant to Section 12 of the Exchange Act or subject to the requirements of Section 15(d) of the Exchange Act or any company registeredas an investment company under the Investment Company Act of 1940.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         Miriam J. Paramore        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Ms. Paramore joined the company as Presidentin August 2017. She has vast experience with healthcare companies, running businesses ranging from start-ups to large divisionsof public and private companies. Her early career was spent at Ernst &amp; Young, as a Healthcare Management Consultant. She hassince occupied executive level and director positions at several healthcare companies. Most recently, from April 2016 to April2017, Ms. Paramore served as COO and CTO of Lucro, Inc., a privately held company located in| Nashville, Tennessee focused on thehealthcare sector. From March 2015 to February 2016, she served as Executive Vice President of PDX a privately held company inFort Worth, Texas that provides health information technology for pharmacies. From May 2008 to December 2013, she served as ExecutiveVice President of Emdeon, Inc. in Nashville, Tennessee, a health information technology and tech-enabled services company.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Aside from that provided above, Ms. Paramoredoes not hold and has not held over the past five years any other directorships in any company with a class of securities registeredpursuant to Section 12 of the Exchange Act or subject to the requirements of Section 15(d) of the Exchange Act or any company registeredas an investment company under the Investment Company Act of 1940.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         Marion Odence-Ford        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Ms. Odence-Ford joined the company as GeneralCounsel and Chief Compliance Officer in February 2021. She is a corporate lawyer with over 20 years of large firm and in-houseexperiences in a broad range of industries including life sciences, high tech, business consulting, professional services, banking,and finance companies. From April 2013 to June 2020, she was a senior member of the legal team at Decision Resources Group, a multi-nationalcorporation that provides global data solutions, analytics and consulting services to pharmaceutical, biotech, medical device,healthcare provider and payer, and managed care companies.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Aside from that provided above, Ms. Odence-Forddoes not hold and has not held over the past five years any other directorships in any company with a class of securities registeredpursuant to Section 12 of the Exchange Act or subject to the requirements of Section 15(d) of the Exchange Act or any company registeredas an investment company under the Investment Company Act of 1940.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         Douglas P. Baker        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Mr. Baker has served as our CFO since May19, 2014. Mr. Baker is a Certified Public Account with a Master’s Degree in Business Administration. He has extensive businessexperience including 9 years in public accounting with Plante Moran, four years as CFO of a privately held printing company, 5years in a variety of divisional financial roles at MascoTech, Inc., a Fortune 500 automotive supplier, and from 1996 to 2014 asChief Financial Officer of Applied Nanotech Holdings, Inc., (“APNT”) a publicly held nanotechnology research and licensingcompany. Mr. Baker was also a member of the Board of Directors of APNT from 2006 through 2014. He was a member of the Board Directorsof Total Health Care, Inc., a Detroit based Health Maintenance Organization from 1987 through January 2020, including his latestrole as Chairman of the Board, until it was acquired by Priority Health, a Michigan based HMO in January 2020. He became a memberof the Priority Health Board in January 2020.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Aside from that provided above, Mr. Bakerdoes not hold and has not held over the past five years any other directorships in any company with a class of securities registeredpursuant to Section 12 of the Exchange Act or subject to the requirements of Section 15(d) of the Exchange Act or any company registeredas an investment company under the Investment Company Act of 1940.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <!-- Field: Page; Sequence: 58; Value: 27 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         29         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         Gus D. Halas        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Mr. Halas joined our company as a Directoron August 7, 2014. Mr. Halas has served as CEO of several companies. He was Chief Executive Officer and President of the CentralOperating Companies at Central Garden &amp; Pet Company from April 2011 through May 2013. Mr. Halas was President and Chief ExecutiveOfficer of T-3 Energy Services, Inc. from May 2003 to March 2009 and also served as Chairman of the Board of Directors from March2004 to March 2009. From August 2001 to April 2003, Mr. Halas served as President and Chief Executive Officer of Clore Automotive,Inc. He also serves as a director for Triangle Petroleum Corp.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Aside from that provided above, Mr. Halasdoes not hold and has not held over the past five years any other directorships in any company with a class of securities registeredpursuant to Section 12 of the Exchange Act or subject to the requirements of Section 15(d) of the Exchange Act or any company registeredas an investment company under the Investment Company Act of 1940.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Mr. Halas is qualified to serve on ourBoard of Directors because of his experience and expertise as an executive and a director with companies implementing “turnaround”strategies.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         Lynn Vos        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Ms. Vos runs VosHealth, LLC. She was thePresident and CEO of the Muscular Dystrophy Association from October 2017 through November 2020. Prior to that, Ms. Vos had beenchief executive officer of ghg | greyhealth group since 1994 and is a champion of using digital capabilities to improve the publichealth. Ms. Vos also serves on the board of nTelos Wireless, a NASDAQ listed company, the Jed Foundation, a leading nonprofit dedicatedto protecting the emotional health of college students, and was a founding board member of MMRF, a pioneering cancer research foundation.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Aside from that provided above, Ms. Vosdoes not hold and has not held over the past five years any other directorships in any company with a class of securities registeredpursuant to Section 12 of the Exchange Act or subject to the requirements of Section 15(d) of the Exchange Act or any company registeredas an investment company under the Investment Company Act of 1940.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Ms. Vos is qualified to serve on our Boardof Directors because of her extensive executive skills in digital marketing and communications in the healthcare industry.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         James Lang        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Mr. Lang joined our Board January 12, 2017.He brings us more than 25 years of experience in healthcare data, analytic, and technology enabled business services. Mr. Langis the CEO of Eversana, a leading independent provider of global commercial services to the life science industry, and also presentlyserves as an executive advisor to Water Street, a strategic private equity firm focused exclusively on building market-leadingcompanies in healthcare. In that capacity, he currently serves as Board Chairman to The Access Group, Health StrategiesGroup, Alliance Life Sciences, and Dohmen Life Science Services.  He is also on the of BioVie (Nasdaq:BIVI)a development-stage company pioneering an innovative therapeutic that targets complications due to liver cirrhosis.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Mr. Lang previously served as CEO of DecisionResources Group, a leading healthcare research and consulting company providing high-value healthcare industry analysis and insights,where he helped transform the company into an industry leader. Earlier, he was president of Strategic Decisions Group, a premierglobal strategy consultancy, and he expanded the life sciences practice and later sold it to IMS Health. He is an active privateinvestor and advisor with healthcare companies, including Boston Heart Diagnostics (acquired by Eurofins) and AlphalmpactRx (acquiredby IMS Health).       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Aside from that provided above, Mr. Langdoes not hold and has not held over the past five years any other directorships in any company with a class of securities registeredpursuant to Section 12 of the Exchange Act or subject to the requirements of Section 15(d) of the Exchange Act or any company registeredas an investment company under the Investment Company Act of 1940.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <!-- Field: Page; Sequence: 59; Value: 27 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         30         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Mr. Lang is qualified to serve on our Boardof Directors because of his extensive executive skills and background in the healthcare industry.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         Patrick Spangler        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Patrick Spangler has over 32 yearsof experience in IPO’s, mergers and acquisitions, operations and financial management experience in the medical device andhealth care IT industries. As a transformational leader he has been responsible for driving high-performance emerging growth firmsas well as large publicly traded companies and has also served in the private equity sector successfully improving operationalresults and exit strategies with a broad array of portfolio companies. He currently serves as Chief Financial Officer of On TargetLaboratories which has developed fluorescent markers to target and illuminate cancer during surgery.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Prior to On Target Laboratories, Mr. Spanglerserved as Chief Financial Officer of MHC Software supplying document automation software to a variety of industries. Previous toMHC, Mr. Spangler served as Chief Financial Officer of Vigilanz Corporation, Chief Financial Officer of Healthland Inc, SVP andCFO for Epocrates (EPOC), SVP and CFO of ev3 Inc. (EVVV), and Executive Vice President and Chief Financial Officer and AssistantSecretary for EMPI Inc (EMPI). Prior to joining EMPI Inc. Mr. Spangler served for over eleven years in various senior finance leadershippositions at Medtronic, Inc (MDT).       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Mr. Spangler holds a Bachelor of Sciencein Accounting from the University of Minnesota, a Master of Business Taxation from the University of Minnesota and a Master ofBusiness Administration from University of Chicago and also serves on the Board of Directors of Lifespace Communities Inc, andpreviously served on the board of Urologix Inc (ULGX) a leader in less invasive in office BPH treatment.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Aside from that provided above, Mr. Spanglerdoes not hold and has not held over the past five years any other directorships in any company with a class of securities registeredpursuant to Section 12 of the Exchange Act or subject to the requirements of Section 15(d) of the Exchange Act or any company registeredas an investment company under the Investment Company Act of 1940.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Mr. Spangler is qualified to serve on ourBoard of Directors because of his extensive executive skills and background in the healthcare industry and his finance experience.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         Greg Wasson        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Mr. Wasson, age 62, joined the Board inJuly 2020. Mr. Wasson is the former President and CEO of Walgreens Boots Alliance. While president and CEO of Walgreens, Wassonled the company to record sales of $76.4 billion in 2014. He created significant shareholder value by completing game-changingmergers and acquisitions, leading complex organizational and structural change, assembling a diverse and high-performance seniorleadership team, and establishing Walgreens as an industry leader. Wasson is largely credited for transforming the iconic 114-year-olddomestic company into the first global pharmacy-led, health, well-being, and beauty enterprise via the successful merger with European-basedAlliance Boots in 2015.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Prior to being appointed president andCEO of the combined companies, Walgreens Boots Alliance, Wasson had risen through the ranks through a number of positions of increasingresponsibility and executive leadership, starting as an intern at Walgreens in 1980.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Aside from that provided above, Mr. Wassondoes not hold and has not held over the past five years any other directorships in any company with a class of securities registeredpursuant to Section 12 of the Exchange Act or subject to the requirements of Section 15(d) of the Exchange Act or any company registeredas an investment company under the Investment Company Act of 1940.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Mr. Wasson is qualified to serve on ourBoard of Directors because of his extensive executive skills and background in the healthcare industry.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <!-- Field: Page; Sequence: 60; Value: 27 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         31         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         Directors        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Our bylaws authorize no less than three(3) and no more than Seven (7) Directors unless changed by the Board of Directors. We currently have six (6) Directors.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         Term of Office        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Our Directors are appointed for a one-yearterm to hold office until the next annual general meeting of our shareholders or until removed from office in accordance with ourbylaws. Our officers are appointed by our board of directors and hold office until removed by the board, subject to their respectiveemployment agreements.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         Significant Employees        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        We have no significant employees.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         Family Relationships        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        There are no family relationships betweenor among the directors, executive officers or persons nominated or chosen by us to become directors or executive officers.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         Involvement in Certain Legal Proceedings        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        During the past 10 years, other than asset forth below, none of our current directors, nominees for directors or current executive officers has been involved in any legalproceeding identified in Item 401(f) of Regulation S-K, including:       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        1. Any petition under the Federal bankruptcylaws or any state insolvency law filed by or against, or a receiver, fiscal agent or similar officer was appointed by a court forthe business or property of such person, or any partnership in which he or she was a general partner at or within two years beforethe time of such filing, or any corporation or business association of which he or she was an executive officer at or within twoyears before the time of such filing;       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        2. Any conviction in a criminal proceedingor being named a subject of a pending criminal proceeding (excluding traffic violations and other minor offenses);       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        3. Being subject to any order, judgment,or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction, permanently or temporarilyenjoining him or her from, or otherwise limiting, the following activities:       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        i. Acting as a futures commission merchant,introducing broker, commodity trading advisor, commodity pool operator, floor broker, leverage transaction merchant, any otherperson regulated by the Commodity Futures Trading Commission, or an associated person of any of the foregoing, or as an investmentadviser, underwriter, broker or dealer in securities, or as an affiliated person, director or employee of any investment company,bank, savings and loan association or insurance company, or engaging in or continuing any conduct or practice in connection withsuch activity;       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        ii. Engaging in any type of business practice;or       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        iii. Engaging in any activity in connectionwith the purchase or sale of any security or commodity or in connection with any violation of Federal or State securities lawsor Federal commodities laws;       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        4. Being subject to any order, judgmentor decree, not subsequently reversed, suspended or vacated, of any Federal or State authority barring, suspending or otherwiselimiting for more than 60 days the right of such person to engage in any type of business regulated by the Commodity Futures TradingCommission, securities, investment, insurance or banking activities, or to be associated with persons engaged in any such activity;       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <!-- Field: Page; Sequence: 61; Value: 27 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         32         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        5. Being found by a court of competentjurisdiction in a civil action or by the SEC to have violated any Federal or State securities law, and the judgment in such civilaction or finding by the Commission has not been subsequently reversed, suspended, or vacated;       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        6. Being found by a court of competentjurisdiction in a civil action or by the Commodity Futures Trading Commission to have violated any Federal commodities law, andthe judgment in such civil action or finding by the Commodity Futures Trading Commission has not been subsequently reversed, suspendedor vacated;       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        7. Being subject to, or a party to, anyFederal or State judicial or administrative order, judgment, decree, or finding, not subsequently reversed, suspended or vacated,relating to an alleged violation of:       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        i. Any Federal or State securities or commoditieslaw or regulation; or       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        ii. Any law or regulation respecting financialinstitutions or insurance companies including, but not limited to, a temporary or permanent injunction, order of disgorgement orrestitution, civil money penalty or temporary or permanent cease-and-desist order, or removal or prohibition order; or       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        iii. Any law or regulation prohibitingmail or wire fraud or fraud in connection with any business entity; or       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        8. Being subject to, or a party to, anysanction or order, not subsequently reversed, suspended or vacated, of any self-regulatory organization (as defined in Section3(a)(26) of the Exchange Act (15 U.S.C. 78c(a)(26))), any registered entity (as defined in Section 1(a)(29) of the Commodity ExchangeAct (7 U.S.C. 1(a)(29))), or any equivalent exchange, association, entity or organization that has disciplinary authority overits members or persons associated with a member.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        On January 29, 2018, FINRA accepted a Letterof Acceptance, Waiver and Consent (No. 2015044865501) (the “Consent”) submitted by William Febbo. From August 2012to October 2015, Mr. Febbo was the Financial and Operations Principal (FinOp) for a registered broker-dealer, Merriman Capital,Inc. (Merriman). During certain months while Mr. Febbo was FINOP, FINRA found that certain of Merriman’s net capital filingswith FINRA were inaccurate because of the method by which Merriman calculated net capital and that, when corrected, it was retroactivelydetermined that Merriman had operated below its minimum net capital requirements. Febbo, as FinOp, signed certain of these reportsand was thus held responsible. Based on the Consent, in settlement, Mr. Febbo, who was then no longer registered with any broker-dealer,accepted a fine of $5,000 and a 10-business day suspension from acting as FinOp for any FINRA member.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         Director Independence        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The Board of Directors reviews the independenceof our directors on the basis of standards adopted by the Nasdaq Stock Market (“Nasdaq”). As a part of this review,the Board of Directors considers transactions and relationships between our company, on the one hand, and each director, membersof the director’s immediate family, and other entities with which the director is affiliated, on the other hand. The purposeof such a review is to determine which, if any, of such transactions or relationships were inconsistent with a determination thatthe director is independent under Nasdaq rules. As a result of this review, the Board of Directors has determined that each ofour directors other than Mr. Febbo is an “independent director” within the meaning of applicable Nasdaq listing standards.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         Committees of the Board        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The Board of Directors has three standingcommittees to facilitate and assist the Board of Directors in the execution of its responsibilities: (1) Nominating and GovernanceCommittee; (2) Audit Committee and (3) Compensation Committee. Each committee acts pursuant to a written charter adopted by theBoard of Directors. Each committee’s charter is available on our corporate website at http://www.optimizerx.com. (The informationcontained in our website is not incorporated into this Annual Report on Form 10-K.) All of the committees are comprised solelyof non-employee, independent directors as defined by Nasdaq market listing standards.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <!-- Field: Page; Sequence: 62; Value: 27 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         33         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <b>         <i>         </i>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         <i>          Nominating and Governance Committee         </i>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The Board of Directors has establisheda Nominating and Governance Committee. In 2020, the committee members were Directors Vos (Chair), Lang, and Halas. The Nominatingand Corporate Governance Committee held 4 meetings during the fiscal year ended December 31, 2020. The Nominating and CorporateGovernance Committee’s responsibilities, which are discussed in detail in its charter, include the responsibility to:       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">        <tbody>         <tr style="vertical-align: top; text-align: justify">          <td style="width: 0.25in">          </td>          <td style="width: 0.25in; text-align: left">           <font style="font: 10pt Times New Roman, Times, Serif">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font: 10pt Times New Roman, Times, Serif">            Developqualifications and criteria for selecting and evaluating directors and nominees;           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">        <tbody>         <tr style="vertical-align: top; text-align: justify">          <td style="width: 0.25in">          </td>          <td style="width: 0.25in; text-align: left">           <font style="font: 10pt Times New Roman, Times, Serif">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font: 10pt Times New Roman, Times, Serif">            Considerand propose director nominees;           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">        <tbody>         <tr style="vertical-align: top; text-align: justify">          <td style="width: 0.25in">          </td>          <td style="width: 0.25in; text-align: left">           <font style="font: 10pt Times New Roman, Times, Serif">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font: 10pt Times New Roman, Times, Serif">            Makerecommendations to the Board regarding Board compensation;           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">        <tbody>         <tr style="vertical-align: top; text-align: justify">          <td style="width: 0.25in">          </td>          <td style="width: 0.25in; text-align: left">           <font style="font: 10pt Times New Roman, Times, Serif">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font: 10pt Times New Roman, Times, Serif">            Makerecommendations to the Board regarding Board committee memberships;           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">        <tbody>         <tr style="vertical-align: top; text-align: justify">          <td style="width: 0.25in">          </td>          <td style="width: 0.25in; text-align: left">           <font style="font: 10pt Times New Roman, Times, Serif">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font: 10pt Times New Roman, Times, Serif">            Developand recommend to the Board corporate governance guidelines;           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">        <tbody>         <tr style="vertical-align: top; text-align: justify">          <td style="width: 0.25in">          </td>          <td style="width: 0.25in; text-align: left">           <font style="font: 10pt Times New Roman, Times, Serif">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font: 10pt Times New Roman, Times, Serif">            Facilitatean annual assessment of the performance of the Board and each of its standing committees;           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">        <tbody>         <tr style="vertical-align: top; text-align: justify">          <td style="width: 0.25in">          </td>          <td style="width: 0.25in; text-align: left">           <font style="font: 10pt Times New Roman, Times, Serif">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font: 10pt Times New Roman, Times, Serif">            Considerthe independence of each director and nominee for director; and           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">        <tbody>         <tr style="vertical-align: top; text-align: justify">          <td style="width: 0.25in">          </td>          <td style="width: 0.25in; text-align: left">           <font style="font: 10pt Times New Roman, Times, Serif">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font: 10pt Times New Roman, Times, Serif">            Performother functions or duties deemed appropriate by the Board.           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         <i>          Compensation Committee         </i>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The Board of Directors has establisheda Compensation Committee. The Compensation Committee held 4 meetings during the fiscal year ended December 31, 2020, and held otherinformal discussions as needed. In 2020, the Committee was composed of Directors Halas, Spangler, Wasson, and Lang, and is chairedby Director Lang. The Compensation Committee’s responsibilities, which are discussed in detail in its charter, include theresponsibility to:       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">        <tbody>         <tr style="vertical-align: top; text-align: justify">          <td style="width: 0.25in">          </td>          <td style="width: 0.25in; text-align: left">           <font style="font: 10pt Times New Roman, Times, Serif">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font: 10pt Times New Roman, Times, Serif">            Inconsultation with our senior management, establish our general compensation philosophy and oversee the development and implementationof our compensation programs;           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">        <tbody>         <tr style="vertical-align: top; text-align: justify">          <td style="width: 0.25in">          </td>          <td style="width: 0.25in; text-align: left">           <font style="font: 10pt Times New Roman, Times, Serif">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font: 10pt Times New Roman, Times, Serif">            Recommendthe base salary, incentive compensation and any other compensation for our Chief Executive Officer to the Board of Directors andreview and approve the Chief Executive Officer’s recommendations for the compensation of all other officers of our companyand its subsidiary;           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">        <tbody>         <tr style="vertical-align: top; text-align: justify">          <td style="width: 0.25in">          </td>          <td style="width: 0.25in; text-align: left">           <font style="font: 10pt Times New Roman, Times, Serif">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font: 10pt Times New Roman, Times, Serif">            Administerour incentive and stock-based compensation plans, and discharge the duties imposed on the Compensation Committee by the termsof those plans;           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">        <tbody>         <tr style="vertical-align: top; text-align: justify">          <td style="width: 0.25in">          </td>          <td style="width: 0.25in; text-align: left">           <font style="font: 10pt Times New Roman, Times, Serif">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font: 10pt Times New Roman, Times, Serif">            Reviewand approve any severance or termination payments proposed to be made to any current or former officer of our company; and           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">        <tbody>         <tr style="vertical-align: top; text-align: justify">          <td style="width: 0.25in">          </td>          <td style="width: 0.25in; text-align: left">           <font style="font: 10pt Times New Roman, Times, Serif">            ●           </font>          </td>          <td style="text-align: justify">           <font style="font: 10pt Times New Roman, Times, Serif">            Performother functions or duties deemed appropriate by the Board of Directors.           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <!-- Field: Page; Sequence: 63; Value: 27 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         34         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         <i>          Audit Committee         </i>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        In 2020, the Audit Committee was comprisedof Directors Halas, Spangler and Vos, and is chaired by Director Spangler. The Audit Committee held four meetings during the fiscalyear ended December 31, 2020 and held informal discussions as necessary.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The Audit Committee approves the selectionof our independent accountants and meets and interacts with the independent accountants to discuss issues related to financialreporting. In addition, the Audit Committee reviews the scope and results of the audit with the independent accountants, reviewswith management and the independent accountants our annual operating results, considers the adequacy of our internal accountingprocedures, including our internal control over financial reporting, and considers other auditing and accounting matters includingfees to be paid to the independent auditor and the performance of the independent auditor.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        For the fiscal year ending December 31,2020, the Audit Committee:       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">        <tbody>         <tr style="vertical-align: top">          <td style="width: 24px">          </td>          <td style="width: 24px">           <font style="font: 10pt Times New Roman, Times, Serif">            1.           </font>          </td>          <td style="text-align: justify">           <font style="font: 10pt Times New Roman, Times, Serif">            Reviewed and discussed the audited financial statements with management, and           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">        <tbody>         <tr style="vertical-align: top">          <td style="width: 24px">          </td>          <td style="width: 24px">           <font style="font: 10pt Times New Roman, Times, Serif">            2.           </font>          </td>          <td style="text-align: justify">           <font style="font: 10pt Times New Roman, Times, Serif">            Reviewed and discussed the written disclosures and the letter from our independent auditors on the matters relating to the auditor’s independence.           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Based upon the Audit Committee’sreview and discussion of the matters above, the board of directors authorized inclusion of the audited financial statements forthe year ended December 31, 2020 to be included in this Annual Report on Form 10-K and filed with the Securities and Exchange Commission.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The Board has determined that each memberof the Audit Committee qualifies as an audit committee financial expert as defined under applicable SEC rules and also meets theadditional criteria for independence of audit committee members set forth in Rule 10A-3(b)(1) under the Securities Exchange Actof 1934, as amended.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         Section 16(a) Beneficial Ownership ReportingCompliance        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Section 16(a) of the Exchange Act requiresour directors and executive officers and persons who beneficially own more than ten percent of a registered class of the Company’sequity securities to file with the SEC initial reports of ownership and reports of changes in ownership of common stock and otherequity securities of the Company. Officers, directors and greater than ten percent beneficial shareholders are required by SECregulations to furnish us with copies of all Section 16(a) forms they file. To the best of our knowledge based solely on a reviewof Forms 3, 4, and 5 (and any amendments thereof) received by us, no persons have failed to file, on a timely basis, the identifiedreports required by Section 16(a) of the Exchange Act during fiscal year ended December 31, 2020, other than the Company was latein filing Form 4s related to its quarterly grant of shares to independent directors in one instance for directors, Lang, Wasson,Vos, Halas, and Spangler. In addition, director Lang had an additional late Form 4 and Director Wasson had a late Form 3 –both related to issues with filing codes. AWM Investment Company, Inc., was late in one instance in filing its Form 4 obligation.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         Code of Ethics        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        In October 2017, the Board of Directorsadopted a Code of Ethics for the Company, which was attached to our 2017 Annual Report on Form 10-K as Exhibit 14.1.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <!-- Field: Page; Sequence: 64; Value: 27 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         35         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <b>         <a name="a_017">         </a>         Item 11. Executive Compensation        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The table below summarizes all compensationawarded to, earned by, or paid to our current named executive officers for the fiscal years ended December 31, 2020 and 2019.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">        <tbody>         <tr style="vertical-align: bottom">          <td style="border-bottom: Black 1.5pt solid; white-space: nowrap">           Name and principal position          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center">           Year          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center">           Salary           <br/>           ($)          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center">           Bonus           <br/>           ($)          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center">           Stock           <br/>           Awards           <br/>           ($)          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center">           Option           <br/>           Awards           <br/>           ($)          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center">           All Other           <br/>           Compensation           <br/>           ($)          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center">           Total           <br/>           ($)          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="width: 16%; text-align: left">           William J. Febbo (1)          </td>          <td style="width: 1%">          </td>          <td style="width: 11%; text-align: center">           2020          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 9%; text-align: right">           350,000          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 9%; text-align: right">           261,187          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 9%; text-align: right">           638,985          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 9%; text-align: right">           -          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 9%; text-align: right">           15,400          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 9%; text-align: right">           1,265,572          </td>          <td style="width: 1%; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="font-style: italic; text-align: left; padding-bottom: 1.5pt">           CEO, Director          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="text-align: center; padding-bottom: 1.5pt">           2019          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           300,000          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           126,990          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           391,800          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           -          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           15,200          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           833,990          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: left">           Stephen L. Silvestro          </td>          <td>          </td>          <td style="text-align: center">           2020          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           300,000          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           185,562          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           380,628          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           -          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           866,190          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="font-style: italic; text-align: left; padding-bottom: 1.5pt">           Chief Commercial Officer          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="text-align: center; padding-bottom: 1.5pt">           2019          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           188,821          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           82,678          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           938,700          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           -          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           1,210,199          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: left">           Miriam Paramore (2)          </td>          <td>          </td>          <td style="text-align: center">           2020          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           275,000          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           136,812          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           228,370          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           -          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           11,400          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           651,582          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="font-style: italic; padding-bottom: 1.5pt">           President          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="text-align: center; padding-bottom: 1.5pt">           2019          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           250,000          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           70,550          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           130,600          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           -          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           11,200          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: left">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: right">           462,350          </td>          <td style="padding-bottom: 1.5pt; text-align: left">          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         Narrative Disclosure to the SummaryCompensation Table        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">        <tbody>         <tr style="vertical-align: top">          <td style="width: 24px">          </td>          <td style="width: 24px">           <font style="font: 10pt Times New Roman, Times, Serif">            (1)           </font>          </td>          <td style="text-align: justify">           <font style="font: 10pt Times New Roman, Times, Serif">            Amounts reflected in All Other Compensation column for Mr. Febbo in 2019 is composed of $11,200 employer matching contributions to the Company’s retirement plan and $4,000 for a term life policy. The 2020 amounts are $11,400 employer matching contributions to the Company’s retirement plan and the balance for a term life policy.           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">        <tbody>         <tr style="vertical-align: top">          <td style="width: 24px">          </td>          <td style="width: 24px">           <font style="font: 10pt Times New Roman, Times, Serif">            (2)           </font>          </td>          <td style="text-align: justify">           <font style="font: 10pt Times New Roman, Times, Serif">            Amount reflected in All Other Compensation for Ms. Paramore for both years reflects employer matching contributions to the Company’s retirement plan.           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Mr. Febbo joined the Company as CEO onFebruary 22, 2016. In March 2020, the Board of Directors amended his contract to provide a base salary of $350,000 per year in2020 and $400,000 per year in 2021. In addition, he is eligible to participate in the Company’s executive bonus plan witha target bonus of 60% of his annual salary. He is also eligible for vacation, sick days, insurance, to participate in the Company’s401k plan, and other benefits covering all employees. Mr. Febbo’s contract also calls for him to be reimbursed $4,000 peryear for a separate term life insurance policy. Mr. Febbo’s contract calls for 12 months of severance if he is terminatedwithout cause.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        In February 2019, the Board of Directorsgranted Mr. Febbo an additional 30,000 shares of restricted common stock if the Company achieves certain targeted stretch revenuegoals in 2019. Those goals were not achieved, so the shares did not vest. In March 2020, the Board of Directors granted Mr.Febbo an additional 84,786 shares of restricted common stock that vested over the course of 2020. In January 2021, the Board ofDirectors granted Mr. Febbo an additional 28,883 shares of restricted stock that vest annually over a 3 year period starting onthe date of grant.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Mr. Silvestro joined the Company as ChiefCommercial Officer on April 29, 2019. Under the terms of his employment agreement, he received an annual base salary of $280,000and a signing bonus of $30,000, paid in two installments of $15,000 in 2019. In March 2020, the Board of Directors amended hiscontract to increase his base salary to $300,000 for 2020. In January 2021, the Board increased his base salary to $330,000 peryear, effective January 1, 2021. In addition, he was eligible to participate in the Company’s executive bonus plan with atarget bonus of 40% of his annual salary. In March 2020, the Board increased his target bonus percentage to 50% of his base salary.He is also eligible for vacation, sick days, insurance, to participate in the Company’s 401k plan, and other benefits coveringall employees. Mr. Silvestro’s contract also calls for 12 months of severance if he is terminated without cause.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Mr. Silvestro also received a grant of90,000 shares of restricted common stock at the time of his employment. The grant vests all at one time upon completion of fiveyears of employment. In March 2020, the Board of Directors granted Mr. Silvestro 105,993 options, which vest quarterly throughout2020, to purchase shares of common stock at a price of $7.51 per share. In January 2021, the Board of Directors granted Mr. Silvestro38,511 options, which vest annually over a three-year period beginning on the date of the grant, with an exercise price of $37.50per share.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Ms. Paramore joined the Company as Presidenton August 1, 2017. On September 10, 2018 Ms. Paramore signed a new employment agreement calling for a base salary of $250,000.In March 2020, the Board of Directors amended her contract to increase her base salary to $275,000 for 2020. In January 2021, theBoard of Directors amended her contract to increase her base salary to $290,000 annually, effective January 1, 2021. In February2021, the Board of Directors increased her annual base salary to $300,000. In addition, she is eligible to participate in the Company’sexecutive bonus plan with a target bonus of 40% of her annual salary. She is also eligible for vacation, sick days, insurance,to participate in the Company’s 401k plan, and other benefits covering all employees. Ms. Paramore’s contract alsocalls for 12 months of severance if she is terminated without cause.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        In February 2019, the Board of Directorsgranted Ms. Paramore 10,000 shares of restricted common stock that would vest if the Company achieves certain targeted stretchrevenue goals in 2019. Those goals were not achieved, so the shares did not vest. In March 2020, the Board of Directors grantedMs. Paramore 63,558 options, which vested quarterly through 2020, to purchase shares of common stock at a price of $7.51 per share.In January 2021, the Board of Directors granted Ms. Paramore 24,093 options, which vest annually over a three-year period beginningon the date of the grant, with an exercise price of $37.50 per share.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        For all three named executive officers,the executive bonus plan contains a provision whereby each officer could receive a bonus ranging from $0 to $1.0 million if achange of control transaction occurs prior to December 31, 2021, depending up on the transaction price.       </p>       <!-- Field: Page; Sequence: 65; Value: 27 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         36         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         Outstanding Equity Awards at FiscalYear-End        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The table below summarizes all unexercisedoptions, stock that has not vested, and equity incentive plan awards for each named executive officers as of December 31, 2020.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">        <tbody>         <tr style="vertical-align: bottom">          <td colspan="35" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">           OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END          </td>         </tr>         <tr style="vertical-align: bottom">          <td colspan="19" style="border-bottom: Black 1.5pt solid; text-align: center">           OPTION AWARDS          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="14" style="border-bottom: Black 1.5pt solid; text-align: center">           STOCK AWARDS          </td>          <td style="padding-bottom: 1.5pt">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="border-bottom: Black 1.5pt solid">           Name          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">           Number of           <br/>           Securities           <br/>           Underlying           <br/>           Unexercised           <br/>           Options (#)           <br/>           Exercisable          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">           Number of           <br/>           Securities           <br/>           Underlying           <br/>           Unexercised           <br/>           Options (#)           <br/>           Unexercisable          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">           Equity           <br/>           Incentive           <br/>           Plan           <br/>           Awards:           <br/>           Number of           <br/>           Securities           <br/>           Underlying           <br/>           Unexercised           <br/>           Unearned           <br/>           Options           <br/>           (#)          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">           Option           <br/>           Exercise           <br/>           Price           <br/>           ($)          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="border-bottom: Black 1.5pt solid; text-align: center">           Option           <br/>           Expiration           <br/>           Date          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">           Number of           <br/>           Shares           <br/>           or Units           <br/>           of Stock That           <br/>           Have Not           <br/>           Vested           <br/>           (#)          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">           Market           <br/>           Value of           <br/>           Shares           <br/>           or Units           <br/>           of Stock           <br/>           That Have           <br/>           Not Vested           <br/>           ($)          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">           Equity           <br/>           Incentive           <br/>           Plan Awards:           <br/>           Number of           <br/>           Unearned           <br/>           Shares,           <br/>           Units or           <br/>           Other           <br/>           Rights           <br/>           That           <br/>           Have Not           <br/>           Vested           <br/>           (#)          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">           Equity           <br/>           Incentive           <br/>           Plan Awards:           <br/>           Market or           <br/>           Payout           <br/>           Value of           <br/>           Unearned           <br/>           Shares,           <br/>           Units or           <br/>           Other           <br/>           Rights           <br/>           That           <br/>           Have Not           <br/>           Vested           <br/>           (#)          </td>          <td style="padding-bottom: 1.5pt">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="width: 10%; text-align: left">           Will Febbo          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 7%; text-align: right">           394,739          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 7%; text-align: right">           -          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 7%; text-align: right">           -          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">           $          </td>          <td style="width: 7%; text-align: right">           3.21          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 9%; text-align: center">           02/21/21          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 7%; text-align: right">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 7%; text-align: right">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 7%; text-align: right">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 7%; text-align: right">          </td>          <td style="width: 1%; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: left">           Steve Silvestro          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           105,993          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           -          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           -          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">           $          </td>          <td style="text-align: right">           7.51          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: center">           03/11/25          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           90,000          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: left">           Miriam Paramore          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           100,000          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           66,667          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           -          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">           $          </td>          <td style="text-align: right">           3.15          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: center">           07/27/22          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td>          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           63,558          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           -          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           -          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">           $          </td>          <td style="text-align: right">           7.51          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: center">           03/11/25          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         Director Compensation        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The table below summarizes all compensationof our directors as of December 31, 2020:       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">        <tbody>         <tr style="vertical-align: bottom">          <td style="border-bottom: Black 1.5pt solid; white-space: nowrap">           Name          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center">           Fees           <br/>           Earned           <br/>           or Paid           <br/>           in Cash           <br/>           ($)          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center">           Stock           <br/>           Awards           <br/>           ($)          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center">           Option           <br/>           Awards           <br/>           ($)          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center">           All Other           <br/>           Compensation           <br/>           ($)          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center">           Total           <br/>           ($)          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="width: 65%; text-align: left">           Gus D. Halas          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 4%; text-align: right">           80,000          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 4%; text-align: right">           100,026          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 4%; text-align: right">           -          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 4%; text-align: right">           -          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 4%; text-align: right">           180,026          </td>          <td style="width: 1%; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: left">           James Lang          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           40,000          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           100,026          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           -          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           -          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           140,026          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: left">           Patrick Spangler          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           45,000          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           100,026          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           -          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           -          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           145,026          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: left">           Lynn Vos          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           40,000          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           100,026          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           -          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           -          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           140,026          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: left">           Greg Wasson          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           20,000          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           50,019          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           -          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           -          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           70,019          </td>          <td style="text-align: left">          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <!-- Field: Page; Sequence: 66; Value: 27 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         37         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         Narrative Disclosure to the DirectorCompensation Table        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Pursuant to our Director Compensation Plan,independent directors (“Outside Directors”) received:       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        (a) an annual cash retainer for Board andCommittee service in 2020 as set forth in the table below, payable in equal quarterly installments, and       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        (b) reimbursement for expenses relatedto Board meeting attendance and any committee participation.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">        <tbody>         <tr style="vertical-align: bottom">          <td style="white-space: nowrap; text-align: justify">          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center">           Annual Fee           <br/>           ($)          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="width: 88%; text-align: justify">           Basic Director Fee          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 9%; text-align: right">           40,000          </td>          <td style="width: 1%; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: justify">           Board Chair          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           40,000          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: justify">           Audit Committee Chair          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           5,000          </td>          <td style="text-align: left">          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        In addition, Outside Directors also eachreceived $100,000 of Common Stock per year, payable in equal quarterly installments, which vested immediately upon issuance. Directorsthat are also employees of our company shall not receive additional compensation for serving on the Board. Both the cash retainerand stock awards are prorated for partial quarters of service when a new Director joins the Board.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Directors are expected to attend four meetingsper year as well as spend an additional 10 – 20 hours per month on company matters.        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         <a name="a_018">         </a>         Item 12. Security Ownership of CertainBeneficial Owners and Management and Related Stockholder Matters.        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         CERTAIN BENEFICIAL OWNERS        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        The following table sets forth thebeneficial ownership by each person, other than executive officers and directors, known to us to beneficially own 5% or moreof our outstanding common stock as of March 3, 2021. For the purposes of this Annual Report, beneficial ownershipof securities is defined in accordance with the rules of the SEC to mean generally the power to vote or dispose ofsecurities, regardless of any economic interest therein, including any such security that the person has the right to acquirewithin 60 days after such date.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">        <tbody>         <tr style="font-style: normal; vertical-align: bottom; font-weight: normal">          <td style="font-style: normal; border-bottom: Black 1.5pt solid; font-weight: normal">           More Than 5% Beneficial Owners:          </td>          <td style="font-style: normal; font-weight: normal; padding-bottom: 1.5pt">          </td>          <td style="font-style: normal; border-bottom: Black 1.5pt solid; font-weight: normal">           Name and Address          </td>          <td style="font-style: normal; font-weight: normal; padding-bottom: 1.5pt">          </td>          <td colspan="2" style="font-style: normal; border-bottom: Black 1.5pt solid; font-weight: normal; text-align: center">           Common           <br/>           Shares           <br/>           Owned          </td>          <td style="font-style: normal; padding-bottom: 1.5pt; font-weight: normal">          </td>          <td style="font-style: normal; font-weight: normal; padding-bottom: 1.5pt">          </td>          <td colspan="2" style="font-style: normal; border-bottom: Black 1.5pt solid; font-weight: normal; text-align: center">           Percentage           <br/>           of Class          </td>          <td style="font-style: normal; padding-bottom: 1.5pt; font-weight: normal">          </td>         </tr>         <tr style="vertical-align: bottom">          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td colspan="2" style="text-align: right">          </td>          <td>          </td>          <td>          </td>          <td colspan="2" style="text-align: right">          </td>          <td>          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: left; width: 38%; vertical-align: top">           Common          </td>          <td style="width: 1%">          </td>          <td style="width: 37%; text-align: left">           BlackRock, Inc.(1)           <br/>           55 East 52nd Street           <br/>           New York, NY 10055          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 9%; text-align: right">           978,200          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 9%; text-align: right">           5.8          </td>          <td style="width: 1%; text-align: left">           %          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: left; vertical-align: top">           Common          </td>          <td>          </td>          <td style="text-align: left">           Ronald L. Chez(2)           <br/>           55 East Monroe Street, Suite 3700           <br/>           Chicago, IL 60603          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           858,500          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           5.1          </td>          <td style="text-align: left">           %          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">        <tbody>         <tr style="vertical-align: top">          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            (1)           </font>          </td>          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            As stated in a Schedule 13G/A filed with the Securities and Exchange Commission on January 29, 2021.           </font>          </td>         </tr>         <tr style="vertical-align: top">          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            (2)           </font>          </td>          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            As stated in a Schedule 13D/A filed with the Securities and Exchange Commission on September 27, 2019.           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <!-- Field: Page; Sequence: 67; Value: 27 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         38         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">        <b>         SECURITY OWNERSHIP OF MANAGEMENT        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Set forth below is certaininformation with respect to beneficial ownership of our common stock as of March 3, 2021, by each director, eachnamed executive officer, and by the directors and all executive officers as a group. Unless otherwise indicated, each personor member of the group listed has sole voting and investment power with respect to the shares of common stock listed.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">        <tbody>         <tr style="vertical-align: bottom">          <td style="border-bottom: Black 1.5pt solid">           Name(1)          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">           Options Included           <br/>           in Beneficial           <br/>           Ownership (2)          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">           Restricted           <br/>           Stock           <br/>           Awards (3)          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">           Common           <br/>           Shares           <br/>           Owned          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">           Common Stock           <br/>           Beneficial           <br/>           Ownership          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td style="padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">           Percentage           <br/>           of Class          </td>          <td style="padding-bottom: 1.5pt">          </td>         </tr>         <tr style="vertical-align: bottom">          <td>          </td>          <td>          </td>          <td colspan="2" style="text-align: right">          </td>          <td>          </td>          <td>          </td>          <td colspan="2" style="text-align: right">          </td>          <td>          </td>          <td>          </td>          <td colspan="2" style="text-align: right">          </td>          <td>          </td>          <td>          </td>          <td colspan="2" style="text-align: right">          </td>          <td>          </td>          <td>          </td>          <td colspan="2" style="text-align: center">          </td>          <td>          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="width: 40%; text-align: left">           William J. Febbo          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 9%; text-align: right">           394,739          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 9%; text-align: right">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 9%; text-align: right">           293,278          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 9%; text-align: right">           688,017          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 9%; text-align: right">           4.0          </td>          <td style="width: 1%; text-align: left">           %          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: left">           Steve Silvestro          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           105,933          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           -          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           105,933          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           <font style="font: 10pt Times New Roman, Times, Serif">            *           </font>          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: left">           Miriam Paramore          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           163,558          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           24,079          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           187,637          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           1.1          </td>          <td style="text-align: left">           %          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: left">           Lynn Vos          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           -          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           31,944          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           31,944          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           <font style="font: 10pt Times New Roman, Times, Serif">            *           </font>          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: left">           Gus D. Halas          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           -          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           63,882          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           63,882          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           <font style="font: 10pt Times New Roman, Times, Serif">            *           </font>          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: left">           Patrick Spangler          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           -          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           21,389          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           21,389          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           <font style="font: 10pt Times New Roman, Times, Serif">            *           </font>          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: left">           James Lang          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           -          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           31,714          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           31,714          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           <font style="font: 10pt Times New Roman, Times, Serif">            *           </font>          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: left">           Greg Wasson          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           16,985          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           16,985          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           <font style="font: 10pt Times New Roman, Times, Serif">            *           </font>          </td>          <td style="text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">           All Executive Officers and Directors as a group (10 persons)          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           756,908          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           -          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           573,491          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           1,330,339          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">          </td>          <td style="text-align: right">           7.6          </td>          <td style="text-align: left">           %          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">        <tbody>         <tr style="vertical-align: top; text-align: justify">          <td style="width: 0in">          </td>          <td style="width: 0.25in; text-align: left">           <font style="font: 10pt Times New Roman, Times, Serif">            *           </font>          </td>          <td style="text-align: justify">           <font style="font: 10pt Times New Roman, Times, Serif">            Lessthan 1%           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -25.9pt">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">        <tbody>         <tr style="vertical-align: top; text-align: justify">          <td style="width: 0in">          </td>          <td style="width: 0.25in; text-align: left">           <font style="font: 10pt Times New Roman, Times, Serif">            (1)           </font>          </td>          <td style="text-align: justify">           <font style="font: 10pt Times New Roman, Times, Serif">            Theaddress of each person named in this table is c/o OptimizeRx Corp., 400 Water Street, Suite 200, Rochester, MI 48307.           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">        <tbody>         <tr style="vertical-align: top; text-align: justify">          <td style="width: 0in">          </td>          <td style="width: 0.25in; text-align: left">           <font style="font: 10pt Times New Roman, Times, Serif">            (2)           </font>          </td>          <td style="text-align: justify">           <font style="font: 10pt Times New Roman, Times, Serif">            This column lists shares that are                                                                                                                                              subject to options exercisable within sixty (60) days of March 3, 2021 and are included in common stock beneficial                                                                                                                                              ownership pursuant to Rule 13d-3(d)(1) of the Exchange Act.           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>         <a name="a_019">         </a>         Item 13. Certain Relationships and RelatedTransactions, and Director Independence        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Other than the transactions described underthe heading “Executive Compensation” (or with respect to which such information is omitted in accordance with SEC regulations),there have not been, and there is not currently proposed, any transaction or series of similar transactions to which we were orwill be a participant in which the amount involved exceeded or will exceed the lesser of $120,000 or one percent of the averageof our total assets at year-end for the last two completed fiscal years, and in which any director, executive officer, holder of5% or more of any class of our capital stock or any member of the immediate family of any of the foregoing persons had or willhave a direct or indirect material interest, other than compensation paid in the normal course of business to executive officers.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <!-- Field: Page; Sequence: 68; Value: 27 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         39         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <b>         <a name="a_020">         </a>         Item 14. Principal Accounting Fees and Services        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Below are tables of Audit Fees (amountsin US$) billed by our auditors in connection with the audit of the Company’s annual financial statements and review of thequarterly financial statements for the years indicated below: Our 2020 financial statements were audited by UHY LLP. Our 2019 financialstatements were audited by Marcum, LLP.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        UHY, LLP       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        <b>        </b>       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">        <tbody>         <tr style="vertical-align: bottom">          <td style="white-space: nowrap; border-bottom: Black 1.5pt solid; text-align: left">           Financial Statements for the Year Ended December 31          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>          <td colspan="2" style="white-space: nowrap; border-bottom: Black 1.5pt solid; text-align: center">           Audit Services          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center">           Audit Related           <br/>           Fees          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>          <td colspan="2" style="white-space: nowrap; border-bottom: Black 1.5pt solid; text-align: center">           Tax Fees          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>          <td colspan="2" style="white-space: nowrap; border-bottom: Black 1.5pt solid; text-align: center">           Other Fees          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="width: 52%; text-align: left">           2020          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">           $          </td>          <td style="width: 9%; text-align: right">           164,900          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">           $          </td>          <td style="width: 9%; text-align: right">           -          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">           $          </td>          <td style="width: 9%; text-align: right">           49,345          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">           $          </td>          <td style="width: 9%; text-align: right">           -          </td>          <td style="width: 1%; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: left">           2019          </td>          <td>          </td>          <td style="text-align: left">           $          </td>          <td style="text-align: right">           -          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">           $          </td>          <td style="text-align: right">           -          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">           $          </td>          <td style="text-align: right">           9,625          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">           $          </td>          <td style="text-align: right">           -          </td>          <td style="text-align: left">          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        Marcum, LLP       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">        <tbody>         <tr style="vertical-align: bottom">          <td style="white-space: nowrap; border-bottom: Black 1.5pt solid; text-align: left">           Financial Statements for the Year Ended December 31          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>          <td colspan="2" style="white-space: nowrap; border-bottom: Black 1.5pt solid; text-align: center">           Audit Services          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>          <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center">           Audit Related           <br/>           Fees          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>          <td colspan="2" style="white-space: nowrap; border-bottom: Black 1.5pt solid; text-align: center">           Tax Fees          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>          <td colspan="2" style="white-space: nowrap; border-bottom: Black 1.5pt solid; text-align: center">           Other Fees          </td>          <td style="white-space: nowrap; padding-bottom: 1.5pt">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="width: 52%; text-align: left">           2020          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">           $          </td>          <td style="width: 9%; text-align: right">           19,570          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">           $          </td>          <td style="width: 9%; text-align: right">           -          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">           $          </td>          <td style="width: 9%; text-align: right">           -          </td>          <td style="width: 1%; text-align: left">          </td>          <td style="width: 1%">          </td>          <td style="width: 1%; text-align: left">           $          </td>          <td style="width: 9%; text-align: right">           -          </td>          <td style="width: 1%; text-align: left">          </td>         </tr>         <tr style="vertical-align: bottom">          <td style="text-align: left">           2019          </td>          <td>          </td>          <td style="text-align: left">           $          </td>          <td style="text-align: right">           439,641          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">           $          </td>          <td style="text-align: right">           -          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">           $          </td>          <td style="text-align: right">           -          </td>          <td style="text-align: left">          </td>          <td>          </td>          <td style="text-align: left">           $          </td>          <td style="text-align: right">           -          </td>          <td style="text-align: left">          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <!-- Field: Page; Sequence: 69; Value: 27 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         40         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">        <b>         <u>          <a name="a_021">          </a>          PART IV         </u>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <b>         <a name="a_022">         </a>         Item 15. Exhibits, Financial Statements Schedules        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <b>        </b>       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">        <tbody>         <tr style="vertical-align: top">          <td style="width: 48px">          </td>          <td style="width: 24px">           <font style="font: 10pt Times New Roman, Times, Serif">            <i>             (a)            </i>           </font>          </td>          <td style="text-align: justify">           <font style="font: 10pt Times New Roman, Times, Serif">            <i>             Financial Statements and Schedules            </i>           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">        The following financial statements and schedules listedbelow are included in this Form 10-K.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">        Financial Statements (See Item 8)       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">        <i>        </i>       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">        <tbody>         <tr style="vertical-align: top">          <td style="width: 0px">          </td>          <td style="width: 48px">          </td>          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            <i>             (b)  Exhibits            </i>           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">        <tbody>         <tr style="background-color: white">          <td style="border-bottom: black 1.5pt solid; vertical-align: top; width: 8%">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Exhibit            <br/>            Number           </font>          </td>          <td style="width: 1%">          </td>          <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 91%; text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Description           </font>          </td>         </tr>         <tr style="background-color: white">          <td style="vertical-align: top">           <font style="font: 10pt Times New Roman, Times, Serif">            3.1           </font>          </td>          <td>          </td>          <td style="vertical-align: bottom; text-align: justify">           <a href="https://www.sec.gov/Archives/edgar/data/1448431/000136110608000414/optimizerx_s1-ex0301.htm">            <font style="font: 10pt Times New Roman, Times, Serif">             Articles of Incorporation of OptimizeRx Corporation (the “Company”)             <sup>              1             </sup>            </font>           </a>          </td>         </tr>         <tr style="background-color: white">          <td style="vertical-align: top">           <font style="font: 10pt Times New Roman, Times, Serif">            3.2           </font>          </td>          <td>          </td>          <td style="vertical-align: bottom; text-align: justify">           <a href="https://www.sec.gov/Archives/edgar/data/1448431/000125529410000605/ex3_1.htm">            <font style="font: 10pt Times New Roman, Times, Serif">             Amended and Restated Bylaws of the Company             <sup>              2             </sup>            </font>           </a>          </td>         </tr>         <tr style="background-color: white">          <td style="vertical-align: top">           <font style="font: 10pt Times New Roman, Times, Serif">            3.3           </font>          </td>          <td>          </td>          <td style="vertical-align: bottom; text-align: justify">           <a href="https://www.sec.gov/Archives/edgar/data/1448431/000121390019003962/f10k2018ex3-5_optimizerx.htm">            <font style="font: 10pt Times New Roman, Times, Serif">             Certificate of Correction, dated April 30, 2018             <sup>              3             </sup>            </font>           </a>          </td>         </tr>         <tr style="background-color: white">          <td style="vertical-align: top">           <font style="font: 10pt Times New Roman, Times, Serif">            10.1           </font>          </td>          <td>          </td>          <td style="vertical-align: bottom; text-align: justify">           <a href="https://www.sec.gov/Archives/edgar/data/1448431/000121390020006161/ea119535ex10-1_optimize.htm">            <font style="font: 10pt Times New Roman, Times, Serif">             Fourth Amended and Restated 2013 Equity Incentive Plan             <sup>              4             </sup>            </font>           </a>          </td>         </tr>         <tr style="background-color: white">          <td style="vertical-align: top">           <font style="font: 10pt Times New Roman, Times, Serif">            10.2           </font>          </td>          <td>          </td>          <td style="vertical-align: bottom; text-align: justify">           <a href="https://www.sec.gov/Archives/edgar/data/1448431/000121390020007491/f10k2019ex10-4_optimizerx.htm">            <font style="font: 10pt Times New Roman, Times, Serif">             Amendment to Employment Agreement with William Febbo, dated March, 10, 2020             <sup>              5             </sup>            </font>           </a>          </td>         </tr>         <tr style="background-color: white">          <td style="vertical-align: top">           <font style="font: 10pt Times New Roman, Times, Serif">            10.3           </font>          </td>          <td>          </td>          <td style="vertical-align: bottom; text-align: justify">           <a href="https://www.sec.gov/Archives/edgar/data/1448431/000121390020007491/f10k2019ex10-5_optimizerx.htm">            <font style="font: 10pt Times New Roman, Times, Serif">             Amendment to Employment Agreement with Stephen Silvestro, dated March, 10, 2020             <sup>              5             </sup>            </font>           </a>          </td>         </tr>         <tr style="background-color: white">          <td style="vertical-align: top">           <font style="font: 10pt Times New Roman, Times, Serif">            10.4           </font>          </td>          <td>          </td>          <td style="vertical-align: bottom; text-align: justify">           <a href="https://www.sec.gov/Archives/edgar/data/1448431/000121390020007491/f10k2019ex10-6_optimizerx.htm">            <font style="font: 10pt Times New Roman, Times, Serif">             Amendment to Employment Agreement with Miriam Paramore, dated March, 10, 2020             <sup>              5             </sup>            </font>           </a>          </td>         </tr>         <tr style="background-color: white">          <td style="vertical-align: top">           <font style="font: 10pt Times New Roman, Times, Serif">            10.5           </font>          </td>          <td>          </td>          <td style="vertical-align: bottom; text-align: justify">           <a href="https://www.sec.gov/Archives/edgar/data/1448431/000121390021008493/ea135275ex10-1_optimizerx.htm">            <font style="font: 10pt Times New Roman, Times, Serif">             Employment agreement with Marion Odence-Ford dated February 8, 2021             <sup>              6             </sup>            </font>           </a>          </td>         </tr>         <tr style="background-color: white">          <td style="vertical-align: top">           <font style="font: 10pt Times New Roman, Times, Serif">            14.1           </font>          </td>          <td>          </td>          <td style="vertical-align: bottom; text-align: justify">           <a href="https://www.sec.gov/Archives/edgar/data/1448431/000121390018002722/f10k2017ex14-1_optimizerx.htm">            <font style="font: 10pt Times New Roman, Times, Serif">             Code of Business Conduct and Ethics             <sup>              7             </sup>            </font>           </a>          </td>         </tr>         <tr style="background-color: white">          <td style="vertical-align: top">           <font style="font: 10pt Times New Roman, Times, Serif">            21.1**           </font>          </td>          <td>          </td>          <td style="vertical-align: bottom; text-align: justify">           <font style="font: 10pt Times New Roman, Times, Serif">            <a href="f10k2020ex21-1_optimizerx.htm" style="-sec-extract: exhibit">             List of Subsidiaries            </a>           </font>          </td>         </tr>         <tr style="background-color: white">          <td style="vertical-align: top">           <font style="font: 10pt Times New Roman, Times, Serif">            23.1**           </font>          </td>          <td>          </td>          <td style="vertical-align: bottom; text-align: justify">           <a href="f10k2020ex23-1_optimizerx.htm">            <font style="font: 10pt Times New Roman, Times, Serif">             Consent of Marcum LLP            </font>           </a>          </td>         </tr>         <tr style="background-color: white">          <td style="vertical-align: top">           <font style="font: 10pt Times New Roman, Times, Serif">            23.2**           </font>          </td>          <td>          </td>          <td style="vertical-align: bottom; text-align: justify">           <a href="f10k2020ex23-2_optimizerx.htm">            <font style="font: 10pt Times New Roman, Times, Serif">             Consent of UHY LLP            </font>           </a>          </td>         </tr>         <tr style="background-color: white">          <td style="vertical-align: top">           <font style="font: 10pt Times New Roman, Times, Serif">            31.1**           </font>          </td>          <td>          </td>          <td style="vertical-align: bottom; text-align: justify">           <font style="font: 10pt Times New Roman, Times, Serif">            <a href="f10k2020ex31-1_optimizerx.htm" style="-sec-extract: exhibit">             Certification of Chief Executive Officer pursuant to Securities Exchange Act Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002            </a>           </font>          </td>         </tr>         <tr style="background-color: white">          <td style="vertical-align: top">           <font style="font: 10pt Times New Roman, Times, Serif">            31.2**           </font>          </td>          <td>          </td>          <td style="vertical-align: bottom; text-align: justify">           <font style="font: 10pt Times New Roman, Times, Serif">            <a href="f10k2020ex31-2_optimizerx.htm" style="-sec-extract: exhibit">             Certification of Chief Financial Officer pursuant to Securities Exchange Act Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002            </a>           </font>          </td>         </tr>         <tr style="background-color: white">          <td style="vertical-align: top">           <font style="font: 10pt Times New Roman, Times, Serif">            32.1**           </font>          </td>          <td>          </td>          <td style="vertical-align: bottom; text-align: justify">           <font style="font: 10pt Times New Roman, Times, Serif">            <a href="f10k2020ex32-1_optimizerx.htm" style="-sec-extract: exhibit">             Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002            </a>           </font>          </td>         </tr>         <tr style="background-color: white">          <td style="vertical-align: top">           <font style="font: 10pt Times New Roman, Times, Serif">            101**           </font>          </td>          <td>          </td>          <td style="vertical-align: bottom; text-align: justify">           <font style="font: 10pt Times New Roman, Times, Serif">            The following materials from the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 formatted in Extensible Business Reporting Language (XBRL).           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">        <tbody>         <tr style="vertical-align: top; text-align: justify">          <td style="width: 0in">          </td>          <td style="width: 0.25in; text-align: left">           <font style="font: 10pt Times New Roman, Times, Serif">            <sup>             1            </sup>           </font>          </td>          <td style="text-align: justify">           <font style="font: 10pt Times New Roman, Times, Serif">            Incorporatedby reference to the Form S-1, filed by the Company with the Securities and Exchange Commission on November 12, 2008.           </font>          </td>         </tr>         <tr style="vertical-align: top; text-align: justify">          <td>          </td>          <td style="text-align: left">           <font style="font: 10pt Times New Roman, Times, Serif">            <sup>             2            </sup>           </font>          </td>          <td style="text-align: justify">           <font style="font: 10pt Times New Roman, Times, Serif">            Incorporatedby reference to the Form 8-K, filed by the Company with the Securities and Exchange Commission on July 16, 2010.           </font>          </td>         </tr>         <tr style="vertical-align: top; text-align: justify">          <td>          </td>          <td style="text-align: left">           <font style="font: 10pt Times New Roman, Times, Serif">            <sup>             3            </sup>           </font>          </td>          <td style="text-align: justify">           <font style="font: 10pt Times New Roman, Times, Serif">            Incorporatedby reference to the Form 10-K, filed by the Company with the Securities and Exchange Commission on March 12, 2019,           </font>          </td>         </tr>         <tr style="vertical-align: top; text-align: justify">          <td>          </td>          <td style="text-align: left">           <font style="font: 10pt Times New Roman, Times, Serif">            <sup>             4            </sup>           </font>          </td>          <td style="text-align: justify">           <font style="font: 10pt Times New Roman, Times, Serif">            Incorporatedby reference to the Form 8-K filed by the Company with the Securities and Exchange Commission on March 12, 2020.           </font>          </td>         </tr>         <tr style="vertical-align: top; text-align: justify">          <td>          </td>          <td style="text-align: left">           <font style="font: 10pt Times New Roman, Times, Serif">            <sup>             5            </sup>           </font>          </td>          <td style="text-align: justify">           <font style="font: 10pt Times New Roman, Times, Serif">            Incorporatedby reference to the Form 10-K, filed by the Company with the Securities and Exchange Commission on March 26, 2020.           </font>          </td>         </tr>         <tr style="vertical-align: top; text-align: justify">          <td style="width: 0in">          </td>          <td style="width: 0.25in; text-align: left">           <sup>            6           </sup>          </td>          <td style="text-align: justify">           Incorporated by reference to the Form 8-K, filed bythe Company with the Securities and Exchange Commission on February 11, 2021          </td>         </tr>         <tr style="vertical-align: top; text-align: justify">          <td style="width: 0in">          </td>          <td style="width: 0.25in; text-align: left">           <font style="font: 10pt Times New Roman, Times, Serif">            <sup>             7            </sup>           </font>          </td>          <td style="text-align: justify">           <font style="font: 10pt Times New Roman, Times, Serif">            Incorporatedby reference to the Form 10-K filed by the Company with the Securities and Exchange Commission on March 8, 2018.           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">        <tbody>         <tr style="vertical-align: top">          <td style="width: 0">          </td>          <td style="width: 0.25in; text-align: left">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            **           </font>          </td>          <td>           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            providedherewith           </font>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">        <b>        </b>       </p>       <!-- Field: Page; Sequence: 70; Value: 27 -->       <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">         <!-- Field: Sequence; Type: Arabic; Name: PageNo -->         41         <!-- Field: /Sequence -->        </p>       </div>       <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">        </p>       </div>       <!-- Field: /Page -->       <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">        <b>        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">        <b>         SIGNATURES        </b>       </p>       <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Pursuant to the requirements of Section13 or 15(d) of the Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,thereunto duly authorized.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">        <tbody>         <tr style="vertical-align: top">          <td colspan="2">           <font style="font: 10pt Times New Roman, Times, Serif">            <b>             OptimizeRx Corporation            </b>           </font>          </td>          <td>          </td>         </tr>         <tr style="vertical-align: top">          <td style="width: 5%">          </td>          <td style="width: 35%; text-align: justify">          </td>          <td style="width: 60%">          </td>         </tr>         <tr style="vertical-align: top">          <td style="text-align: justify">           <font style="font: 10pt Times New Roman, Times, Serif">            By:           </font>          </td>          <td style="border-bottom: black 1.5pt solid">           <font style="font: 10pt Times New Roman, Times, Serif">            /s/ William J. Febbo           </font>          </td>          <td>          </td>         </tr>         <tr style="vertical-align: top">          <td>          </td>          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            William Febbo           </font>          </td>          <td>          </td>         </tr>         <tr style="vertical-align: top">          <td>          </td>          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            Chief Executive Officer, Principal Executive Officer           </font>          </td>          <td>          </td>         </tr>         <tr style="vertical-align: top">          <td>          </td>          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            March 8, 2021           </font>          </td>          <td>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">        <tbody>         <tr style="vertical-align: top">          <td style="width: 5%">           <font style="font: 10pt Times New Roman, Times, Serif">            By:           </font>          </td>          <td style="border-bottom: black 1.5pt solid; width: 35%">           <font style="font: 10pt Times New Roman, Times, Serif">            /s/ Douglas P. Baker           </font>          </td>          <td style="width: 60%">          </td>         </tr>         <tr style="vertical-align: top">          <td>          </td>          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            Douglas P. Baker           </font>          </td>          <td>          </td>         </tr>         <tr style="vertical-align: top">          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            Title:           </font>          </td>          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer           </font>          </td>          <td>          </td>         </tr>         <tr style="vertical-align: top">          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            Date:           </font>          </td>          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            March 8, 2021           </font>          </td>          <td>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">        Pursuant to the requirements of the SecuritiesExchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacitiesand on the dates indicated.       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">        <tbody>         <tr style="vertical-align: top">          <td style="width: 5%">           <font style="font: 10pt Times New Roman, Times, Serif">            By:           </font>          </td>          <td style="border-bottom: black 1.5pt solid; width: 35%">           <font style="font: 10pt Times New Roman, Times, Serif">            /s/ William J. Febbo           </font>          </td>          <td style="width: 60%">          </td>         </tr>         <tr style="vertical-align: top">          <td>          </td>          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            William J. Febbo           </font>          </td>          <td>          </td>         </tr>         <tr style="vertical-align: top">          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            Title:           </font>          </td>          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            Chief Executive Officer, Principal Executive Officer and Director           </font>          </td>          <td>          </td>         </tr>         <tr style="vertical-align: top">          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            Date:           </font>          </td>          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            March 8, 2021           </font>          </td>          <td>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">        <tbody>         <tr style="vertical-align: top">          <td style="width: 5%">           <font style="font: 10pt Times New Roman, Times, Serif">            By:           </font>          </td>          <td style="border-bottom: black 1.5pt solid; width: 35%">           <font style="font: 10pt Times New Roman, Times, Serif">            /s/ James Lang           </font>          </td>          <td style="width: 60%">          </td>         </tr>         <tr style="vertical-align: top">          <td>          </td>          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            James Lang           </font>          </td>          <td>          </td>         </tr>         <tr style="vertical-align: top">          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            Title:           </font>          </td>          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            Director           </font>          </td>          <td>          </td>         </tr>         <tr style="vertical-align: top">          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            Date:           </font>          </td>          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            March 8, 2021           </font>          </td>          <td>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">        <tbody>         <tr style="vertical-align: top">          <td style="width: 5%">           <font style="font: 10pt Times New Roman, Times, Serif">            By:           </font>          </td>          <td style="border-bottom: black 1.5pt solid; width: 35%">           <font style="font: 10pt Times New Roman, Times, Serif">            /s/ Gus D. Halas           </font>          </td>          <td style="width: 60%">          </td>         </tr>         <tr style="vertical-align: top">          <td>          </td>          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            Gus D. Halas           </font>          </td>          <td>          </td>         </tr>         <tr style="vertical-align: top">          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            Title:           </font>          </td>          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            Chairman and Director           </font>          </td>          <td>          </td>         </tr>         <tr style="vertical-align: top">          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            Date:           </font>          </td>          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            March 8, 2021           </font>          </td>          <td>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">        <tbody>         <tr style="vertical-align: top">          <td style="width: 5%">           <font style="font: 10pt Times New Roman, Times, Serif">            By:           </font>          </td>          <td style="border-bottom: black 1.5pt solid; width: 35%">           <font style="font: 10pt Times New Roman, Times, Serif">            /s/ Patrick Spangler           </font>          </td>          <td style="width: 60%">          </td>         </tr>         <tr style="vertical-align: top">          <td>          </td>          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            Patrick Spangler           </font>          </td>          <td>          </td>         </tr>         <tr style="vertical-align: top">          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            Title:           </font>          </td>          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            Director           </font>          </td>          <td>          </td>         </tr>         <tr style="vertical-align: top">          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            Date:           </font>          </td>          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            March 8, 2021           </font>          </td>          <td>          </td>         </tr>         <tr style="vertical-align: top">          <td>          </td>          <td>          </td>          <td>          </td>         </tr>         <tr style="vertical-align: top">          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            By:           </font>          </td>          <td style="border-bottom: black 1.5pt solid">           <font style="font: 10pt Times New Roman, Times, Serif">            /s/ Lynn Vos           </font>          </td>          <td>          </td>         </tr>         <tr style="vertical-align: top">          <td>          </td>          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            Lynn Vos           </font>          </td>          <td>          </td>         </tr>         <tr style="vertical-align: top">          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            Title:           </font>          </td>          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            Director           </font>          </td>          <td>          </td>         </tr>         <tr style="vertical-align: top">          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            Date:           </font>          </td>          <td>           <font style="font: 10pt Times New Roman, Times, Serif">            March 8, 2021           </font>          </td>          <td>          </td>         </tr>         <tr style="vertical-align: top">          <td>          </td>          <td>          </td>          <td>          </td>         </tr>         <tr>          <td style="vertical-align: top">           <font style="font: 10pt Times New Roman, Times, Serif">            By:           </font>          </td>          <td style="border-bottom: black 1.5pt solid; vertical-align: top">           <font style="font: 10pt Times New Roman, Times, Serif">            /s/ Greg Wasson           </font>          </td>          <td>          </td>         </tr>         <tr>          <td style="vertical-align: top">          </td>          <td style="vertical-align: top">           <font style="font: 10pt Times New Roman, Times, Serif">            Greg Wasson           </font>          </td>          <td>          </td>         </tr>         <tr>          <td style="vertical-align: top">           <font style="font: 10pt Times New Roman, Times, Serif">            Title:           </font>          </td>          <td style="vertical-align: top">           <font style="font: 10pt Times New Roman, Times, Serif">            Director           </font>          </td>          <td>          </td>         </tr>         <tr>          <td style="vertical-align: top">           <font style="font: 10pt Times New Roman, Times, Serif">            Date:           </font>          </td>          <td style="vertical-align: top">           <font style="font: 10pt Times New Roman, Times, Serif">            March 8, 2021           </font>          </td>          <td>          </td>         </tr>        </tbody>       </table>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">        42       </p>       <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p>       <!-- Field: Rule-Page -->       <div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%">        <div style="border-top: Black 1.5pt solid; font-size: 1pt">        </div>       </div>       <!-- Field: /Rule-Page -->      </text>     </description>    </filename>   </sequence>  </type> </document></body>